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Abstract
The intervertebral disc is composed of concentrically arranged components: annulus fibrosus, the 
transition zone, and central nucleus pulposus. The major disc cell type differs in various parts of the 
intervertebral disc. In annulus fibrosus a spindle shape fibroblast like cell mainly dominates, 
whereas in central nucleus pulposus the more rounded chondrocyte-like disc cell is the major cell 
type.
 At birth the intervertebral disc is well vascularized, but during childhood and adolescence blood 
vessels become smaller and less numerous. The adult intervertebral disc is avascular and is 
nourished via the cartilage endplates. On the other hand, degenerated and prolapsed intervertebral 
discs are again vascularized, and show many changes compared to normal discs: Including, nerve 
ingrowth, change in collagen turnover, and change in water content. Furthermore, the prolapsed 
intervertebral disc tissue has a tendency to decrease in size over time. 
Growth factors are polypeptides which regulate cell growth, extracellular matrix protease activity, 
and vascularization. Oncoproteins c-Fos and c-Jun heterodimerize, forming the AP-1 transcription 
factor which is expressed in activated cells. 
In this thesis the differences of growth factor expression in normal intervertebral disc, the 
degenerated intervertebral disc and herniated intervertebral disc were analyzed. Growth factors of 
particular interest were basic fibroblast growth factor (bFGF, FGF-2), platelet-derived growth factor 
(PDGF), vascular endothelial growth factor (VEGF), and transforming growth factor beta (TGF ).
Cell activation was visualized by the expression of the AP-1 transcription promoters c-Fos and c-
Jun. The expression was shown with either mono- or polyclonal antibodies by indirect avidin-
biotin-peroxidase immunohistochemical staining method. The normal control material was 
collected from a tissue bank of five organ donors. The degenerated disc material was from twelve 
patients operated on for painful degenerative disc disease, and herniated disc tissue material was 
obtained from 115 patients operated on for sciatica.
Normal control discs showed only TGF  immunopositivity. All other factors studied were 
immunonegative in the control material. Prolapsed disc material was immunopositive for all factors 
studied, and this positivity was located either in the disc cells or in blood vessels. Furthermore, 
neovascularization was noted. Disc cell immunoreaction was shown in chondrocyte-like disc cells 
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or in fibroblast-like disc cells, the former being expressed especially in conglomerates (clusters of 
disc cells). TGF  receptor induction was prominent in prolapsed intervertebral disc tissue. 
In degenerated disc material, the expression of growth factors was analyzed in greater detail in 
various parts of the disc: nucleus pulposus, anterior annulus fibrosus and posterior annulus fibrosus. 
PDGF did not show any immunoreactivity, whereas all other studied growth factors were localized 
either in chondrocyte-like disc cells, often forming clusters, in fibroblast-like disc cells, or in small 
capillaries. Many of the studied degenerated discs showed tears in the posterior region of annulus 
fibrosus, but expression of immunopositive growth factors was detected throughout the entire disc. 
Furthermore, there was a difference in immunopositive cell types for different growth factors. 
The main conclusion of the thesis, supported by all substudies, is the occurrence of growth factors 
in disc cells. They may be actively participating in a network regulating disc cell growth, 
proliferation, extracellular matrix turnover, and neovascularization. Chondrocyte-like disc cells, in 
particular, expressed growth factors and oncoproteins, highlighting the importance of this cell type 
in the basic pathophysiologic events regarding disc degeneration and disc rearrangement. 
The thesis proposes a hypothesis for cellular remodelling in intervertebral disc tissue. In summary, 
the model presents an activation pattern of different growth factors at different intervertebral disc 
stages, mechanisms leading to neovascularization of the intervertebral disc in pathological 
conditions, and alteration of disc cell shape, especially in annulus fibrosus. Chondrocyte-like disc 
cells become more numerous, and these cells are capable of forming clusters, which appear to be 
regionally active within the disc.  The alteration of the phenotype of disc cells expressing growth 
factors from fibroblast-like disc cells to chondrocyte-like cells in annulus fibrosus, and the 
numerous expression of growth factor expressing disc cells in nucleus pulposus, may be a key 
element both during pathological degeneration of the intervertebral disc, and during the healing 
process after trauma.  
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1. List of original publications 
This thesis is based on the following publications: 
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fibroblast growth factor immunoreactivity in blood vessels and cells of disc 
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II Tolonen J, Grönblad M, Virri J, Seitsalo S, Rytömaa T, Karaharju E (1997) Platelet-
derived growth factor and vascular endothelial growth factor expression in disc 
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Transforming growth factor  receptor induction in herniated intervertebral disc 
tissue: an immunohistochemical study. Eur Spine J 10:172-176 
IV Tolonen J, Grönblad M, Virri J, Seitsalo S, Rytömaa T, Karaharju E (2002) 
Oncoprotein c-Fos and c-Jun immunopositive cells and cell clusters in herniated 
intervertebral disc tissue: an immunohistochemical study. Eur Spine J 11:452-458 
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(2006) Growth factor expression in degenerated intervertebral disc tissue. 
 An immunohistochemical analysis of extracellular matrix turnover regulators 
 transforming growth factor , fibroblast growth factor and platelet-derived 
 growth factor. Eur Spine J 15:588-596 
The above publications will be referred to in the text by their Roman numerals. 
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2. Abbreviations 
ABC Avidin-biotin-peroxidase complex 
AF Annulus fibrosus 
FGF Fibroblast growth factor 
FGFR Fibroblast growth factor receptor 
aFGF Acidic fibroblast growth factor (=FGF-1) 
AP-1 Activating protein 1 
bFGF Basic fibroblast growth factor (=FGF-2) 
BMP Bone morphogenetic protein 
c-fos oncogene c-fos
c-Fos Oncoprotein c-Fos 
CI confidence interval 
c-jun oncogene c-jun
c-Jun Oncoprotein c-Jun 
CML n-carboxymethyllysine 
DAB Peroxidase substrate solution 
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DN Normal intervertebral disc tissue 
DHT Herniated intervertebral disc tissue 
ECM  Extracellular matrix 
EGF  Epidermal growth factor 
EGF-R Epidermal growth factor receptor 
EGP Epiphyseal growth plate 
H2O2 Hydrogen peroxide 
IFN-  Interferon gamma 
IGF-1  Insulin-like growth factor –1 
IL-1 Interleukin 1 
kD Kilo-Dalton 
LAP Latency associated peptide 
LTBP1 Latent TGFß binding protein-1 
mAb Monoclonal antibody 
MAPK Membrane activated protein kinase 
MMP Matrix metalloproteinase 
MRI Magnetic resonance imaging 
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mRNA Messenger RNA 
NGF Nerve growth factor 
NP Nucleus pulposus 
OA Osteoarthritis 
PBS Phosphate-buffered saline solution 
PCNA Proliferating cell nuclear antigen 
PDGF Platelet-derived growth factor 
pAb Polyclonal antibody 
RA Rheumatoid arthritis 
r.t Room temperature 
RT-PCR Reverse transcriptase polymerase chain reaction 
TGF  Transforming growth factor 
TIMP-1  Tissue inhibitor of matrix metalloproteinase-1 
TNF-  Tumour necrosis factor alpha 
VEGF Vascular endothelial growth factor (=VPF/vascular permeability factor) 
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3. Review of the literature
Intervertebral discs stabilize the spine by anchoring adjacent vertebral bodies to each other. They 
absorb and distribute the gravitational loads applied to the spine and, at the same time, give 
flexibility allowing the movement between the vertebral bodies. Like other connective tissues, the 
intervertebral discs are composed of different cell types surrounded by the extracellular matrix 
components and water.  The mechanical properties of the disc depend on the extracellular 
macromolecules and their interaction with water. 
The intervertebral disc is composed of four concentrically arranged components (Buckwalter 1982): 
1) the outer annulus fibrosus, a ring of highly oriented densely packed collagen fibrils, 2) the 
fibrocartilaginous inner annulus fibrosus, 3) the transition zone, a thin zone between annulus 
fibrosus and nucleus pulposus, and 4) the central nucleus pulposus. Vertebral endplates, composed 
of hyaline cartilage, form the superior and inferior boundaries from the intervertebral disc to the 
adjacent vertebral bodies. 
The outer annulus fibrosus contains fibroblast-like or fibrocyte-like cells, whereas the inner annulus 
and the transition zone contain more chondrocyte-like cells (Buckwalter 1982). The nucleus 
pulposus initially contains primarily notochordal cells, but in early adulthood they disappear leaving 
only chondrocyte-like cells (Buckwalter 1982, Troutt et al.1982a and b). 
Collagens and proteoglycans are the primary structural components of the extracellular matrix in 
intervertebral disc tissue (Eyre et al. 1989). Proteoglycans interacting with water give stiffness to 
the tissue, and resilience to compression, while collagens give the tensile strength. In the outer 
annulus fibrosus of young people, collagens account for 70% of the dry weight, whereas in the 
nucleus pulposus they account for only 20%. In contrast, proteoglycans account for only a few 
percent of the dry weight in the outer annulus, but 50% in the nucleus pulposus. The type of 
collagen also varies in different parts of the intervertebral disc. The outer annulus fibrosus consists 
almost entirely of type I collagen (80%) and only of small amounts of type V collagen (3%) 
(Buckwalter 1995). Inside the outer annulus fibrosus the amount of type II collagen increases 
11
toward the centre reaching 80% in the nucleus pulposus, where type I collagen is entirely absent. 
The nucleus pulposus contains small amounts (3%) of type XI collagen, and both the nucleus 
pulposus and the annulus fibrosus less than 2% type IX collagen. Type VI fine collagen filaments 
account for 10% in the nucleus pulposus and 15 % in the annulus fibrosus. 
Throughout the disc tissue also exists a variety of noncollagenous proteins and small amounts of 
elastin (Buckwalter 1982, Eyre et al. 1989). 
3.1 Disc growth 
In general, it is very difficult to see the difference between ”normal aging” and ”pathological” 
degeneration.   Simplifying, the intervertebral disc behaves in a genome-coded manner. This means, 
that the development and growth processes are mainly primarily similar to those seen in response to 
traumatic tears, or degeneration.  Indeed, it is easier to understand pathological responses by first 
viewing normal growth and aging. 
In fetal discs the number of lamellar bundles is higher in the anterior annulus than in the posterior 
annulus (Tsuji et al. 1993). The posterior middle annulus has a very complex structure, with a high 
percentage of incomplete/discontinuous lamellar bundles and larger fibre-interlacing angles. 
Furthermore, a loose connection of the lamellar bundles of posterior outer annulus was observed in 
fetal discs.  
Chondromodulin-I (an antiangiogenic factor) is highly expressed during the gestational period and 
decreases after maturation (Takao et al. 2000). It is detected in both extracellular matrix and 
chondrocytes in the zone of hypertrophic cartilage, the zone of proliferative cartilage and the zone 
of resting cartilage in fetal discs. It is also present in annulus fibrosus, nucleus pulposus, and end-
plate cartilage in mature discs. In degenerative discs, chondromodulin-1 expression tended to be 
elevated in the remaining chondrocytes.  
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At birth the disc tissue is separated from the vertebral bodies by hyaline cartilage endplates 
(Buckwalter 1995).  Small blood vessels could be detected especially in the posterolateral regions 
of the disc, occasionally penetrating the inner annulus fibrosus. Nucleus pulposus composes nearly 
half of the disc and consists of soft gelatinous matrix and clusters of notochordal cells (Troutt et al. 
1982a). Collagen fibrils have a nearly uniform small diameter. Furthermore, annular proteoglycan 
aggregates from newborn and infants have the same structure as hyaline cartilage. In nucleus 
pulposus only 1/3 resemble the large aggregates, the remaining 2/3 consist of aggrecan clusters 
lacking a visible central hyaluronate filament (Buckwalter 1985). 
During childhood and adolescence disc volume markedly increases, and at the same time blood 
vessels become smaller and less numerous. At this time nucleus pulposus still composes nearly half 
of the total disc, but the fibrocartilaginous annulus fibrosus increases in size with time (Buckwalter 
1995). In nucleus pulposus the number of notochordal cells decreases, and chondrocyte-like cells 
appear in this area (Troutt et al. 1982b). The mean diameter and the variability in diameter of 
collagen fibrils increase. At the same time the proteoglycan aggrecan size decreases, and large 
proteoglycan aggregates similar to that in articular cartilage disappear (Buckwalter et al. 1985, 
Pearce 1993). Clusters of short aggrecan molecules and no aggregated proteoglycans almost 
entirely create the proteoglycan population in the nucleus pulposus. 
In adult life many of the remaining peripheral blood vessels disappear. The size of the outer annulus 
fibrosus remains the same, but the fibrocartilaginous inner annulus expands at the expense of the 
nucleus pulposus (Buckwalter 1995). In annulus fibrosus normal collagen fibril organization is lost, 
creating fissures and cracks. Nucleus pulposus changes from soft, translucent tissue to firm white 
tissue, and concentration and diameter of collagen fibrils increase. The number of viable cells 
decreases, especially in the most central regions of the disc (Troutt et al. 1982a and b). At this time 
nucleus pulposus consists almost entirely of chondrocyte-like cells (Troutt et al.  1982b) and at the 
same time the water content and the amount of proteoglycans decrease (Urban and McMullin 
1988), and noncollagenous protein components increase (Dickson et al. 1967). Dense granular 
material accumulates in matrix tissue especially in regions immediately surrounding the cells 
(Troutt et al. 1982a and b). 
Taken together, after skeletal maturity, age related changes in intervertebral disc tissue appear to 
decrease the structural integrity thereby increasing the probability of disc herniation (Andersson 
1993).
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In the elderly, the entire disc inside the outer annulus fibrosus becomes a stiff fibrocartilaginous 
plate (Buckwalter 1995). The disc loses its height, and the nucleus pulposus region becomes smaller 
in diameter, with less densely and less organized packed collagen fibrils, and few remaining viable 
cells. The spine loses mobility, and degeneration of facet joints and spinal stenosis may develop 
(Andersson 1993). 
Development stages of the intervertebral disc is complex, involving several different connective 
tissue types, yet little is known of the developing extracellular matrix (ECM). The earliest collagen 
detected is type III, which is subsequently replaced by type II in the cartilaginous inner annulus and 
joined by type I in the fibrous outer annulus (Hayes et al. 2001). In the outer annulus type IV 
collagen appears, associated with myofibroblast-like cells of the orienting collagenous lamellae. In 
later stages extracellular matrix proteins laminin and fibronectin co-distribute here, although overall 
they have a wider distribution. Another extracellular matrix protein aggrecan occurs in the early 
nucleus pulposus and then appears in the inner annulus, in association with cartilage differentiation. 
Extracellular matrix protein versican appears later in the inner annulus, and also in the dorsal region 
of the outer annulus. Comparisons of glycosaminoglycan and proteoglycan label allowed 
extrapolations to be made as to likely glycosaminoglycan components of the large proteoglycans, 
and of other proteoglycans that may be present. Thus, differential distribution of aggrecan and 
keratan sulphate label suggested the presence of fibromodulin and/or lumican. Functionally 
aggrecan would confer compression resistance to cartilaginous structures (Hayes et al. 2001).
Type I collagen is seen in normal annulus fibrosus and in degeneratively altered nucleus pulposus, 
but not within the endplate, regardless of degenerative changes (Freemont et al. 1998). Type II and 
IX collagens occur in normal nucleus pulposus, inner annulus fibrosus and the end-plate. The type 
II and IX collagen expression seems to be enhanced in areas of minor degenerative lesions, but 
reduces in advanced lesions and in the degenerated endplate. Type III and VI collagens are 
significantly increased in areas of minor to advanced degeneration in all anatomical settings, while 
type V collagen showed only minor changes in its expression pattern.   
Furthermore, type I collagen is seen abundantly in the outer zone and outer lamellas of the inner 
zone of the annulus fibrosus (Schollmeyer et al. 2000). In longitudinal sections, type I collagen 
distribution takes the shape of a wedge. In horizontal sections, its positive area takes the shape of a 
ring that is wider anteriorly than posteriorly. This suggests that the three-dimensional shape of the 
type I collagen-positive tissue in annulus fibrosus can be described as a doughnut that is wider 
anteriorly than posteriorly. Schollmeyr et al showed that type II collagen was present in the entire 
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inner area of the annulus fibrosus, but not in the outer zone. In addition, type II collagen was found 
in the cartilaginous endplates. Type III collagen showed some codistribution with type II collagen, 
particularly in pericellular locations in areas of spondylosis, at the endplates, vertebral rim, and 
insertion sites of annulus fibrosus (Schollmeyer  et al. 2000). 
There appears to be no distinct border between central nucleus pulposus and inner annulus fibrosus, 
the main difference being in their fibrous structure (Humzah and Soames 1988). Fluid space is 
important in nutrition of the disc, showing plastic deformation, and recovery characteristics. 
Humzah and Soames have stated that the structural elements, both macroscopically and 
microscopically, together with  biochemical elements, are intimately related to function. The 
intervertebral disc should not be thought of as a homogeneous and static structure. It has a 
heterogeneous composition and responds dynamically to applied loads. Neither should it be 
considered an isolated structure because it interacts with vertebral bodies, together constituting the 
vertebral unit. Furthermore, changes within the disc can, and do, have dramatic effects on vertebral 
column kinematics. The intervertebral disc is not inactive, but is capable of self-maintenance. In 
injury it can repair itself and has considerable regenerative properties (Humzah and Soames 1988).  
Synthesis in intervertebral discs, measured as the content of types I and II procollagen markers, is 
highest in the neonatal and 2-5-yr age groups (Antoniou et al. 1996). Antoniou and co-workers have 
showed that the contents of these epitopes/molecules progressively diminished with increasing age. 
In the oldest age group (60-80 yr) and in highly degenerated discs, however, type I procollagen 
epitope level increased significantly. The percentage of denatured type II collagen, assessed by the 
presence of an epitope that is exposed with cleavage of type II collagen, increased two-fold from 
the neonatal discs to the discs of young 2-5 yr age group. Thereafter, the percentage progressively 
decreased with increasing age, however, it still increased significantly in the oldest group and in 
highly degenerated discs. Three matrix turnover phases have been identified. Phase I (growth) is 
characterized by active synthesis of matrix molecules and active denaturation of type II collagen. 
Phase II (maturation and ageing) is distinguished by a progressive drop in synthesis activity and a 
progressive reduction in denaturation of type II collagen. Phase III (degeneration and fibrotic) is 
characterized  by evidence of a lack of increased synthesis of aggrecan and type II procollagen, but 
also by an increase in collagen type II denaturation and type I procollagen synthesis, both dependent 
on age and grade of tissue degeneration (Antoniou et al. 1996).
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Age-related changes have been classified by Boos et al. (2002)  A diminished blood supply of the 
end-plate has been demonstrated, resulting in tissue breakdown beginning in nucleus pulposus and 
starting in the second life decade. Specific markers for disc alterations with age have been noted, 
allowing better correlation with disc function. Perhaps the best marker for ongoing age-related 
changes is the deposition of n-carboxymethyllysine (CML), a biomarker for oxidative stress 
(Nerlich et al. 1997).  This is first observed after age 10 in nucleus pulposus, and increases 
significantly with age. In the elderly, both annulus fibrosus and nucleus pulposus show extensive 
CML deposition. Furthermore, Nerlich and co-workers detected that the nuclear collagen pattern 
was changed after the occurrence of CML in nucleus pulposus. First, collagen types II, III and VI 
were raised, followed by a decrease in type II, the occurrence of type I, and at the same time 
persistence of high levels of types III and VI. Finally, types III and VI decreased again. Nucleus 
pulposus cells of adolescents and young adults stained exclusively for collagen type IV. At a higher 
age with advanced degenerative changes collagen type X was expressed by these same cells. 
3.2 Disc degeneration 
Two major morphological features occur during aging and degeneration of the intervertebral disc:  
1. nucleus pulposus decreases in volume, 2. the nucleus becomes histologically less distinguishable 
from annulus fibrosus. (Brown 1971, Hirsch and Schajowicz 1953, Donohue 1939) 
From age 30 the cell type in the nucleus pulposus changes (Pritzher 1977). In addition to the former 
fibrocyte-like cell  two new cell types appear . First, groups of large chondroid cells, chondrocyte-
like cells appear in increasing numbers. Second, groups of small chondroid cells (minichondrons) 
are seen, but only in association with microfracture of the cartilage endplate. In annulus fibrosus, 
cells appear as mature fibrocytes, oriented in the direction of surrounding collagen fibres. With 
aging the cells near the innermost annular fibres appear identical to the adjacent giant chondrons of 
the nucleus pulposus (Pritzher 1977). 
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Potential causes of the age-related degeneration of intervertebral discs include declining nutrition, 
loss of viable cells, cell senescence, post-translational modification of matrix proteins, accumulation 
of degraded matrix molecules, and fatigue induced failure of matrix tissue (Buckwalter 1995). The 
most important of these mechanisms appears to be decreasing nutrition of the central disc that 
allows for accumulation of cell waste products and degraded matrix molecules, impairing cell 
nutrition, and causing a fall in pH levels that further compromises cell function and may cause cell 
death.
hydrodynamic size and had a higher glucosamine to galactosamine ratio (Lyons et al. 1981). It has 
been  suggested that a large proportion of proteoglycans from normal disc have undergone a degree 
of degradation in the hyaluronate binding region and that proteoglycan synthesis in this tissue is 
slower than in degenerate tissue. 
By interacting with cell surface integrins fibronectin helps to organize the extracellular matrix and 
provides environmental cues. In other tissues, its synthesis is elevated in response to injury. 
Fibronectin fragments can stimulate cells to produce metalloproteases and cytokines and inhibit 
matrix synthesis. Fibronectin is elevated in degenerated discs and frequently present as fragments 
(Oegema et al. 2000). Elevated levels of fibronectin suggest that disc cells are responding to the 
altered environment. Fibronectin fragments resulting from normal or enhanced proteolytic activity 
could be a mechanism that induces the cell to further degrade matrix tissue.  
The rate of collagen biosynthesis in degenerated human annulus fibrosus has also been estimated 
(Kääpä et al. 2000). The turnover of collagen was found to be faster compared to normal annulus 
fibrosus. However, this process did not seem to cause any significant changes to its mature 
pyridinium crosslink concentrations. 
Endplate injury has been reported to be strongly associated with disc degeneration (Kerttula et al. 
2000). In this study no correlation was, however, seen between previous vertebral fracture and back 
pain.
An animal model was developed to test the hypothesis that discrete peripheral tears within the 
annulus lead to secondary degenerative changes in other disc components (Osti et al. 1990). 
Although the outermost annulus showed ability to heal, the defect induced by the cut initially led to 
deformation and bulging of the collagen bundles, eventually to inner extension of the tear and 
finally to complete failure. These findings suggest that discrete tears of the outer annulus may have 
In 1981 Lyons and co-workers showed that degenerate disc proteoglycans were of larger average 
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a role in the formation of concentric clefts and in accelerating the development of radial clefts. 
Peripheral tears of  annulus fibrosus therefore, may play an important role in the degeneration of the 
intervertebral joint complex (Osti et al. 1990).  
The tenascins are a family of extracellular matrix proteins with repeated structural domains 
homologous to epidermal growth factor, fibronectin type III and fibrinogens. In young discs, 
tenascin was by Gruber et al found to be localized throughout the annulus. In the nucleus, 
localization was confined to pericellular matrix (Gruber et al. 2002). In normal adult and 
degenerating disc specimens, tenascin in the annulus was localized primarily in pericellular matrix 
regions encircling either single cells or clusters of disc cells. In rare instances localization was more 
diffuse in the intraterritorial matrix. 
In an experimental model of disc degeneration metaplasia into fibrocartilage originating from the 
cells along the margins of the annular wound, showed that proliferation of cells change almost the 
entire disc space into fibrocartilage (Lipson and Muir 1981). A vertebral osteophyte occurred 
through an endochondral ossification sequence. Aggregating proteoglycans had two periods of 
repletion in the early course of degeneration. The water content of the disc was rapidly but only 
transiently restored in the first two days after herniation, and the changes in the total proteoglycan 
content of the disc paralleled these changes. Hyaluronic acid content decreased rapidly after 
herniation, but the size of the proteoglycan monomers did not change with degeneration. It was 
suggested that loss of confined fluid mechanics signals an abortive repair attempt rather than that of 
biochemical changes in proteoglycans which initiate disc degeneration (Lipson and Muir 1981).
Nerve ingrowth has been observed in degenerated intervertebral discs (Freemont et al. 1997). In the 
healthy back only the outer third of annulus fibrosus of the intervertebral disc is innervated. 
Observation of isolated nerve fibres that express substance P deep within diseased intervertebral 
discs and their association with pain suggests an important role for nerve growth into the 
intervertebral disc in the pathogenesis of chronic lower back pain.
A field of its own in intervertebral disc degeneration is the regulation of the extracellular matrix by 
proteinases. A correlation is found between increasing levels of matrix metalloproteinase 2 and 9 
and the grade of degenerative disc disease. In addition, the levels of these enzymes show a 
differential expression across the scoliotic disc with the highest levels in samples taken from the 
convexity of the curve (Crean et al. 1997). The difference between the concave and convex side of 
the scoliotic curve indicates that mechanical loads might influence the expression of these enzymes. 
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The increased expression of these enzymes in both degenerative disc disease and scoliosis strongly 
suggests that they may affect the progressive nature of these diseases. 
Healthy human intervertebral discs contain relatively few cells and these are sparsely distributed. A 
characteristic feature of disc degeneration, however, is the appearance of cell clusters, particularly 
in damaged areas. How these clusters form is currently unknown. Excised pathological human discs 
have been investigated for evidence of cell proliferation (Johnson et al. 2001). In this study disc 
sections were immunostained for the proliferating cell nuclear antigen (PCNA) and the 
proliferation-associated Ki-67 antigen. PCNA immunopositive cells occured  within degenerated 
discs, commonly though not exclusively, in cell clusters. Cells immunopositive for the Ki-67 
antigen were less prevalent than those for PCNA, but similarly, were frequently observed within 
clusters in degenerated discs. In contrast, immunopositivity for these markers was not common in 
less degenerate discs or in areas of the disc where cell clusters did not occur. These observations 
suggest that disc cell proliferation is associated with disc degeneration (Johnson et al.  2001).  
Chondrocyte markers have been compared in normal and degenerated human intervertebral discs 
(Sive et al. 2002). Chondrocyte markers SOX9 and type II collagen expression occurred in a similar 
pattern in normal and degenerated discs, in nucleus pulposus cells, and was absent or weak in 
annulus fibrosus cells. In addition, aggrecan was expressed strongly in normal nucleus pulposus, 
and not in normal annulus fibrosus. In degenerated discs aggrecan was absent in both these areas of 
the disc. 
To help evaluate the degree of degeneration on MRI scans a classification method has been 
developed in which the degree of degeneration is divided into five categories (Pfirrmann et al. 
2001).  The benefit of this method is good reproducibility and reliability. 
Genetic links for degenerative disc disease have also been observed (Annunen et al. 1999). In the 
COL9A2 gene, which codes for one of the polypeptide chains of collagen type IX a putative 
disease-causing sequence variation converting a codon for glutamine to one of tryptophan has been 
identified. The logarithm of the odds ratio score was 4.5, and subsequent linkage disequilibrium 
analysis conditional on linkage, gave an additional logarithm odds ratio score of 7.1. 
In a large population based study (Jim et al. 2005) especially the Trp2 allele of COL9A2 gene is a 
significant risk factor for disc degeneration. The association was age-dependent and the risk was 
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especially high (4-fold) at age 30-39. In addition, the Trp2 allele was also associated with more 
severe degeneration. 
Furthermore, mutations of type IX collagen may cause certain forms of degenerative disease in the 
spine as well as in joints (Kimura et al. 1996).  
In genetic studies, subjects with shorter variable numbers of tandem repeat length of the aggrecan 
gene have a risk of developing multilevel disc degeneration at an early age (Kawaguchi et al. 1999).  
Two intragenic polymorphisms of the vitamin D receptor gene revealed an association with disc 
degeneration (Videman et al. 1998). The specific vitamin D receptor alleles associated with 
intervertebral disc degeneration as measured by T2-weighted signal intensity in MRI. 
Experimental attempts to delay the degeneration process have been undertaken, including trying 
reinsertion of autogenous nucleus pulposus (Okuma et al. 2000). The direct reinsertion of activated 
nucleus pulposus cells into the disc offers a promising line of investigation for delaying 
intervertebral disc degeneration. However, these results obtained with notochordal cells may not 
necessarily apply when using mature central nucleus pulposus cells (Okuma et al 2000).   
Discs receiving an intact nucleus pulposus showed least degeneration, followed by discs receiving 
nucleus pulposus cells, both of which were better than no treatment. These findings correlated 
directly with the intensity of immunohistochemical staining for type II collagen. Allogenic grafts 
did not induce any appreciable host-versus-graft response. Injection of nucleus pulposus and 
nucleus pulposus cells retarded intervertebral disc degeneration. Injection of intact nucleus pulposus 
was, however, more effective than injection of nucleus pulposus cells alone (Nomura et al. 2001).   
3.3 Disc herniation 
The histological difference between degenerated and herniated discs is small. Basically, the same 
kind of cellular response is seen in both pathological states. Avascularity is essential in the normal 
intact adult intervertebral disc. After disc herniation, of particular importance is the contact of 
herniated disc with surrounding tissues, producing inflammatory responses, neovascularization and 
tissue degradative responses. Disc herniation can be divided into subgroups (Spengler et al. 1990): 
Protrusion, in which annulus fibrosus bulges but remains continuous and its periphery remains 
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attached to the vertebral body bony rim; Extrusion, in which intervertebral disc herniates through 
the posterior longitudinal ligament into the epidural space, however, continuity occurs with the 
remaining disc;  Sequestration, in which one or several separate disc fragments occur in the epidural 
space.
Disc herniation can also be classified differently. In contained disc herniation the herniated disc 
material remains inside the posterior longitudinal ligament. In non-contained herniation this 
ligament is broken and the disc material has penetrated through it. 
Disc herniation tissue contains vascular ingrowth, promoting granulation tissue formation (Doita et 
al. 1996; Hirabayashi et al. 1990; Hirsch 1957; Leao 1960; Lindblom and Hultqvist 1950; Weidner 
and Rice 1988; Yasuma et al. 1993). Inflammation, either from direct chemical irritation (Marshall 
et al. 1977; McCarron et al. 1987; Saal et al. 1990), or secondary to an autoimmune response to the 
nucleus pulposus (Bobechko and Hirsch 1965; Elves et al. 1975; Gertzbein et al. 1975; Gertzbein
1977; Naylor et al. 1975; Pennington et al. 1988; Woertgen et al. 2000), is  suggested to be involved 
in this granulation tissue formation. Furthermore, it is suggested that if the nucleus pulposus portion 
of the herniated mass perforates the posterior longitudinal ligament, it may be subject to a stronger 
neovascularization reaction (Ozaki et al. 1999). In addition, at the stage when the posterior 
longitudinal ligament is still intact, these vessels are observed to have difficulty reaching the inner 
disc portion. 
The prolapsed disc tissue tends to diminish in size with time (Maigne et al. 1992; Saal et al. 1990). 
Furthermore, proteolytic activity has been demonstrated in herniated intervertebral discs (Ng et al. 
1986). It is also suggested that there are enhanced apoptotic events (Ahsan et al. 2001), possibly 
caused by oxygen stress. In addition, inflammatory processes have been discussed (Goupille et al. 
1998; Guiot and Fessler 2000; Hicks et al. 2002; Lipets 2002). 
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3.4 Fibroblast growth factor superfamily (FGF) 
The fibroblast growth factors (FGFs) constitute a family of several structurally related polypeptides 
(Jave et al. 1986; Abraham et al. 1986; Dickson and Peters 1987; Taira et al. 1987; DelliPovi et al. 
1987; Zhan et al. 1988; Marics et al. 1989; Finch et al. 1989). Primarily the family consists of two 
closely related isoforms (basic and acidic FGF: bFGF and aFGF) which were identified as 
embryonic inducers (Slack et al. 1987; Kimmelman and Kirschner 1987; Knochel and Tiedemann 
1989).They share common receptors (Neufeld  and Gospodarowicz 1986), and have similar effects 
on a wide variety of tissues. 
Fibroblast growth factors (FGF) were first isolated from bovine pituitary gland (Gospodarowicz et 
al. 1975) and soon after from bovine brain (Westall et al. 1978). To date the FGF family consists of 
22 members (Dailey et al. 2005). FGF signals through a single-pass transmembrane receptor with 
tyrosine kinase activity. FGF/FGF-receptor binding and dimerization requires the presence of 
heparin/heparin sulphate proteoglycans (Mohammadi et al. 2005) 
Angiogenesis is one of the most important effects induced by FGF (Gospodarowicz et al. 1977). It 
induces capillary endothelial cells to invade extracellular matrices and form capillaries, the 
development of which is proportional to the amount of FGF present (Mignatti et al. 1986). Repeated 
application of FGF to a rat cell culture produces increased formation of granulation tissue (Buntrock 
et al. 1982). Increase in angiogenesis seems to suggest that in the studied in vivo model FGF proves 
to be, first of all, a factor of angiogenesis rather than a factor of fibroblast growth (Buntrock et al. 
1982).
Both local and systemic FGF-1 (former acidic FGF) increase new bone formation and bone density. 
Systemic FGF-1 also appears to restore bone microarchitecture and prevent bone loss associated 
with oestrogen-withdrawal (Hamada et al. 1999). 
Fibroblast growth factor has been highlighted in chondrocytes and chondrogenesis. Expression of 
Fgf-18 gene by adenovirus-mediated gene transfer in murine pinnae resulted in a significant 
increase in chondrocyte number. Furthermore, the addition of FGF-18 to the culture media of 
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primary articular chondrocytes increased the proliferation of these cells and increased their 
production of extracellular matrix (Ellsworth et al.  2002). 
Fgf-18 gene is expressed in and required for osteogenesis and chondrogenesis in mouse embryos 
(Ohbayashi et al. 2002). It appears to regulate cell proliferation and differentiation positively in 
osteogenesis and negatively in chondrogenesis.
Indeed, mice lacking Fgf-18 display delayed ossification and decrease expression of osteogenic 
markers, phenotypes not seen in mice lacking Fgfr-3. These data demonstrate that FGF-18 signals 
through another FGF-receptor (FGFR) to regulate osteoblast growth. Signalling to multiple FGFRs 
FGF-18 coordinates chondrogenesis in the growth plate with osteogenesis in cortical and trabecular 
bone (Ohbayashi et al. 2002).
In cell culture, multiple members of the fibroblast growth factor (FGF) family (FGFs-2, -4, and -9) 
have significantly stimulated H-thymidine uptake by chondrocytes grown in an adherent serum-free 
culture system (Rousche et al. 2001). 
Furthermore, in the rat chondrocyte-derived cell line FGF induces tyrosine kinase activity 
(Rozenblatt-Rosen et al. 2002). Upon FGF stimulation, FGFR-3 is selectively removed from local 
adhesions, which is followed by their disassembly and disruption of the organized cytoskeleton. 
Induced genes include c-jun, JunD, cyclin-D1, NFkappaB1 and plasma-membrane microdomain 
morphology, such as ezrin. The transcription factor Id1 is down regulated, consistent with exit of 
the cells from the mitotic cycle. Moreover, following FGF stimulation, levels of FGFR-3 mRNA 
and protein decline, as does downstream signalling through the MAPK pathway (Rozenblatt-Rosen 
et al. 2002). 
 In an additional experimental model, treatment of chondrocytes with bFGF (FGF-2) (1-100 ng/ml) 
stimulated the mRNA expression of bFGF and TGF-beta up to 121-604% and 130-220% 
respectively, at 12 h compared to controls (Shida et al. 2001). On the other hand, the treatment of 
chondrocytes with bFGF (1-100 ng/ml) suppressed IGF-1 mRNA expression  47-79% at 12 h.
Differences between FGFs have been noted. FGFs -2, -4, and -9 strongly stimulate avian 
chondrocyte proliferation, while FGFs -6 and -8 stimulate proliferation to a lesser extent (Praul et 
al. 2002). Assessment by RT-PCR has indicated that FGF-2 and FGF-4 are expressed in the 
postnatal avian epiphyseal growth plate, while FGF-8 and FGF-9 are not. Thus, FGF-2 and FGF-4 
have been observed to stimulate chondrocyte proliferation, and both to be present in the epiphyseal 
growth plate.
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The effects of FGF-18 closely resemble those of FGF-2, whereas FGF-10 affects none of these 
cells. FGF-18 may, therefore, compensate for the action of FGF-2 on bone and cartilage (Shimoaka 
et al. 2002).
In fracture healing, injected recombinant human bFGF (FGF-2) into the fracture site immediately 
after the fracture, has produced size enlargement of cartilage (Nakajima et al. 2001). Maturation of 
chondrocytes and replacement of the cartilage by osseous tissue, however, were not enhanced by 
exogenous bFGF. 
Fibroblast growth factor (FGF) and its receptor (FGFR) are thought to be negative regulators of 
chondrocytic growth, as exemplified by achondroplasia and related chondrodysplasias, which are 
caused by constitutively active mutations in FGFR-3. FGF's growth inhibitory effects of 
chondrocytes appear to be mediated, at least partially, through p21 induction and the subsequent 
inactivation of cyclin E-Cdk2 and activation of pRb (Aikawa  et al. 2001). 
Recent experiments have established that Sox9 is required for chondrocyte differentiation. FGFs 
markedly enhance Sox9 expression in mouse primary chondrocytes, as well as in C3H10T1/2 cells 
that express low levels of Sox9. FGFs also strongly increased the activity of a Sox9-dependent 
chondrocyte-specific enhancer in the gene for collagen type II (Murakami et al. 2000). 
In the neonatal rat, immunolocalization of FGFR-1, -2, and -3 was found in the middle of the 
condylar cartilage, mainly in the hypertrophic zone of the tibial cartilage (Dunstan et al. 1999). At 
three weeks of age, the three FGFRs were broadly observed in both the tibial and femoral cartilages. 
At eight weeks, localization of FGFR-3 was absent in the hypertrophic cell layer of the condyle, 
whereas it was still broadly observed in tibial growth plate cartilage. At the same stage, FGFR-1 
and FGFR-2 showed similar localization in both cartilages compared to that at three weeks of age. 
All these observations suggest that FGFRs play an important role in the differential growth pattern 
of condylar cartilage.
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3.5 Platelet-derived growth factor (PDGF) 
Platelet-derived growth factor (PDGF) is structurally a dimer of A chains (17kD) and B chains 
(16kD). It appears either in the form of an A-A or a B-B homodimer or as an A-B heterodimer 
(Johnsson et al. 1984). It stimulates growth of vascular endothelial cells (Ross et al. 1974), and 
fibroblasts (Stiles 1983). Furthermore, it acts as a chemotactic signal for fibroblasts, even at very 
low concentrations (Postlethwaite et al. 1987). Additionally PDGF promotes the migration of 
smooth muscle cells, and acts as a true chemoattractant for vascular smooth muscle cells 
(Grotendorst et al. 1982).  
In cartilage, PDGF has been suggested to increase the level of intracelluar calcium ions in 
chondrocytes (Fukuo et al. 1989), to stimulate DNA and proteoglycan synthesis in cartilage tissue 
(Fukuo et al. 1989), and increase chondrocyte proliferation (Guerne et al. 1994). Furthermore, 
PDGF has been shown to stimulate cell replication and generalized protein synthesis by 
differentiated cells (Canalis 1985). 
Treatment with recombinant human platelet-derived growth factor (rh-PDGF-BB) has also been 
evaluated concerning fibroblast migration. The presence of rh-PDGF-BB resulted in a significantly 
greater fibroblast invasion as compared to untreated scaffolds (Gosiewska et al. 2001).  In meniscal 
cells PDGF has been demonstrated to increase cell migration and DNA synthesis in a dose-
dependent manner (Bhargawa et al. 1999). In cartilage PDGF-BB enhanced matrix production, but 
at the same time prevented progression of cells along the endochondral maturation pathway 
(Kieswetter et al. 1997).
In different age groups chondrocytes respond differently to PDGF. Cells from young donors (ages 
10-20) responded better to platelet-derived growth factor, AA chain homodimer (PDGF-AA) than 
to TGF beta-1, while the inverse pattern was seen in cells from adult donors. This decrease in the 
response to PDGF-AA correlated significantly with increasing skeletal maturity (Guerne et al. 
1995).
In osteoarthritic cartilage, more intense PDGF-AA and PDGF-BB expression has been compared to 
that in healthy cartilage. Activated chondrocytes were located in the middle and partly in the deeper 
layer of cartilage (Moos et al. 1999). 
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Interaction between different growth factors in cartilage has been observed. Human articular 
chondrocytes released TGF  activity.  PDGF up-regulated TGF  -1 and TGF -3 mRNAs with a 
corresponding increase in protein secretion (Villiger and Lotz 1992). 
Wroblewski and Edwall (1992) analyzed the role of two isoforms (PDGF AA and PDGF BB) of 
platelet derived growth factor either alone or in combination with insulin-like growth factor I, in the 
regulation of proliferation and differentiation of the rat rib growth plate chondrocytes. Both 
homodimers play an important role in chondrocyte differentiation and, together with IGF-I interact 
in the regulation of longitudinal bone growth.
3.6 Vascular endothelial growth factor (VEGF) 
Vascular endothelial growth factor (VEGF), first known as a vascular permeability factor (VPF), is 
a dimeric heparin-bonding protein with a molecular weight of 45 kD (Ferrara and Henzel 1989; 
Ferrara et al. 1991a). It is expressed in various tissues including brain, kidney, pituitary gland, lung, 
adrenal gland, heart, liver, stomach, and ovary as well as in various tumours (Berse et al. 1992; 
Ferrara et al. 1991b). New family members are being identified, for example VEGF-A (also known 
as VPF or VEGF), VEGF-B, VEGF-C, VEGF-D and placenta growth factor (Tammela et al. 2005). 
Of the three different VEGF-receptors, VEGFR-2 is the main signal transducer of VEGF-mediated 
angiogenesis (Tammela et al.2005).   
VEGF regulates endothelial differentiation including vascular growth and blood vessel repair 
(Peters et al. 1993). VEGF shares homologies of about 21% and 24%, with the A and B chains of 
PDGF (Tischer et al. 1989). It also promotes blood vessel hyperpermeability, endothelial cell 
growth, and enhanced glucose transport (Connolly 1991). In addition, it is suggested to be involved 
in hypoxia-induced angiogenesis (Schweiki et al. 1992). 
Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) induces endothelial 
cell migration and proliferation in culture and is strongly angiogenic in vivo (Carlevaro et al. 2000). 
VEGF synthesis occurs in both normal and transformed cells and it is actively responsible for 
hypertrophic cartilage neovascularization through a paracrine release by chondrocytes, with 
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invading endothelial cells as a target. Furthermore, VEGF receptor localization and signal 
transduction in chondrocytes, strongly support the hypothesis of a VEGF autocrine activity also in 
morphogenesis and differentiation of a mesoderm derived cell (Carlevaro et al. 2000).  
VEGF-mediated capillary invasion is an essential signal that regulates growth plate morphogenesis 
and triggers cartilage remodelling. Thus, VEGF is an essential coordinator of chondrocyte death, 
chondroclast function, and extracellular matrix remodelling, angiogenesis and bone formation in the 
growth plate (Gerber et al. 1999).
Vascular endothelial growth factor (VEGF)-mediated angiogenesis is an important part of bone 
formation. Expression of VEGF (164) and/or VEGF (188) is important for normal endochondral 
bone development, not only to mediate bone vascularization but also to allow for normal 
differentiation of hypertrophic chondrocytes, osteoblasts, endothelial cells, and osteoclasts (Maes et 
al. 2002). 
VEGF is expressed by articular chondrocytes in normal and OA human knee cartilage (Pfander et 
al. 2001). The percentage of VEGF immunopositive chondrocytes significantly increases in late 
stages of the OA.
VEGF has recently been shown to play an important role during endochondral bone formation in 
hypertrophic cartilage remodelling, ossification, and angiogenesis. Apart from its production in 
hypertrophic chondrocytes, VEGF is also produced in chondrocytes of OA cartilage. While the 
splice variant VEGF (189) binds to extracellular matrix proteoglycans, VEGF (121) is diffused 
freely. Both proteins are believed to contribute to the inflammatory process by autocrine/paracrine 
stimulation of chondrocytes, chemotaxis of macrophages, and promotion of angiogenesis (Pufe et 
al. 2001). 
Angiogenesis shown to be essential for the replacement of cartilage by bone during growth and 
repair.
VEGF was absent in chondrocytes in the resting zone and only weakly expressed by occasional 
chondrocytes in the proliferating region. In the hypertrophic zone the number of chondrocytes 
stained and the intensity of staining for VEGF increased with chondrocyte hypertrophy, with 
maximum expression of VEGF being observed in chondrocytes in the lower hypertrophic and 
mineralised regions of the cartilage (Horner et al.1999). 
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3.7 Transforming growth factor  superfamily (TGF )
The transforming growth factor  (TGF ) superfamily is composed of several growth factors: 
mammalian TGF s -1, -2, -3, more than 20 BMPs, activins/inhibins, Nodal, myostatin and anti-
Mullerian hormone (Derynck et al. 1985; Miyazano et al. 2005). TGF  has been found in almost all 
tissues studied (Assoian et al. 1983; Moses et al. 1981; Roberts et al. 1981). It regulates cellular 
growth and stimulates extracellular matrix protein incorporation as well as collagen, hyaluronic 
acid, and fibronectin production (Ignotz and Massagues 1986; Raghow et al. 1987). Furthermore, 
subcutaneous injection of TGF  in mice results in rapid induction of fibrosis and angiogenesis 
(Roberts et al. 1986). In cartilage, TGF  has been demonstrated to stimulate the production of tissue 
inhibitor of metalloproteinase (TIMP) (Wright et al. 1991), thus participating in the control of 
connective tissue degradation. Furthermore, it is involved in articular inflammation (Lotz et al. 
1992; Pujol et al. 1991), chondrogenesis and osteogenesis (Frenz et al. 1994; Joyce et al. 1990). 
TGF s are secreted from cells in a latent form, which does not have the capability to bind to TGF
receptors. The latency-associated peptide is removed through enzymatic degradation by proteases, 
resulting in the activation of TGF  (Burmester et al. 1993; Flaumenhaft et al. 1993; Massaque 
1990; Sato and Rifkin 1989). Latent TGF  binding proteins allows fore more specificity and control 
on TGF  action (Rifkin 2005). 
The actions of TGF  are mediated via binding to cell surface receptors (Wrana et al. 1992). TGF
binds to the type II receptor, which recruits and phosphorylates the type I receptor (Bachmann and 
Park 2004).  This leads to activation of the kinase domain of the type I receptor and the subsequent 
regulation of the SMAD proteins. Activated SMAD complexes assembly transcriptional complexes 
for target genes (Massague et al. 2005). There is strong evidence that absence of the type II receptor 
can completely abrogate TGF  signalling (Bachmann and Park 2004). The type III receptor, also 
known as betaglycan, can exist in soluble forms and has the capacity to strongly bind two TGF
molecules. This can allow a greater concentration of TGF  molecules to be present at the cell 
surface (Lopetz et al 1993). Of the other cell surface receptors (type IV, type V, and type VI), 
especially the type V receptor has been demonstrated to inhibit cell growth (Huang and Huang 
2005).
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Transforming growth factor beta-1 (TGF -1) is secreted in a biologically inactive form and stored 
in extracellular matrix as a 290 kD complex consisting of mature TGF -l homodimer (Mr 25 kD), 
latency-associated peptide (LAP; Mr 75 kD), and latent TGF -l binding protein-1 (LTBP1; Mr 190 
kD) (Maeda et al. 2002). Latent TGF -l, composed of these three components, is known as the 
"large latent TGF -1 complex." In contrast, latent TGF -l without LTBP1 is known as "small latent 
TGF -1." For all latent forms, dissociation of the TGF -l homodimer from LAP is necessary for 
growth factor activation and acquisition of biological activity. Matrix vesicles contain enzymes, 
especially MMP-3, which are responsible for release of TGF -1 from matrix, most of which is in 
latent form. Further, data suggest that release of the large complex occurs via cleavage at several 
novel sites in the 130 kD LTBP1 molecule. Since matrix vesicle MMP-3 is also able to activate 
small latent TGF -1, these results suggest that the large latent TGF -1 complex protects against 
activation of small latent TGF -1. Thus, data suggest that release of the large latent TGF -l
complex from matrix and activation of the latent growth factor are only two steps of what must be 
at least a three-step process (Maeda et al. 2002).
Chondrocytes from normal human cartilage, when cultured in gelled agars, have shown correlations 
between the expression of TGF R-II/TGF -1 and intracellular levels of TIMPs, indicating that a 
TGF  autocrine pathway may contribute to homeostasis of ECM in normal cartilage. The relations 
between MMPs, TIMPs, and ECM molecules support the idea that a physiological balance between 
MMPs and TIMPs results in a well-controlled matrix turnover in normal cartilage (Wang et al. 
2002).
Indeed, TGF  has a proven role in chondrocyte maturation and endochondral ossification. TGF
production, release, and activation are developmentally regulated in chondrocytes (Dangelo et al. 
2001).
TGF  and bone morphogenetic protein-2 induce chondrophyte formation at the joint margins. 
Studies using scavenging TGF  soluble receptor identified endogenous TGF  involvement in 
spontaneous cartilage repair and chondrophyte and subsequent osteophyte formation in arthritic 
conditions (van den Berg et al. 2001).
Furthermore, overexpression of active TGF -1 in the knee joint results in OA-like changes and 
suggests synovial lining cells to be contributing to the chondro-osteophyte formation (Bakker et al. 
2001).
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TGF  has different actions in mesenchymal precursor cells for chondrocytes, osteoblasts, and 
osteoclasts in different stages (Bostrom and Asnis 1998). Although TGF s appear to stimulate 
proliferation of precursor cells, it seems that TGF s have an inhibitory effect on mature cell lines. 
In vivo studies indicate the presence of TGF  protein and TGF  gene expression in normal fracture 
healing, whereas exogenous TGF  administration stimulates recruitment and proliferation of 
osteoblasts in fracture healing (Bostrom and Asnis 1988).  
Furthermore, TGF  is present in a latent form in matrix of costochondral chondrocytes. It is 
suggested that chondrocytes are able to regulate both temporal and spatial activation of latent 
TGF , even at sites distant from the cell, in a relatively avascular environment (Pedrozo et al. 
1998).
TGF -1 has been shown to stimulate synthesis of both DNA and proteoglycan in a bimodal fashion 
(Qi and Scully 1997). The presence of extracellular type-II collagen increased the rate of DNA and 
proteoglycan synthesis in a dose-dependent fashion in cultures stimulated by TGF -1, whereas 
heat-inactivated type-II collagen abrogated the effects observed with type-II collagen for synthesis 
of both DNA and proteoglycan. Type-II collagen has a specific role in chondrocyte regulation and 
mediates chondrocyte response to TGF -1.
Furthermore, the responsiveness to TGF s changes as cells differentiate and these changes in TGF
receptor profile may account for some of these differences (Moses  and Serra 1996).  
TGF  is particularly dependent upon the context in which it acts, eliciting seemingly opposite 
effects under different experimental conditions. TGF  and other factors interact to modulate their 
respective actions, creating effector’s cascades and feedback loops of intercellular and intracellular 
events that control articular chondrocyte functions (Trippel 1995). 
In addition, TGF  has a dual effect on proliferation of joint chondrocytes. In medium with a low 
serum concentration, it inhibits cell growth, while in medium supplemented with 10% fetal calf 
serum it stimulates cell growth (Pujol et al. 1994). 
Exogenous TGF -1 has a stabilizing effect on the prehypertrophic epiphyseal chondrocytes 
(Ballock et al. 1993). It reversibly has been shown to prevent terminal differentiation of epiphyseal 
chondrocytes into hypertrophic cells. It maintains gene expression for the cartilage matrix proteins, 
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type II collagen, and aggrecan core protein, as well as inhibits expression of genes encoding 
metalloproteases collagenase and stromelysin.   
Using immunohistochemical staining analysis with specific TGF  antibodies (Thorp  et al. 1992), 
TGF  -1, -2, -3 were identified to be localized in hypertrophic chondrocytes, chondroclasts, 
osteoblasts and osteoclasts  in developing growth plate, epiphysis and metaphysis.  
TGF  has been suggested to have a potentially important autocrine function in modulating 
chondrocyte proliferation and matrix synthesis in endochondral calcification (Rosier et al.  1989). 
In regulating the extracellular matrix, TGF  has in cell culture, had an inhibitory effect on the level 
of TIMP-2 and membrane type 1matrix metalloproteinase (MT1-MMP) (Pattison et al. 2001). 
The responsiveness of cultured human articular chondrocytes to TGF  appeared reduced with age 
(Hickery et al. 2003). The responsiveness tended to rise up to the age of 20, and there after reduced 
linearly.
3.8 Oncoproteins c-Fos and c-Jun 
Proto-oncogenes encode proteins with three main sites of action: the cell-surface membrane, 
cytoplasm and nucleus (Angel et al. 1988). First observed in cancer research (Bohmann et al. 1987), 
the jun oncogene is expressed as a 65-kD protein Jun (Bos et al. 1988).  It is a member of the early 
activating protein (AP-1) family of transcription factors, which mediate regulation of gene 
expression in response to extracellular signalling (Bohmann and Tijan 1989). Stimulation of 
quiescent murine fibroblasts by growth factors has resulted in a rapid and transient transcriptional 
activation of proto-oncogenes (Jahner and Hunter 1991). In addition, transient inhibition of protein 
synthesis has induced expression of proto-oncogenes and stimulated resting cells to enter the cell 
cycle (Rosenwald et al. 1995). 
The proto-oncogene protein products (c-Fos and c-Jun) heterodimerize through their leucine zippers 
consisting of AP-1 transcription factor (Papavassiliou et al. 1992). The transcriptional activity of 
this heterodimer is regulated by signal-dependent phosphorylation and dephosphorylation. 
The effect of c-fos on human chondrocytes and in cartilage destruction of rheumatoid arthritis (RA) 
have been highlighted (Tsuji et al. 2000). Introduction of c-fos in chondrocytes decreased 
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endogenous transcription of Type II collagen and TIMP-1, and increased that of MMP-1.  MMP-1 
promoter was clearly activated by Jun related proteins as well as Fos/Jun related protein 
heterocomplex. On the other hand, c-fos combined with any of the Jun related proteins failed to 
stimulate the TIMP-1 promoter, although it was activated by Fra-1 or Fra-2/Jun related protein 
heterocomplexes. Expression of c-fos mRNA was detected in chondrocytes in the mid and deep 
layers of cartilage in 11/15 patients (73%) with RA, but only in the superficial layer of cartilage 
from 2/10 patients (20%) with OA (Tsuji et al. 2000).   
Furthermore, c-Fos combined with any of the Jun-related proteins failed to stimulate the TIMP-1 
promoter, though the collagenase promoter was effectively activated by any Fos/Jun-related protein 
heterocomplex (Tsuji et al. 1996). This may indicate that the c-fos expression may govern cartilage 
metabolism and hence may play an important role in the pathogenesis of joint destruction in 
arthritis.
In cell culture, induction of c-fos has resulted in the concomitant increase in the expression of fra-1
and c-jun, further highlighting the importance of AP-1 transcription factors in chondrocyte 
differentiation. Indeed, c-fos overexpression directly inhibits chondrocyte differentiation in vitro
(Thomas et al. 2000). 
In an attempt to define molecular influences on rat interstitial collagenase gene expression in 
cartilage, the promoter function was characterized using a transient transfection assay, 
electrophoresis mobility shift assay, and genetic analysis in isolated growth plate chondrocytes 
(Grumbles et al. 1997). One of the factors involved was identified as the nuclear protein, c-Jun. 
Indeed, c-Jun directed antisense oligonucleotides reduced rat interstitial collagenase mRNA.    
In addition, basic fibroblast growth factor (bFGF, FGF-2) has been demonstrated to have an 
inductive effect on c-fos in primary cultures of rat rib growth plate chondrocytes (Wroblewski and 
Edwall-Arvidsson 1995).  
Furthermore, Zarafullah et al. (1992) has showed that normal and osteoarthritic human articular 
cartilage chondrocytes, released enzymatically in the presence of 0.5% fetal calf serum, display 
constitutive expression of early response activating protein (AP-1) genes, c-fos, c-jun, and jun-B.
Among the late AP-1 responsive genes, total metallothionein (MT) and stromelysin mRNAs are 
expressed at high levels in both normal and OA chondrocytes, while collagenase and hMT-IIA 
mRNA levels are elevated only in OA individuals.
32
3.9 Growth factors in intervertebral disc tissue 
During the past decade intervertebral disc research has focused both on the expression of growth 
factors in normal discs and in pathological conditions. The rationale is based on understanding of 
disc cell function. That function has been considered one of the key elements in degenerative 
processes in the intervertebral disc (Gruber and Hanley 2003). Growth factor research has mainly 
followed two pathways: the neovascularization process and regulation of extracellular matrix 
formation and remodelling. 
In cell cultures, TGF , FGF, and IGF-I and EGF have been demonstrated to be potent cellular 
proliferation stimulators (Thompson et al. 1991). Cells from nucleus pulposus and the transition 
zone reacted more than annulus fibrosus cells. Greatest stimulation was gained by TGF  and EGF. 
IGF-I stimulated the cells from nucleus pulposus, but not annular or transition zone cells.  
In addition, TGF -1 and IGF-I regulate matrix metalloproteinase production in nucleus pulposus 
cells (Pattison et al. 2001). They both decrease the level of active gelatinase-A (MMP-2). 
Furthermore, the surface levels of metalloproteinase inhibitors have been decreased by these 
factors.
In nucleus pulposus cell culture, proteoglycan synthesis is stimulated in a dose-dependent manner 
by IGF-I. The expression of IGF-I and its receptor is especially noted in young nucleus pulposus 
(Osada et al. 1996). 
This is supported by the finding that IGF-I receptor expression is clearly decreased with age (Okuda 
et al. 2001). Furthermore, proteoglycan synthesis is reduced and IGF-I binding protein-1 is more 
strongly expressed with age. 
In annulus fibrosus cell culture, apoptosis is significantly reduced by IGF-I and PDGF (Gruber et al. 
2000a). In addition, IL-1  sensitizes annular cells to fluid-induced shear stress resulting in increased 
Ca-intake (Elfervig et al. 2001). Furthermore, annulus fibrosus cells grown in three-dimensional 
agarose or alginate culture assumes a rounded phenotype and forms colonies. In the presence of 
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TGF -1 there is first a significant enhancement of proliferation, and after 10 days of exposure to 
TGF , a lessened mitogenic response (Gruber et al. 1997).  In addition, in human annulus cell 
cultures, higher age, female gender, more advanced disc degeneration, and surgical derivation 
diminishes the proliferation potential of the cells (Gruber et al.  2001). 
Co-culturing murine peritoneal macrophages and human herniated intervertebral disc tissue, a 
marked increase in macrophage VEGF expression and an increase in neovascularization was shown 
by Haro et al. in herniated tissue (Haro et al. 2002). TNF-  was required for induction of VEGF. 
The induction was strongly inhibited by anti-VEGF antibody, and enhanced by recombinant VEGF. 
Co-culturing intervertebral disc tissue and peripheral blood mononuclear cells, revealed significant 
numbers of mononuclear cells attached  to extruded disc tissue, compared to control discs (Doita et 
al. 2001).  In addition, cytokine incubation of isolated cells from herniated discs, showed 
significantly higher production of MMP-1 and MMP-3. 
Furthermore, VEGF has been localized in extruded and sequestrated intervertebral discs, in the 
spindle shaped cells og the granulation tissue area (Koike et al. 2003) 
By using collagen/hyaluronan scaffold, biomaterial has been evaluated as to supporting the viability 
and function of disc cells (Alini et al. 2003). Nucleus and annulus cells behaved in a similar 
manner. Production of proteoglycan was greatest with the presence of TGF- 1. Proteoglycan 
production, however, never exceeded 10% of that present in mature nucleus pulposus, and the 
production was not uniform within the scaffold. Instead it was increased near its periphery. 
In animal models, growth factor expression has especially been demonstrated in growing animals. 
TGF  expression decreased with age in a senescence-accelerated mice model (Matsunaga et al. 
2003; Nagano et al. 2000). Degenerative changes were recognized at 50 weeks. In young mice, 
TGF -1, -2, -3 and receptor types I and II were localized to both fibrocartilaginous annulus cells 
and notochord-like nucleus pulposus cells. Furthermore, in senescence-accelerated mice, BMP-2/4 
and its receptors, were localized in hyaline cartilaginous cells within the end-plate in young mice 
(Takae et al. 1999). With age, the expression moved to fibrous cells of annulus fibrosus and to 
calcified cartilage. 
In an experimental mouse spondylosis model, BMP-4 and BMP receptors have at the early stage 
been localized mainly in cells of the anterior margin (Nakase et al. 2001). At the late stage, BMP-4 
expression decreased, whereas growth and differentiation factor (GDF)-5 and BMP-6 expression 
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increased, and was localized in cells undergoing chondrogenesis. The expression of BMP receptors 
remained the same. 
In a recent experimental study, using a real-time PCR technique Sobajima et al. (2005) showed that 
during degenerative process in intervertebral disc, TGF  had a double peak characteristic in its 
expression. The first early peak increased by week 3, and the second late peak at 24 weeks. BMP-2, 
BMP-7, and IGF-I only had a late peak expression. 
In an experimental rabbit model that mimics the sequestration type intervertebral disc herniation, 
bFGF stimulated neovascularization and proliferation of inflammatory cells (Minamide et al. 1999). 
Indeed, the degradative process was enhanced and the effect was dose-dependent. 
In an experimental degeneration model induced by annular laceration of rabbit intervertebral disc, a 
profile of possibly important genes was observed (Anderson 2002).  There was notable up 
regulation of the genes for collagen Type I, collagen Type II, fibronectin, Fas, MMP-1, MMP-9 and 
MMP-13 in these degenerated discs. Degeneration induced down regulation of the gene for decorin. 
The expression level of genes IL-1 , BMP-2, and TNF-  was not affected. 
In degenerated rat intervertebral discs bFGF and its receptor have been shown to be localized 
mostly in chondrocyte-like rounded cells. Proliferation capacity of these cells exceeded that of 
normal annular spindle-shaped cells (Nagano et al. 1995). 
When comparing injured annulus fibrosus of merinos to intact ones, bFGF (FGF-2), TGF-  and 
osteonectin were strongly localized in blood vessels and cells in the vicinity of the annular lesion 
(Melrose et al. 2002). The reaction was maximal 12 month after the operation, and diminished by 
26 months. Osteonectin was also elevated in outer annulus fibrosus cells distant to the lesion site.  
In control discs, the expression of FGF-2, TGF- , and osteonectin was localized to sparsely 
distributed cells in annulus fibrosus. 
Epidural injection of bFGF has been demonstrated to facilitate resorption of the intervertebral disc, 
relocated to the epidural space (Minamide et al. 1999).  
Intradiscal injection of osteogenic protein-1 in normal adolescent rabbits has increased both disc 
height and proteoglycan content in nucleus pulposus (An et al. 2004). 
35
In an in vivo model, TGF -1 gene has been transferred to rabbit intervertebral disc. The 
accumulation of TGF -1 into disc cells was analyzed immunohistochemically, and in cell culture 
TGF -1 production and proteoglycan synthesis were also analyzed (Nishida et al. 1999). 
Adenovirus-mediated TGF -1 gene transfer exhibited intensive and extensive positive 
immunostaining of TGF -1 in disc cells. Furthermore, nucleus pulposus cells showed a 30-fold 
increase of inactive TGF -1 production and a five-fold increase in total (latent and active) TGF -1
production. The overall proteoglycan synthesis exhibited a 100% increase. 
In addition, human intervertebral disc cells were treated successfully with adenovirus-containing 
marker genes (Moon et al. 2000). The adeno associated viral vector has proved to be a valuable 
method in experimental analysis of transgene expression (Lattermann et al. 2005). This method is 
known to be less immunogenic than the commonly used adenoviral vectors. 
Of special interest is a recent study by Steck et al. (2005) showing that incubation of human adult 
bone marrow mesenchymal stem cells with TGF  produces induction of stem cells to chondrocyte-
like cells. The phenotype of these cells more closely resembles native intervertebral disc cells than 
native joint cartilage cells.  
During development of the human intervertebral disc, there are certain changes in type II 
procollagen expression (McAlinden et al. 2001).  At day 54 of gestation, the developing disc is 
divided into outer annulus fibrosus containing collagen types I and III, inner annulus fibrosus 
containg type IIA procollagen, and the notochord containing all three fibrillar collagens. Moreover, 
at day 54 of gestation type IIA N-terminal propeptide is localized in extracellular matrix, whereas, 
at day 101 of gestation the localization of this propeptide is in cytoplasm of inner annular cells. This 
domain of type IIA procollagen binds to BMP-1 and TGF- .
In painful degenerative human intervertebral discs, neovascularization from adjacent vertebral 
bodies, has been causally linked to nociceptive nerve ingrowth with the production of NGF 
(Freemont et al. 2002).  Such NGF expression has only been identified in discs painful at 
discography, not in painless discs. 
In extruded or sequestrated human intervertebral disc herniations, IL-1 and bFGF have been 
localized particularly in the granulation tissue area at the surface of the herniated disc (Doita et al. 
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1996).  In addition, this study showed that bFGF expression was far more intense in extruded or 
sequestrated discs compared to protruded ones, and enhanced the proliferation of endothelial cells. 
In the protrusion type of disc herniation chondrocyte-like disc cells have been demonstrated to 
express TGF -1, IGF-I, IL-6, IL-6R and fibronectin (Specchia et al. 2002). 
As demonstrated by reverse transcription-polymerase chain reaction, TNF- , IL-8, IL-1 , IL-10 
and TGF  have been expressed in herniated lumbar intervertebral discs (Ahn et al. 2002). IL-8 
mRNA expression was associated with the development of radicular pain by back extension, and 
short symptom duration (average 3.8 weeks). This is supported by the finding that IL-8 levels in 
cerebrospinal fluid were higher in patients operated on for sciatica and short duration of pain, and in 
more pronounced herniations (extrusion or sequestration) (Brisby et al. 2002). With respect to 
serum levels of IL-8 there were no differences as compared to the normal control group. 
Furthermore, the cerebrospinal concentration of IL-1 , IL-6, IFN-  and TNF-  was similar in 
sciatica patients and controls. 
In one study, mRNA coding for TGF- , EGF, TGF -1, TGF -3,  EGF-R, and TGF  type-II 
receptor, were found only occasionally in herniated human intervertebral discs (Konttinen et al. 
1999).
Apoptosis in herniated disc cells has also been evaluated (Kohyama et al. 2000). This paper showed 
that apoptotic cell death was significantly higher in herniated disc cell than in control disc cells. 
Furthermore, culturing disc cells revealed a release of nitric oxide from disc cells, and the 
suppressive action of this agent. 
.
Table 1 summarizes the comparative observed effects on disc and cartilage cells of the growth 
factors present in this thesis.  
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 Table 1. Comparison of growth factor effects on disc - and cartilage cells. 
Disc cells    Cartilage cells
TGF  Cell proliferation (Thompson et al. 1991) Cell proliferation (Fukumoto et
     al. 2000; Olney 2004) 
 Proteoglycan synthesis/ matrix turnover  Proteoglycan synthesis/ matrix 
 (Alini et al. 2003)   turnover (van Beuningen et al. 
     1994) 
 MMP-2  (Pattison et al. 2001)  TIMP-1 and TIMP-3  (Hickery
     et al. 2003) 
bFGF Cell proliferation (Thompson et al. 1991) Cell proliferation (varying
Neovascularization (Minamide et al. 1999) effects by various FGF
 Disc degradation, extruded disc resorption isoforms) 
 (Minamide et al. 1999)   (Fukomoto et al. 2000; van der  
Eerden et al. 2003; Dailey et al. 
2003; Veilleux et al. 2005; 
Henson et al 2005) 
     2004) 
PDGF Apoptosis  (Gruber et al. 2000a) Cell proliferation (Olney et al.
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VEGF Neovascularization   Neovascularization 
     Proliferation, differentiation, 
     chondrocyte survival (van der  
     Eerden et al 2004;  Maes et al.  
     2004; Zelzer et al. 2004) 
TGF  = transforming growth factor , bFGF = basic fibroblast growth factor, PDGF = platelet-
derived growth factor, VEGF = vascular endothelial growth factor; MMP = matrix 
metalloproteinase, TIMP = tissue inhibitor of matrix metalloproteinase,  = expression decreased, 
= expression increased.     
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4. Aims of the study 
The objective was to analyze the differences in growth factor expression in normal, degenerated, 
and herniated intervertebral disc tissues. The rationale for this is based on the importance of growth 
factors in cell growth, in cell activation, and in regulation of extracellular matrix turnover, as well 
as, in neovascularization. 
Cellular activation was observed by the putative expression of the transcription promoters c-Fos and 
c-Jun in disc tissue cells. 
Specific aims: 
1. To study the expression of growth factors involved in neovascularization, cell activation and 
control of extracellular matrix turnover in herniated disc tissue and in normal control discs. In 
addition, to study differences in growth factor expression in order to gain deeper understanding of 
the basic pathophysiological events leading to disc herniation and disc rearrangement. TGF  and 
FGF are well documented cell activation regulators, and extracellular matrix regulators in many 
tissues including cartilage, whereas PDGF and especially VEGF promote vascularization. The role 
of these factors in intervertebral disc tissue was not well documented in 1994, when this work 
commenced. Special interest was focused on identifying the disc cell types expressing growth 
factors, and characterizing possible differences between normal and herniated discs (I-III). 
2. To evaluate whether cell activation markers, oncoproteins c-Fos and c-Jun, are expressed 
differently in herniated disc tissue, and control disc tissue. Furthermore, if expressed, in which cell 
type? To determine whether there is activation centres in intervertebral discs during pathological 
processes (IV)? 
3. To study growth factor expression patterns in degenerated versus normal control disc tissue and 
to compare the results with those obtained from herniated disc tissue in order to understand basic 
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pathophysiology involved in intervertebral disc degeneration and disc rearrangement. To study the 
expression of growth factors in different degenerated disc regions, and to investigate in more detail 
which cell types show signs of activation (V). 
4. To create a theoretical model for pathophysiological mechanisms of human disc degeneration and 
the disc tissue remodelling process on basis of results obtained regarding growth factor expression 
and expression of oncoproteins 
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5.   Material and methods 
5.1 Operations 
5.1.1 Disc herniation tissue (DHT) (I-IV) 
DHT material was obtained from a total of 115 patients operated on for sciatic radicular pain. 
Clinical records of the patients described their age, sex, duration of preoperative radicular pain 
period, straight leg raising (SLR), the level of disc herniation and the type of herniation. 
After removal, the DHT material was rapidly frozen to –70oC in the operation theatre. The clinical 
data of DHT material is summarized in Table 2.  
(I) DHT material was obtained from 27 discectomy patients. The age of patients varied from 25 to 
68. There were eight female patients. Preoperative radicular pain duration ranged from 0.5 months 
to 16 months. The operating surgeon classified thirteen of the DHT samples as sequesters (free disc 
material in the epidural space, and the disc has lost its continuity). Eleven were extrusions, i.e. disc 
tissue was exposed to the epidural space, but there was, however, still continuity with the rest of the 
disc. Three were protrusions, i.e. the annulus fibrosus bulged abnormally, but remained intact and 
the periphery of the annulus fibrosus remained attached to the vertebral body bony rim. 
(II) DHT material was obtained from 50 discectomy operations. The age of the patients ranged from 
24 to 71. There were 26 male and 24 female patients. Mean preoperative pain duration was 4.12 
months. Twenty-five DHT were classified as extrusions, twenty were sequesters, two were not 
reported and the remaining three were protrusions. 
(III, IV) DHT material was obtained from 38 discectomy operations. The age of the patients ranged 
from 20 to74. Mean preoperative radicular pain duration was 6.9 months (range 3 weeks-36 
months). Twelve were sequesters, 24 were extrusions, and two were protrusions. There were 22 
male and 16 female patients. 
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Table 2.  Clinical data of the disc herniation tissue (DHT) obtained from the patients operated on 
for sciatic pain. Roman numbers I-IV refer to different substudies of the thesis. 
________________________________________________________________________________
  I  II  III-IV 
Patients (n)  27  50  38 
Gender (F/M) 8/19  24/26  16/22 
Age (years)  25-68  24-71  20-74 
(mean)  45.4  43.2  41.6 
Preoperative pain 
duration (months) 0.5-16  0.25-24  0.75-36 
(mean)  4.10  4.12  6.9 
Prolapse type (n) 
Not reported  -  2  - 
Protrusion  3  3  2 
Extrusion  11  25  24 
Sequester  13  20  12 
________________________________________________________________________________
5.1.2 Degenerated intervertebral disc tissue (DD) (V) 
Sixteen degenerated intervertebral discs were obtained from 12 patients operated on for 
degenerative disc disease (Table 3.). In the operation the anterior fusion method was used and the 
degenerated disc was removed. After removal, anterior annulus fibrosus, posterior annulus fibrosus, 
and nucleus pulposus were each rapidly frozen to –70o C in the operating theatre. 
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Table 3. Clinical data of the patients operated on for degenerative disc disease 
________________________________________________________________________________
Patients (n)  12 
Gender (F/M) 5/7 
Age (years)  29-63 
(mean)  44.8 
________________________________________________________________________________
5.1.3 Normal control disc tissue (DN) 
As a normal control, disc material from eight discs from a tissue bank of five organ donors was 
used (Table 4.). None of the donors had a history of lower back pain. No sign of autolysis was 
observed, i.e. all discs looked intact and they all showed a normal morphology, macroscopically. 
The mean age of the donors was 36.2 (range, 13-53).  
Table 4. Clinical data of the normal control disc patients (organ donors) 
________________________________________________________________________________
Patients (n)  5 
Gender (F/M) 3/2 
Age (years)  13-53 




All tissue material was treated identically. After removal the tissue material was immediately rinsed 
in phosphate-buffered saline (PBS) and frozen in liquid nitrogen to –70oC in the operating theatre. 
The tissue material was kept in a –70oC freezer until analysis. 
Using the avidin-biotin-peroxidase (ABC) method (Hsu et al. 1981) 8 µm thick cryostat sections 
were subjected to indirect immunohistochemistry. Prior to immunostaining, slides were fixed in ice 
cold (4oC) acetone at room temperature. In the TGF  study (III) some specimens were prefixed in 
Zamboni solution, to detect a possible difference in immunoreaction between prefixed and section-
fixed samples. Prior to treatment with primary antibody, non-specific binding was blocked by 
treatment with non-immune serum (horse normal serum).  
Endogenous peroxidase was inhibited by incubation in 0.3% H2O2 in 70% methanol-PBS at room 
temperature for 30 minutes, before treatment with the ABC reagent. 
Control sections were stained omitting the primary antibody. Furthermore, preincubation with the 
corresponding antigen was performed (at 1:10). As a positive control, tissue material from 
rheumatoid synovia was used. 
5.2.1 Detailed protocol for immunostaining method of frozen sections using 
avidin-biotin-peroxidase complex (ABC) (Hsu et al. 1981) (I-V) 
Incubations were carried out at room temperature in a humid chamber. The staining sequence was 
as follows: 
1) Incubation with diluted normal serum for 20 min, 2) blotting out of excess serum and incubation 
with primary antibody overnight at 4oC, 3) rinsing section slides in PBS for 10 min, 4) incubation 
with diluted biotinylated antibody for 30 min, 5) rinsing in PBS for 10 min, 6) inhibiting 
endogenous peroxidase activity by incubation for 30 min in 0.3 % H2O2, 7) rinsing for 20 min in 
PBS,  8) incubation of sections for 30-50 min with diluted Vectastain ABC reagent, 9) rinsing in 
PBS for 10 min, 10) incubation for 2-7 min with peroxidase substrate solution (DAB), 11) rinsing 
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in tap water for 5 minutes, 12) 1-2 min counterstaining with haematoxylin, 13) rinsing in tap water 
for 5 min, and finally, 14) embedding in Aqua mount (BDH Limited, Poole, UK). 
Table 5. Summary of the antibodies used in these studies (I-V) 
Antibody  Antibody Studies in   Source  
specificity  type which used 
bFGF  pAb I,V R & D Systems Inc, Minneapolis, Minn,  
    USA 
c-Fos  mAb IV Santa Cruz Biotechnology, Santa Cruz, CA, 
    USA 
c-Jun  mAb IV Santa Cruz Biotechnology, Santa Cruz, CA, 
    USA  
PDGF  pAb II, V R & D Systems Inc., Minneapolis, Minn, 
    USA 
TGF -I  pAb III, V Santa Cruz Biotechnology, Santa Cruz, CA,
    USA 
TGF -II  pAb III, V Santa Cruz Biotechnology, Santa Cruz, CA, 
    USA 
TGF  receptor type II pAb III, V Santa Cruz Biotechnology, Santa Cruz, CA, 
    USA 
VEGF  pAb II Santa Cruz Biotechnology, Santa Cruz, CA, 
    USA 
vWF  pAb I,II Dakopatts, Copenhagen, Denmark 
bFGF: basic fibroblast growth factor, c-Fos: oncoprotein c-Fos, c-Jun: oncoprotein c-Jun, mAb: 
monoclonal antibody, PDGF: platelet-derived growth factor, pAb: polyclonal antibody, TGF :
46
transforming growth factor , VEGF: vascular endothelial growth factor, vWF: von Willebrand 
factor
5.3 Statistical analyses 
Statistical analysis was done either using non-parametric Mann-Whitney test (III) or Chi-square and 
Fisher exact tests (IV, V). Mann-Whitney test was performed using SOLO statistical software 
program (BMDP, Los Angeles, CA, USA) (III) and the Chi-square and Fisher exact tests either with 
the same program (IV) or the Sigma Stat Version 1.0 (Statistic software, Jandel Scientific GmgH, 
Erlerath, Germany) (V). Level of statistical significance was set at P < 0.05. 
5.4 Quantitation by immunohistochemistry 
The number of immunopositive cells was estimated semiquantitatively by using the following 
grades: -/immunonegative, no cells, (+)/(immunopositive), a few scattered cells, and 
+/immunopositive, abundant cells (more than 20 immunopositive cells in total). Two observers 
performed the cell counting independently and analyzed three different sections, per antibody.  If 
the result differed between sections, we chose the highest immunopositive cell estimate. 
The TGF  study required a more detailed immunoquantitation. (III) Again two observers performed 
the analyses in blind review. Positive staining for TGF  antibodies was quantified as the ratio of 
positive disc cells per cross sectional area compared to all disc cells. We took five random 
microscopic fields at the magnification 250x from all control discs and ten herniated discs, and used 
the mean cell counts obtained by the two observers. Altogether, counts included 50 fields from 
herniated disc samples and 40 fields from normal controls. Different groups were then compared 
statistically, as previously described. 
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6. Results 
Tables 6 and 7 summarize the immunostaining results of studied growth factors in normal control 
disc tissue, in degenerated intervertebral disc tissue, and in disc herniation tissue. Table 6 shows the 
total occurrence of these factors, and Table 7 differentiates between disc cell immunopositivity and 
blood vessel associated immunopositivity. 
Table 6.  Occurrence of growth factors in normal and pathological disc tissues. 
bFGF PDGF VEGF TGF 1 TGF 2 TGF rec
DN - - - 100% 100% 100% 
DD 100% - N.A. 94% 94% 100% 
DHT 81% 78% 88% 100% 100% 100% 
DN = normal disc, DD = degenerated disc, DHT = disc herniation tissue; bFGF = basic fibroblast 
growth factor, PDGF = platelet-derived growth factor, VEGF = vascular endothelial growth factor, 
TGF  = transforming growth factor beta, TGF rec = transforming growth factor beta receptor  type 
II.  N.A. = not analyzed.  
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Table 7.  Occurrence of growth factors in disc cells (DC) and blood vessels (BV) in normal and 
pathological disc tissues. 
bFGF PDGF VEGF TGF 1 TGF 2 TGF rec
DN
DC: - - - 100% 100% 100% 
BV: - - - - - - 
DD
DC: 100% - - 94% 94% 100% 
BV: some - N.A. some some some 
DHT
DC: 67% 38% - 100% 100% 97% 
BV: 48% 54% 88% 58% 37% 37% 
DN = normal disc, DD = degenerated disc, DHT = disc herniation tissue; bFGF = basic fibroblast 
growth factor, PDGF = platelet-derived growth factor, VEGF = vascular endothelial growth factor, 
TGF  = transforming growth factor beta, TGFrec = transforming growth factor beta receptor type 
II. N.A. = not analyzed.   
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6.1 Basic fibroblast growth factor (bFGF) immunoreactivity in blood vessels and 
cells of disc herniations (I) 
Histologically, 11/27 DHT samples contained only annular tissue, 9/27 contained both annulus 
fibrosus and nucleus pulposus, whereas 5 contained only nuclear tissue, and two of the DHT 
samples remained undefined. The classification was made by morphology. 
Altogether, 22/27 (81%) samples showed bFGF immunopositivity. bFGF immunopositive 
capillaries were found in 13/27 (48%) of the DHT samples, and 18/27 (67%) of the disc cells were 
also bFGF immunopositive. The latter finding often formed small clusters (Figure 1 in I). The 
capillary bFGF (Figure 3b in I) immunopositivity was confirmed by colocalization of von 
Willebrand factor (vWF) immunoreactivity (Figure 3a in I). All capillaries, however, were not 
bFGF immunopositive. 
All disc protrusions contained bFGF immunopositive capillaries. Eight (62%) sequesters showed 
vascular bFGF immunoreactivity, and two of the extrusions contained bFGF immunopositive 
vascular ingrowth. Furthermore, nine (69%) of the sequesters showed bFGF immunopositive disc 
cells, and seven out of eleven (64%) extrusions contained bFGF immunopositive disc cells. 
Sections stained, omitting the primary antibody, did not show any bFGF immunoreactivity (Figure 
4 in I). The five normal control discs did not show any bFGF immunoreactivity either. 
No clear evident relationship existed between the preoperative radicular pain duration and the 
localization of the bFGF immunoreaction, vascular or cellular. For all patients the median duration 
of such pain was 3.5 months (range 0.5-16 months). For those exhibiting both vascular and cellular 
bFGF immunoreactivity median pain duration was 3 months (range 1.5-9 months), and for those 
exhibiting only cellular immunoreactivity it was 3.5 months (range 1.5-16 months). In addition, for 
the patients totally immunonegative the median duration of sciatica was 1.5 months, the range being 
wide (0.5-12 months). 
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6.2 Platelet-derived growth factor (PDGF) and vascular endothelial growth 
factor (VEGF) expression in disc herniation tissue: an immunohistochemical 
study (II) 
Altogether, 38 DHT samples (78%) showed PDGF immunopositivity. In 27 (54%) this 
immunoreactivity was located in capillaries (Figure 1a in II), whereas in 19 (38%) disc cells were 
immunopositive (Figure 2 in II). Six samples (12%) also showed PDGF immunopositive fibroblasts 
(Figure 3 in II). VEGF immunopositive capillaries were noted in 44/50 (88%) of the DHT samples 
(Figure 1b in II). Once again, this capillary immunoreactivity was confirmed by 
immunolocalization of vWF to the same capillaries (Figure 1c in II). 
The five normal control discs did not show any immunoreactivity for either of the growth factors 
(Figure 4 in II). Furthermore, sections stained omitting the primary antibody, did not show any 
immunoreactivity.
VEGF or PDGF immunopositivity did not show any dependence on preoperative pain duration. 
In all DHT patients the mean pain duration was 4.12 months (median 3 months). In the VEGF 
immunopositive group this was 4.51 months (median 3 months), and for the PDGF immunopositive 
group 4.16 months (median 3 months). In the VEGF immunonegative group mean duration of pain 
was 4.08 months (median 4 months), and in the PDGF immunonegative group 3.54 months (median 
3 months). 
More specifically, in the group where disc cells showed VEGF immunopositivity the mean duration 
of preoperative radicular pain was 5.46 months (median 4 months), and the PDGF immunopositive 
capillary group 4.13 months (median 3.5 months). 
When comparing PDGF and VEGF immunoreactivity in different prolapse types, it was noted that 
23/25 extrusions showed VEGF immunoreactivity and 21/25 PDGF immunoreactivity. PDGF 
immunopositivity was located in 11/25 extrusions of disc cells, in 16/25 in capillaries, and in 3/25 
in fibroblasts. 
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In sequesters VEGF immunopositivity was detected in all 20 studied samples. PDGF 
immunoreactivity was observed in 16 samples. In eight discs this finding was cell associated, in 10 
discs blood vessel associated, and in three discs present in fibroblasts. 
Of the protrusions, one showed immunoreactivity to both PDGF and VEGF. Two of the DHT 
samples remained undefined by the operating spine surgeon. 
When comparing different age groups, VEGF did not show any age dependence, and the finding 
was present in more than 80% of the samples. Blood vessel associated PDGF immunoreactivity was 
more common in younger patients (under 40 years of age). 
6.3 Transforming growth factor (TGF)  receptor induction in herniated 
intervertebral disc tissue: an immunohistochemical study (III) 
All discs studied, both DHT and DN, showed TGF -1 (Figure 1a in III), TGF -2 (Figure 1c in IIII, 
Figure 2a in III) and TGF  receptor type II immunopositivity (Figure 1b in IIII). The 
immunoreaction was mainly disc cell associated, located in the cytoplasm of the cells. In some 
DHT samples, TGF  immunopositive capillaries also existed. 
All studied DHT samples showed TGF -1 and TGF -2 immunopositive disc cells, whereas only 
one such sample lacked such immunoreactivity for TGF  receptor type II. 
Capillary immunoreactivity was observed in 22/38 (TGF -1), 14/38 (TGF -2) and 14/38 (TGF
receptor type II) DHTs. 
We did not see any difference between different prolapse types with respect to immunoreactivity. 
Sections stained omitting the primary antibody, did not show any immunoreactivity. Furthermore, 
preincubation with the corresponding antigen blocked the immunoreactivity (Figure 2b in IIII). The 
positive rheumatoid arthritic synovia controls showed immunopositivity for all three antibodies, and 
the comparison between pre-fixed and section-fixed samples did not show any differences in 
immunoreactivity.
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Normal control discs (n=8) showed fewer TGF  and TGF  receptor immunopositive disc cells than 
DHT samples. When comparing the two groups by Mann-Whitney test, significant differences 
(p<0.0001) were calculated for all three antibodies. 
6.4 Oncoproteins c-Fos and c-Jun immunopositive cells and cell clusters in 
herniated intervertebral disc tissue (IV) 
All studied control discs were immunonegative for both c-Fos and c-Jun. Rheumatoid arthritic 
synovia and dermal samples, studied as positive controls, showed c-Fos and c-Jun immunopositive 
cells. Sections stained omitting the primary antibodies, did not show immunoreactivity, neither did 
sections preabsorbed with the corresponding antigen. 
c-Fos immunoreactivity was observed in 15/38 (39%) of DHT samples, and c-Jun in 28/38 (74%). 
Immunopositive clusters of disc cells (conglomerates, i.e.  3 cells) stained in 7/28 (25 %) of the 
total immunopositive samples. The immunoreaction in these clusters was mainly of the c-Jun type. 
No gender related differences could be observed regarding immunoreactivity. Furthermore, there 
were no statistically significant differences regarding proto-oncogene immunoreactions in 
extrusions compared with sequestrations. The total number of protrusions (n=2) was too small to 
make any statistical analysis. 
No statistically significant oncoprotein expression difference existed between the radicular pain 
duration groups. Furthermore, the presence of immunoreaction in cell groups (conglomerates) did 
not show any statistical difference between different radicular pain duration groups. 
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6.5 Growth factor expression in degenerated intervertebral disc tissue. 
An immunohistochemical analysis of TGF , FGF and PDGF (V) 
According to the Dallas Discogram Description the degree of degeneration was calculated as level 3 
in five discs and level 2 in six discs. In one disc the degree of degeneration was level 1, and 
discography data were missing from three discs. 
TGF -1 (Figure 1b in V) and TGF –2 immunoreactivity occurred in 15/16 discs, whereas all discs 
were TGF  receptor type II immunopositive (Figure 1c in V). Furthermore, all discs were bFGF 
immunopositive, but none showed any PDGF immunoreactivity (Figure 1a in V). 
In normal control discs no PDGF or bFGF immunoreactivity was observed, whereas TGF -1,
TGF –II, and TGF  receptor type II immunoreactivity did occur. 
Sections stained, omitting the primary antibody and sections preabsorbed with the corresponding 
antigen, were totally immunonegative. 
In degenerated discs, immunoreactivity was observed in either fibroblast-like disc cells, mainly seen 
in the annular region of the disc, or in chondrocyte-like disc cells, scattered more evenly throughout 
the disc, but especially noted in nucleus pulposus. Fibroblast-like disc cells were spindle shaped, 
often in lines, whereas chondrocyte-like disc cells were more rounded, often forming cell clusters. 
We also detected immunopositive blood vessels. 
When statistically comparing the immunostaining results for anterior annulus fibrosus, posterior 
annulus fibrosus and nucleus pulposus, specific differences could be observed: 
In the anterior part of the annulus, bFGF immunopositivity was far more common in chondrocyte-
like disc cells than in fibroblast-like disc cells (p=0.0063). In posterior annulus fibrosus, such 
overexpression of immunopositive chondrocyte-like disc cells was observed for both bFGF and 
TGF -2 (p=0.0001 and p=0.0092). TGF -1 immunopositive chondrocyte-like disc cells were more 
common in posterior annulus fibrosus than in the anterior part. Comparing nucleus pulposus with 
anterior annulus fibrosus, chondrocyte-like disc cell immunopositivity was statistically more often 
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observed in nucleus pulposus for TGF -1, TGF -2, and TGF  receptor type II (p=0.016, p=0.0006 
,and p=0.012). 
TGF  receptor type II immunopositivity in fibroblast-like disc cells was statistically observed more 
often in the anterior part of annulus fibrosus than in nucleus pulposus (p=0.016). 
Furthermore, in nucleus pulposus, immunoreactivity for all growth factors (bFGF, TGF -1, TGF -
2, and TGF  receptor type II) was far more often located in chondrocyte-like disc cells than in 
fibroblast-like disc cells (p=0.00000006, p=0.0011, p=0.00002, and p=0.000003) 
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7. Discussion 
7.1 FGF in herniated disc tissue (I) 
Blood vessels are not usually observed in adult intervertebral disc. Yasuma et al (1993) has 
demonstrated vascular invasion as a sign of intervertebral disc aging.  In their cadaver study, they 
have seen capillary invasion only in patients over 40.
FGF has been demonstrated to be a potent inducer of angiogenesis (Buntroc et al. 1982, 
Gospodarowicz et al. 1977) as well as chondro- and osteogenesis (Ellsworth et al. 2002, Ohbyashi 
et al. 2002).
FGF research on intervertebral disc tissue has started with a novel finding of the stimulatory effect 
of this growth factor in in vitro disc cells (Thompson et al. 1991). By now, this finding  has 
immunohistochemically been located (Doita et al. 1996; Melrose et al. 2002; Nagano et al. 1995) 
both in degenerated and in herniated intervertebral disc tissue.  Furthermore, FGF effect on the 
intervertebral disc has been analyzed in an experimental model in which FGF was injected into the 
epidural space (Minamide et al. 1999). FGF enhanced the degradative process in a dose-dependent 
manner. 
We observed bFGF immunopositivity (Tolonen et al. 1995) in 22/27 (81%) herniated discs (Table 
6.). This immunoreactivity was especially abundant in chondrocyte-like disc cells (67%), but also in 
blood vessels (48%) (Table 7). Small capillaries were identified by immunostaining with vWF, a 
marker for capillary endothelial cells. All vWF immunopositive vessels did not stain for bFGF. 
Colocalization of bFGF in some of these vWF immunopositive capillaries in parallel slides, led to 
the postulation of an active neovascularization process in herniated disc tissue. It should also be 
noted that FGF immunoreaction in blood vessels may show particularly active blood vessel 
formation from capillary endothelial cells (Eguchi 1992). We also observed bFGF 
immunopositivity in the granulation tissue area near the surface of the prolapsed disc. Doita et al 
(1996) noted similar result. They reported especially intense staining in extruded disc samples 
compared to protruded ones. Furthermore, in an animal model mimicking the disc degeneration 
process, bFGF was localized especially in cells and vessels near the trauma area (Melrose et al. 
2002). Interestingly, the peak of this expression occurred after 12 months, and thereafter 
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diminished. In addition, FGF has shown direct enhancement of proteolytic activity in tissues, even 
though it also induces the pericellular activator inhibitor (Lucore et al. 1988; McCarron et al. 1987). 
The FGF-dependent endothelial cell invasion, however, is inhibited by metalloproteinase inhibitors, 
such as TIMP, which counteracts stromelysin and collagenases (Edwards et al. 1987; Mignatti et al. 
1986; Mignatti et al. 1989). Moreover, FGF has been observed to enhance the expression of TIMP 
regulating the proteolytic activity in extracellular matrix, and to regulate plasminogen activator 
activity (Laiho and Keski-Oja 1989).  In addition, FGF stimulates plasminogen activator and 
interstitial collagenase production (Moscatelli et al. 1986). Plasminogen activation is the most 
effective inducer of extracellular matrix proteolysis (Saksela et al. 1988). Plasminogen is activated 
to an effective serine protease plasmin, which degrades most extracellular glycoproteins and protein 
parts of the glycosaminoglycans. Furthermore, plasmin activates latent collagenase, possibly 
together with stromelysin (He et al. 1989). Previously, Ng et al (1986) demonstrated such 
proteolytic activity in disc herniation tissue. We mainly localized FGF immunoreactivity to newly 
formed capillaries and in chondrocyte-like disc cells. Thus, FGF may also regulate the proteolytic 
activity in disc herniation tissue. This is further supported by the finding that these same 
chondrocyte-like disc cells are immunopositive to stromelysin (Grönblad et al. 1994). 
In our study all protruded discs were immunopositive to FGF, but sample number (n=3) were too 
small to make any further conclusions. The prolapse type did not otherwise show any statistical 
difference with respect to the immunolocalization of FGF, either cellular or vascular. Furthermore, 
the preoperative radicular pain duration did not show any clear relationship to the expression of 
FGF. In totally immunonegative samples, however, pain duration was the shortest with a mean time 
of only 1.5 months.  In discs showing only a vascular reaction the mean preoperative radicular pain 
duration was 3 months and for both the vascular and the cellular expression group it was 3.5 
months. The total number of studied discs was, however, too small to give further statistical power. 
Furthermore, a too wide range of preoperative radicular pain durations in different groups, existed. 
An earlier observation of the FGF peak expression at 12 months after trauma in an animal model 
(Melrose et al. 2002), and the immunolocation of FGF in disc cells and vessels in herniated discs in 
our study, especially the lack of FGF in normal control discs, suggests that FGF is inactive in 
normal avascular adult intervertebral disc. After some kind of trauma, either mechanical, as in 
experimental models, or with herniation into the epidural space, an active neovascularization of the 
disc is initiated. This first starts in the granulation tissue area, either near the trauma, or near the 
surface of prolapsed disc, and thereafter spreads throughout the disc, thereby accelerating the 
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resorption process. This can be noted by follow-up studies of disc herniation (Maigne et al. 1990; 
Saal et al. 1990).
Intense expression of FGF in disc cells and capillaries, the activation of neovascularization and 
proliferation induced by FGF in an experimental model, and especially the stimulation of disc 
resorption after disc herniation (Minamide et al. 1999), confirm a central role for FGF in 
intervertebral disc tissue.   
The presence of bFGF in disc cells and capillaries in disc herniated tissue, and the total absence of 
bFGF in normal control disc tissue, underlines the importance of bFGF in disc cell metabolism, and 
also in vascular endothelial cell proliferation.  
7.2 VEGF and PDGF in herniated disc tissue (II) 
VEGF is a potent inducer of angiogenesis, both in vitro (Ferrara and Henzel 1989; Connolly 1991) 
and in vivo (Carlevaro et al. 2000). In addition to our study on human herniated disc tissue (Tolonen 
II, 1997) there are two additional observations of this growth factor in intervertebral disc tissue. 
Haro et al (2002) showed that co-culturing human herniated discs with murine peritoneal 
macrophages, induced intense expression of VEGF in macrophages and neovascularization in 
herniated disc tissue. Koike et al. (2003) localized VEGF in herniated human lumbar discs in 
spindle-shaped cells in granulation tissue area. PDGF stimulates migration of smooth muscle cells, 
and is a true chemoattractant for vascular smooth muscle cells (Grotendorst et al. 1982). 
Additionally, it stimulates cell replication and protein synthesis (Canalis 1985) as well as invasion 
by fibroblasts (Gosiewska et al. 2001). Only three studies show PDGF in intervertebral disc tissue. 
Our group has located PDGF immunohistochemically in herniated disc tissue (Tolonen II, 1997) 
and analyzed PDGF in human degenerative discs (Tolonen V, 2005). In cell culture additional 
PDGF has been shown to reduce apoptotic activity (Gruber et al. 2000a).
Chondrocyte-related data of both these growth factors (PDGF and VEGF) are mainly from cartilage 
research. PDGF stimulates cell migration and DNA-synthesis in a dose-dependent manner 
(Kieswetter et al. 1997). Interestingly, especially young chondrocytes express PDGF intensely 
(Guerne et al. 1995). Furthermore, the expression of PDGF is intense in osteoarthritic chondrocytes 
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(Moos et al. 1999). VEGF, on the other hand, has been shown to be expressed in hypertrophic 
chondrocytes and osteoarthritic chondrocytes (Pufe et al. 2001). In cartilage VEGF has a prominent 
role during both growth and repair (Horner et al. 1999). It is, however, absent in chondrocytes of 
the resting zone, and expression is weak in the proliferation zone chondrocytes, whereas in the 
hypertrophic zone expression of chondrocytes is intense. 
Several studies report an active neovascularization process in herniated intervertebral disc tissue 
(Freemont et al. 2002; Haro et al. 2002; Minamide et al. 1999; Ozaki et al. 1999; Tolonen et al. I; II; 
III).  We observed VEGF expression in 44/50 (88%) of herniated discs, and PDGF in 38/50 (78%) 
(Tolonen et al. II). VEGF expression was located in the capillaries and PDGF was present in 54% in 
capillaries, in 38% in chondrocyte-like disc cells, and in 12% in fibroblast-like disc cells. 
Interestingly, PDGF immunopositivity was observed particularly in the youngest group of patients 
(< 40 years). This may suggest that the reactivity for PDGF decreases with age. Preoperative pain 
duration did not relate to the reactivity. Nor was any statistical difference between different 
prolapse types seen. Only one of the three protrusions showed immunoreactivity for PDGF and/or 
VEGF, whereas all sequesters were VEGF immunopositive and 23/25 extrusions showed VEGF 
immunoreactivity. In both sequesters and extrusions PDGF immunoreaction was located more often 
in capillaries than in disc cells. We also, however, noted disc cell associated reaction either in 
chondrocyte-like or in fibroblast-like disc cells. 
The presence of active angiogenic growth factor VEGF in herniated disc tissue, both in capillaries 
(Tolonen et al. II) and in spindle-shaped cells (Koike et al. 2003) suggests an active role for this 
growth factor in the neovascularization process. Indeed, a linear correlation for cellular VEGF 
expression in endothelial cells and macrophages has been demonstrated (Koike et al. 2003).
The expression of PDGF both in disc cells and in capillaries in disc herniation may suggest an 
active role for this growth factor in the regulation of intradiscal cells and vascular endothelial cells. 
On the other hand, normal control discs were totally immunonegative for this growth factor. 
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7.3 Transforming growth factor beta in herniated disc tissue (III) 
TGF  stimulates extracellular matrix component formation and regulates cellular growth and 
extracellular proteolysis (Campbell et al. 1994; Ignotz and Massagues 1986; Laiho and Keski-Oja 
1986; Raghow et al. 1987; Roberts et al. 1986; Wright et al. 1991). Furthermore, TGF  participates 
in angiogenesis and in the early phase of inflammation (Lotz et al.1992; Pujol et al. 1991; Roberts 
et al. 1986). Such proteolytic activity also exists in herniated disc tissue (Ng et al. 1986). 
TGF  has a well-documented role in chondrocyte maturation (Dangelo et al. 2001). Furthermore, it 
is postulated that TGF  in chondrocytes can by an autocrine route regulate the contents of 
extracellular matrix (Wang et al. 2002). It inhibits matrix metalloproteinase inhibitors (Pattison et 
al. 2001). Especially intense expression has been noted during development. For example, in the 
developing growth plate, hypertrophic chondrocytes, chondroclasts, osteoblasts and osteoclasts 
expressed TGF  (Thorp et al. 1992). 
In addition, TGF  has a dual role, it is stimulatory for precursor cells and inhibitory for mature cell 
lines (Bostrom and Asnis 1998). In cell culture with low serum concentration, TGF  also shows 
inhibitory effects on cell growth, whereas addition of 10% calf serum changes the action of TGF
stimulatory for cell growth (Pujol et al. 1994).  Chondrocytes have a specific mechanism in TGF
function (Pedrozo et al. 1999). They can activate the latent TGF  from extracellular matrix. 
It is notable that in our study (Tolonen et al. III) all samples, both herniated discs (n=50) and 
normal control discs (n=8), were immunopositive to TGF -1, TGF -2 and TGF  receptor Type II. 
This reaction was located in chondrocyte-like disc cells and in some samples in capillaries. The 
most important finding was that by immunoquantitation assay the number of immunopositive cells 
for both TGF  and receptor Type II was statistically (p<0.0001) higher in herniated discs than in 
control discs. The 95% CI did not overlap at all. The key finding was that the number of TGF
receptor Type II positive cells increased. This would suggest that TGF  can autoregulate its 
receptor and promotes receptor induction in herniated intervertebral discs. It could be that as in 
cartilage, TGF  may be latent in extracellular matrix, and that chondrocyte-like cells can respond as 
chondrocytes and that TGF  may in an autocrine way activate disc cells and latent TGF . The 
neovascularization seen after disc herniation allows another route to TGF  for disc cell stimulation. 
In intervertebral disc tissue TGF  is, in addition to lymphokines, the most studied cytokine. During 
development and growth its expression decreases with age (Matsunaga et al. 2003; Nagano et al. 
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2000). Both fibrocartilaginous cells in annulus fibrosus and notochord-like cells in nucleus 
pulposus, show intense TGF  expression in young discs. Furthermore, Thompson et al (1991) 
showed that especially TGF  stimulates disc cells in cell cultures. Cells from nucleus pulposus and 
the transition zone were more reactive than cells from annulus fibrosus. In later studies, an intense 
stimulation of both nucleus pulposus and annulus fibrosus cells has been demonstrated (Alini et al. 
2003).
In an experimental animal model for the intervertebral disc degeneration process, TGF  was located 
in disc cells and vessels in the granulation tissue area near the annular tear (Melrose et al. 2002). 
Interestingly, the investigators also noted scattered TGF  immunopositive cells in control discs. 
Furthermore, TGF -1 gene transferred into a rabbit intervertebral disc shows 100% elevation in 
proteoglycan synthesis and a 30-fold more active TGF -1 presentation in nucleus pulposus cells 
(Nishida et al. 1999). 
Our study was mainly concerned with extruded and sequestrated disc herniations. In disc 
protrusions TGF -1 is located in chondrocyte-like disc cells (Specchia et al. 2002). Konttinen et al 
(1999) only occasionally observed TGF  -1, TGF –3 and TGF  receptor Type II. This difference 
in results could be due to the small total number (n=10) of herniated discs in their study. Nor did 
they report the type of prolapse or preoperative pain duration. In that study RT-PCR for TGF s and 
receptor were also negative, but another study demonstrated RT-PCR positivity in human herniated 
disc specimens (Ahn et al. 2002). Ahn et al. (2002) observed TGF  in 5/10 studied disc samples. 
Thus, the intervertebral disc appears to be a difficult tissue for modern molecular biological 
techniques. Perhaps the main reason for this is the small number of total cells in disc tissue and the 
huge overexpression of extracellular matrix and its components compared to disc cells. 
Nevertheless, a need exists for further investigation of the role of active and latent TGF  and their 
location in the extracellular matrix, as well as the total activation process in intervertebral disc 
tissue.
We showed marked statistical difference between TGF  and its receptor type II immunopositivity 
in disc herniation tissue compared to such immunopositivity in normal control disc tissue, 
highlighting the activation of TGF . Especially the statistical difference in TGF  receptor type II 
expression suggests receptor induction in disc herniation tissue. Such an extended expression in disc 
herniation tissue, compared to normal control disc tissue may suggest pronounced local production 
of TGF  and positive loop control of the production: An elevated level of TGF  may stimulate the 
receptor production and the enhanced receptor activation further stimulate the production of TGF .
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TGF  is present and active during the development and growth of the intervertebral disc. During 
maturation and after disc tissue has become avascular, TGF  does not disappear. It is still present in 
cells of avascular tissue and perhaps also in a latent form in extracellular matrix, being again 
activated after some kind of trauma, either mechanical trauma affecting the annular area or 
degeneration and herniation of the intervertebral disc. Furthermore, TGF  allows for autoregulation 
of the cells through its receptor induction. 
7.4 Oncoprotein c-Fos and c-Jun expression, cellular activation and cell clusters 
in herniated disc tissue (IV) 
A healthy adult disc contains relatively few cells distributed sparsely throughout the disc. In 
contrast, in damaged or degenerated disc the cell number has increased. Disc cell clusters are 
typically seen (Pritzher 1977), particularly in damaged areas (Johnson et al. 2001). The proliferation 
markers PCNA (proliferation cell nuclear antigen) and Ki-67 have immunohistochemically been 
located especially in these clusters. PCNA is expressed more than Ki-67. These markers were not 
common in less degenerated discs or in areas of the degenerated discs where no clusters occurred 
(Johnson et al. 2001). 
In addition, in herniated discs proliferation activity marker Ki-67 has been localized in disc cells 
(Paajanen et al. 1999).  Interestingly, in that study Ki-67 occurred in first-time prolapses but was 
absent in recurrent ones. This may indicate that enhanced extracellular matrix proliferation is not 
associated with recurrent prolapses. 
We observed components of the early transcription factor AP-1 (c-Fos and c-Jun) in human 
herniated discs (Tolonen et al. IV).  Nuclear oncoproteins c-Fos and c-Jun (or their related proteins 
JunB or JunD) represent the AP-1, and they act as intracellular messengers converting short-term 
signals generated by extracellular stimulators into long-term changes in cell phenotype. This is done 
by regulating the expression of downstream genes that possess an AP-1 binding site (Angel et al. 
1991).
The importance of AP-1 transcription factors in chondrocyte differentiation was highlighted in vitro
by Thomas et al (2000). In particular, the induction of c-Fos resulted in concomitant increase in the 
expression of fra-1 and c-jun. The overexpression of c-Fos also directly inhibited chondrocyte 
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differentiation and it has previously been observed that the growth-stimulatory effect of TGF -1 in 
chondrocytes is mediated by activation of the c-fos oncogene (Osaki et al. 1999). This is mediated 
by protein kinase activation (Yonekura et al. 1999).
Interestingly, our normal control discs did not express these AP-1 factors. In herniated discs c-Jun 
was expressed more frequently than c-Fos, in 28/38 (74%) and in 15/38 (39%). This may indicate 
that in disc cell activation, after the disc herniation, c-Jun plays a more important role. Observation 
in cell culture studies show that either c-fos or c-jun alone, or a combination of these is able to 
stimulate matrix metalloproteinase –1 (MMP-1) transcription activity (Tsuji et al. 2000). Moreover, 
c-fos alone decreases the transcription activity of Type II collagen and TIMP-1. Furthermore, in 
another cell culture study the combination of c-Fos and c-Jun did not affect the transcription activity 
of TIMP-1, but stimulated that of MMPs (Tsuji et al. 1996). We did not observe lone c-Fos 
immunopositivity, whereas lone c-Jun immunoreactivity occurred as well as the immunoreactivity 
to both oncoproteins. This may suggest that proteolytic activity, in herniated disc also, is controlled 
by expression of c-Fos and c-Jun. 
We saw no correlation when focusing on preoperative pain duration or gender related differences in 
oncoprotein expression. Furthermore, prolapse type did not seem to matter either. 
Oncoprotein immunopositive cell clusters occurred in 7/28 (25%) of the studied herniated discs. 
Interestingly, that expression was mainly of the c-Jun type, possibly indicating, that c-Jun may be 
more important than c-Fos in the disc cell clusters. Indeed, turnover of matrix components is 
established with an intricate balance between synthesis and degradation of associate molecules, 
such as MMP and TIMP. Previously, c-fos had been observed to be degradative (Tsuji et al. 2000), 
whereas Jun related proteins stimulated both MMP and TIMP (Tsuji et al. 2000). This may indicate 
that disc cell clusters participate in the turnover of the extracellular matrix.  Regulation of the 
previously noted degradative enzyme activity (Ng et al. 1986) and activation of matrix 
metalloproteinases (Roberts et al. 2000) in herniated disc tissue could also be partly mediated by 
AP-1 protein in disc tissue. 
This presence of c-Jun, and also to some extent c-Fos, demonstrates that these clusters exhibit 
transcriptional activity, being active components in the herniated discs. The formation of such 
clusters is associated with degenerative disease (Pritzher 1977; Johnson et al. 2001). The pattern of 
proliferation cell nuclear antigen (PCNA) and proliferation associated antigen Ki-67 positivity in 
degenerated disc tissue samples, suggests that disc cell clusters arise through increased cell 
proliferation (Johnson et al. 2001). This is further supported by our observation of AP-1 proteins in 
disc cell clusters in herniated disc tissue. Furthermore, a previous observation of colony formation 
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in vitro, by annular cells from patients with degenerative disc disease, and from young normal discs, 
exists (Desai et al. 1999). 
7.5 Cellular remodelling in different areas of degenerated intervertebral disc 
tissue (V) 
Degenerated discs have lost their normal architecture, and changes occur both in nuclear and 
annular parts of the disc.  Annulus cells change markedly (Pritzher 1977). Spindle-shaped 
fibroblast-like cells become more rounded chondrocyte-like cells. At the same time they are 
surrounded by unusual accumulations of extracellular matrix components (Gruber and Hanley 
2000b).
We observed growth factor immunopositivity in both fibroblast-like disc cells and chondrocyte-like 
disc cells. Interestingly, PDGF immunopositivity was, however, entirely absent. One benefit of our 
study was the ability to compare different parts of the degenerated discs: nucleus pulposus, anterior 
annulus fibrosus and the ruptured posterior annulus fibrosus. Some important differences in growth 
factor expression in these areas exist. As could be expected in nucleus pulposus an intense staining 
occurred for all immunopositive growth factors in chondrocyte-like cells. Posterior and anterior 
annulus fibrosus (AF) differed from each other and from nucleus pulposus (NP). Posterior AF 
somewhat resembled NP. An intense immunopositivity was seen in chondrocyte-like disc cells for 
bFGF, TGF -2, and TGF  receptor type II. 
An intense immunopositivity was observed in anterior annulus fibrosus for bFGF and TGF
receptor type II in chondrocyte-like cells and for TGF  receptor type II in fibroblast-like cells. 
Many of these degenerated painful discs showed posterior or posterolateral ruptures within annulus 
fibrosus, and in some small protrusions. A few discs were totally ruptured. This growth factor 
expression result suggests that the important site for the degenerating process is the border between 
nucleus pulposus and posterior annulus fibrosus. Intense staining for growth factors in posterior AF 
in chondrocyte-like disc cells compared to fibroblast-like disc cells demonstrates that especially 
chondrocyte-like disc cells are probably activated. Clusters of these chondrocyte-like disc cells 
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were also observed. The activation of growth factors also in the anterior part of annulus fibrosus 
means that in the degeneration process the whole disc is involved. The signal spreads to the entire 
disc. In the anterior AF only bFGF showed an intense immunoreaction in chondrocyte-like disc 
cells. This may suggest that FGF is activated before TGF , in the cellular remodelling process. 
Interestingly, TGF  receptor type II showed an intense reaction in both chondrocyte-like and 
fibroblast-like disc cells in anterior AF. Moreover, in fibroblast-like disc cells this was the only very 
intense immunopositive reactivity observed. Indeed, this could highlight the importance of TGF . It 
may be that at this stage TGF  is activated from a latent form in extracellular matrix and that 
cellular activation comes later. Altogether, the observed growth factor immunoreactivity in disc 
cells suggests that these cells may be actively regulating the turnover of extracellular matrix 
components. An interesting subgroup was the most degenerated discs (degree of degeneration level 
3 in the Dallas Discogram Description) (Sachs et al. 1987). None of these samples showed 
fibroblast-like disc cell immunoreactivity. In nucleus pulposus all samples showed chondrocyte-like 
disc cell immunopositivity, whereas in the annular area such immunoreactivity could only be 
observed for TGF  receptor type II. Unfortunately the total number of such severely degenerated 
discs was too small for further statistical analyses. 
In an experimental animal model the degeneration process could be delayed with reinsertion of 
autogenous activated nucleus pulposus (Okuma et al. 2000). This activation was produced by co 
culturing nucleus pulposus cells with annulus fibrosus cells. During the co-culture both cell types 
were proliferating.  In addition, reinsertion of activated nucleus pulposus, especially delayed the 
formation of clusters of chondrocyte-like disc cells. We observed such clusters in both nucleus 
pulposus and annulus fibrosus. Furthermore, injection of intact nucleus pulposus is far more 
effective in delaying degeneration than injection of only nucleus pulposus cells (Nomura et al. 
2001), thus highlighting the importance of the extracellular matrix. In addition, in chondrocyte-like 
disc cell clusters marked matrix metalloproteinase activity has been demonstrated (Roberts et al. 
2000). Interestingly, such enzyme activity was particularly intense in herniated discs (Roberts et al.  
2000). The presence of growth factors (Tolonen et al. I; II; III; V), matrix metalloproteinases 
(Roberts et al. 2000) and oncoproteins (Tolonen et al. IV) suggest that these particular chondrocyte-
like disc cells have been activated in pathological processes (including degeneration and herniation) 
of the intervertebral disc tissue. They may regulate the turnover of extracellular matrix. 
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Since a time gap between discography and the operation existed in our study, the possible local 
irritation caused by the discography procedure was not present at the time when tissue samples were 
taken, for further analysis. Of note, we observed growth factor immunopositivity throughout the 
whole discs, not only restricted to the disrupted posterior annulus fibrosus. 
Comparing the results of growth factor expression in degenerated intervertebral disc to that of 
herniated discs revealed some differences. Firstly, PDGF is expressed in herniated discs, but not in 
degenerated discs. Furthermore, normal control discs were also totally immunonegative for PDGF, 
possibly indicating that until PDGF is activated it may be in a latent form. Alternatively, PDGF is 
delivered together with inflammatory cells. The key element may be the posterior longitudinal 
ligament.  We hypothesize that PDGF is not activated until the disc has ruptured through the 
posterior longitudinal ligament. Bulging through this ligament exposes the disc to the epidural 
space and inflammatory responses may proceed, and PDGF is delivered to the disc. One source of 




The cell proliferative and angiogenic FGF can be concluded to be expressed in herniated 
intervertebral disc tissue, both in disc cells and in small capillaries. Furthermore, normal adult disc 
tissue does not express this growth factor. Thus, FGF most likely participates in neovascularization 
of herniated disc tissue and is part of a more extensive growth factor network regulating 
extracellular matrix turnover and cell proliferation. PDGF appears to have a similar expression 
pattern as FGF in herniated intervertebral disc tissue and in normal adult discs. VEGF is expressed 
in capillaries of herniated intervertebral disc tissue, but not in normal discs. The lack of expression 
of FGF, PDGF and VEGF, in normal disc tissue suggests that these growth factors are activated 
after disc herniation and may be participants in the trauma healing process. They may also have a 
role in disc tissue resorption after herniation. TGF  differs from the previous growth factors. It is 
expressed in both normal and herniated disc tissue. The observed expression in normal adult disc 
tissue may suggest a specific role for TGF  in the maintenance and control of normal intervertebral 
extracellular disc tissue matrix turnover. A clear receptor type II induction, in herniated disc tissue, 
and a statistically marked increase in expression of TGF  compared to normal disc tissue exits, 
thus, suggesting TGF  activation in herniated disc tissue.  
Thus, one can conclude that PDGF, FGF, VEGF and TGF  are all part of a disc growth factor 
network which crosstalks between cell surface, surrounding extracellular matrix, and the 
intracellular signal cascade system. Presently it is not known which growth factor is initially 
activated and which is the most important. TGF  can be highlighted, however, also for its 
expression in normal adult disc tissue. 
In herniated disc tissue the main cell type which expresses PDGF, FGF and TGF  appears to be the 
chondrocyte-like disc cell. Because of the often undefined nature of herniated disc material, it is 
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difficult to determine whether true nucleus pulposus cells are the active cells or the spindle shaped 
cells from annulus fibrosus, that have remodelled in to a more chondrocyte-like cell type. 
In disc herniation tissue cell activation is prominent. Oncoprotein c-Fos or c-Jun expression could 
not be shown in normal discs. In herniated disc tissue the expression was more often of the c-Jun 
type. The expression was mainly located in chondrocyte-like disc cells, and interestingly, we 
detected conglomerates (groups of immunopositive disc cells). This highlights the importance of 
chondrocyte-like disc cells and conglomerates acting as activation centres, in herniated disc tissue. 
Different parts of the intervertebral disc tissue could separately be observed from the intervertebral 
disc material, of patients operated on for painful degenerative disc disease. Nucleus pulposus 
chondrocyte-like disc cells expressed FGF, TGF -1, TGF -2, and TGF  receptor type II. In 
posterior annulus fibrosus such expression was observed for FGF, TGF -2, and TGF  receptor type 
II in chondrocyte-like disc cells, whereas in anterior annulus fibrosus expression was shown for 
FGF and TGF  receptor type II expression in chondrocyte-like disc cells and for TGF  receptor 
type II in fibroblast-like disc cells. Even in the annulus fibrosus, chondrocyte-like cells are the main 
cells expressing growth factors. Interestingly, PDGF was totally absent in degenerated 
intervertebral disc tissue. PDGF could only be observed in herniated intervertebral disc tissue. Since 
PDGF is important in vascularization and tissue healing, its total absence in degenerated and normal 
disc tissue may partly explain poor healing properties of disc ruptures and fissures. 
In the intervertebral disc tissue, growth factors actively participate in a network regulating disc cell 
growth, proliferation, extracellular matrix turnover and neovascularization. The cell type expressing 
growth factors and also oncoproteins, is the chondrocyte-like disc cell, highlighting the importance 
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of this particular cell type in the basic pathophysiologic events relating to disc degeneration and 
rearrangement. 
9. Hypothesis of cellular remodelling in intervertebral disc tissue 
A simplified hypothesis of the role played by various growth factors in intervertebral disc 
remodelling, from a normal vascular developing and growing disc tissue to an avascular stage, 
followed by pathological alterations induced by degeneration and disc herniation may be presented. 
During development and growth the intervertebral disc is a vascularized tissue (A in Figure 1). 
Vascularity disappears during the second decade of life, during which time the disc obtains its 
normal avascular structure. At this stage an animal model reported intense expression of TGF
(Matsunaga et al. 2003; Nagano et al. 2000) and IGF-1 (Osada et al. 1996). Interestingly, this 
expression decreased with age. 
At the adult stage (B in Figure 1) disc cell nutrition is mainly supplied to the disc through the end-
plates and disc cells are at a resting stage. Nucleus pulposus cells are rounded chondrocyte-like 
cells, and annulus fibrosus cells are mainly spindle-shaped fibroblast-like cells. At this stage disc 
cells express TGF -1, TGF –2 and TGF  receptor type II. Despite the disappearance of vascularity 
during growth, disc cells may remain capable of reacting to possible neovascularization. Cell 
responses after trauma appear to be similar to those observed in growing disc tissue. 
Mechanical trauma, overload, and genetic predisposition may produce the susceptibility for 
disruption of the circular collagen lamellae in annulus fibrosus (C in Figure 1), and activation of 
disc cells. The essential site may be the border between nucleus pulposus and inner zone of the 
posterior annulus fibrosus. Disc cells begin to produce, besides TGF s, other growth factors 
influencing themselves, extracellular matrix, and the neovascularization process. Growth factors 
can act basically by three different routes (Figure 2): 1. Endocrine, in which the growth factor is 
delivered to the area by vascular supply, 2. Paracrine, the growth factor affects surrounding cells, 
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and 3. Autocrine, when the growth factor affects the producing cell itself. In a delayed paracrine 
route growth is activated from extracellular matrix, where the growth factor is stored. 
An alteration of disc shape also exits. Additional annular cells become chondrocyte-like cells and 
the disruption of extracellular matrix proceeds, producing more serious tissue damage. This cellular 
remodelling may spread from the initial starting point, the border area between nucleus pulposus 
and posterior annulus fibrosus, to the entire disc. Different growth factors are expressed at various 
time points of this process.  At the disc degeneration stage (C in Figure 1), nerve ingrowth is also 
coupled with neovascularization and, although debated, some authors have suggested that this 
process may be painful (Coppes et al. 1997; Freemont et al. 1997). 
Later on, mechanical stress is more intense in the posterior region of annulus fibrosus due to more 
pronounced cellular remodelling and collapse of normal lamellar architecture of collagen. This may 
in the end lead to disc herniation (D in Figure 1), producing sciatica. At this stage (D) the 
neovascularization process and cellular remodelling still proceed. New elements also appear. 
Bulging of disc tissue through the posterior longitudinal ligament exposes the disc to the epidural 
space. Being there it can irritate surrounding tissue (Ozaki et al. 1999) and at the same time be 
affected itself. Inflammatory cells, for example macrophages, present in the granulation tissue area 
may deliver totally new growth factors to the intervertebral disc tissue. Growth factors may be part 
of an important network consisting of cytokines, lymphokines, proteolytic enzymes and their 
regulators. These factors affect the surrounding tissue and at the same time will be affected by other 
local factors. Furthermore, it may be that the key element, ” the most important growth factor” has 
not yet been recognized. Nevertheless, the disc cell, and especially the remodelling of annular disc 
cells may play an essential role in intervertebral disc metabolism and in maintenance of the 
structure of the disc.
cellular remodelling process continues over time in the prolapsed intervertebral disc tissue. The 
same process takes place in remaining intervertebral disc. This process may end in a steady-state 
situation (E in Figure 1), characterized possibly by a slow reorganization of the disc structure, or in 
reherniation. The disc degeneration process (C) may also end in a reorganized end-state (E). 
With time the size of the herniated disc becomes smaller (Maigne et al. 1992; Saal et al. 1990). The
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Figure 1. Schematic showing the pattern of growth factor expression in normal young and adult 
intervertebral disc (A and B), in degenerated intervertebral disc (C) and in herniated intervertebral 
disc (D). (E) shows reorganization of disc tissue.











































Figure 2. Schematic showing different routes of growth factor action. 
                                         
1.Endocrine
2. Paracrine 









This study was carried out at the Department of Orthopaedics and Traumatology and the Spine 
Research Unit Laboratory, University of Helsinki, during the years 1994-2005. For the opportunity 
to be able to do this work, as well as the guiding support throughout the study, I would like to 
express my greatest gratitude to Professor Erkki O. Karaharju, MD, PhD, the leader of the research 
group and my supervisor. Furthermore, I am most grateful to my supervisor Professor Tapio 
Rytömaa, MD, PhD, for his help and support during the course of the work. 
I also want to thank Professor Pentti Rokkanen, MD, PhD, the Head of the Department of 
Orthopaedics and Traumatology –2000 and Professor Seppo Santavirta, MD, PhD, the Head of the 
Department of Orthopaedics and Traumatology 2000-2005, for giving me the opportunity to do this 
study at the Department. 
The most important person supporting this work was my supervisor Docent Mats Grönblad, MD, 
PhD, the Head of the Department of Physical Medicine and Rehabilitation, to whom I am most 
grateful. Those enthusiastic discussions and debates were superb. I remember with respect his 
continuous activity and interest in intervertebral disc tissue research. 
I would like to thank my co-authors Professor Seppo Seitsalo, MD, PhD, Department of Surgery, 
Jorvi Hospital, Helsinki District University Hospital, presently Orton Orthopaedic Hospital, 
Professor Heikki Vanharanta, MD, PhD, The Head of  the Department of Physical Medicine and 
73
Rehabilitation, University of Oulu, and Dr Richard D Guyer, Texas Back Pain Institute, Plano, 
Texas, for their productive collaboration and support. 
My co-author Johanna Virri, MSc and the member of our research group Dr Aklilu Habtemariam, 
MD, PhD, are gratefully acknowledged for their friendship and support, and for valuable help in 
laboratory work. 
Professor Kjell Olmarker, MD PhD, Department of Orthopaedics, Sahlgrenska Academy, Göteborg 
University, Gothenburg; Sweden and associate professor Dan CE Nordström, MD PhD, Helsinki 
University Central Hospital, Department of Medicine and Rheumatology are also thanked for their 
kind and precise revision of the thesis. 
I also want to thank Docent Juhani Partanen, MD, PhD, the Head of the Internal Medicine Division, 
Jorvi Hospital, Helsinki District University Hospital for his support during the late course of this 
study. This support was essential for finishing this thesis. 
Most of all, I would like to thank my whole family Emmi, Arttu, Sanni, and especially Kirsti, my 
wife, for their understanding and support through all these years. And of course our Bernese 
Mountain Dog Siiri for the inspiring walks during which most of the ideas were developed. 
74
11. References 
Abraham JA, Mercia A, Whang JL et al  (1986). Nucleotide sequence of a bovine  clone encoding 
the angiogenic protein, basic fibroblast growth factor. Science 233:545-8 
Ahn SH, Cho YW, Ahn MW, Jang SH, Sohn YK, Kim HS (2002). MRNA expression of cytokines 
and chemokines in herniated lumbar intervertebral discs. Spine 27:911-7 
Ahsan R, Tajima N, Chosa E, Sugamata M, Sumida M, Hamada M (2001). Biochemical and 
morphological changes in herniated human intervertebral disc. J Orthop Sci  6:510-8
Aikawa T, Segre GV, Lee K (2001). Fibroblast growth factor inhibits chondrocytic growth through 
induction of p21 and subsequent inactivation of cyclin E-Cdk2. J Biol Chem 276:29347-52  
Alini M, Li W, Markowic P, Aebi M, Spiro RC, Rouhgley PJ (2003). The potential and the 
limitations of a cell-seeded collagen/hyaluronan scaffold to engineer in intervertebral disc like 
matrix. Spine 28:446-54  
An HS, Tagekami K, Kamada H, et al. (2004). Intradiscal administration of osteogenic protein-1 
increases intervertebral disc height and proteoglycan content in the nucleus pulposus in normal 
adolescent rabbits. Spine 30:25-32 
Anderson DG,  Izzo MW, Hall DJ, et al. (2002). Comparative gene expression profiling of normal 
and degenerative discs: analysis of a rabbit laceration model. Spine 27:1291-6 
Andersson GBJ (1993). Intervertebral disk: Clinical aspects. Musculoskeletal soft tissue aging: 
Impact on mobility. In: Buckwalter JA, Goldberg VM, Woo SL-Y, eds. Rosemont, IL: American 
Academy of Orthopaedic Surgeons, 331-47 
Angel P, Allegretto EA, Okino ST, et al. (1988). Oncogen jun encodes a sequence-specific trans-
activator similar to AP-1. Nature 332:166-71 
75
Angel P, Karin M (1991). The role of Jun, Fos and the AP-1 complex in cell-proliferation and 
transformation. Biochim Biophys Acta 1072:129-57 
Annunen S, Paassilta P, Lohiniva J, et al (1999). An allele of COL9A2 associated with 
intervertebral discs. Science 285:409-12 
Antoniou J, Steffen T, Nelson F, et al. (1996). The human lumbar intervertebral disc: evidence for 
changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, 
ageing, and degeneration. J Clin Invest 98:996-1003
Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB (1983). Transforming growth factor 
beta in human platelets. J Biol Chem 258:7155-60 
Bachmann KE, Park BH (2004). Duel nature of TGF-  signalling: tumor suppressor vs. tumor 
promoter. Curr Opin Oncol 17:49-54 
Ballock RT, Heydemann A, Wakefield LM, Flanders KC, Roberts AB, Sporn MB (1993). TGF-
beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage 
matrix proteins and metalloproteases. Dev Biol  158:414-29  
Bakker AC, van de Loo FA, van Beuningen HM, et al. (2001). Overexpression of active TGF-beta-
1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. 
Osteoarthritis Cartilage  9:128-36
Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR (1992). Vascular permeability factor 
(vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages 
and tumors. Mol Biol Cell 3:211-20 
Bhargava MM, Attia ET, Murrell GA, Dolan MM, Warren RF, Hannafin JA (1999). The effect of 
cytokines on the proliferation and migration of bovine meniscal cells. Am J Sports Med 27:636-43  
Bobechko WP, Hirsch C (1965). Auto-immune response to nucleus pulposus in the rabbit, J Bone 
Joint Surg [Br] 47:574-80 
76
Bohmann D, Tijan R (1989). Biochemical analyses of transcriptional activation by Jun: differential 
activity of c- and v-jun. Cell 59:709-17 
Bohmann D, Bos TJ, Admon A, Nishimura T, Vogt PK, Tijan R (1987). Human proto-oncogene c-
jun encodes a DNA binding protein with structural and functional properties of transcription factor 
AP-1. Science 238:1386-92 
Boos N, Weissbech S, Rohrbach H, Weiler C, Spratt KF, Nehrilch AG (2002). Classification of 
age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science. Spine 
27:2632-44
Bos TJ, Bohmann D, Tsuchie H, Tijan R, Vogt PK (1988). v-jun encodes a nuclear protein with 
enhancer binding properties of AP-1.  Cell 52:705-12 
Bostrom MP, Asnis P (1998). Transforming growth factor beta in fracture repair. Clin Orthop 355 
Suppl:S124-31
Brisby H, Olmarker K, Larsson K, Nutu M, Rydevik B (2002). Proinflammatory cytokines in 
cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur Spine J (11):62-6 
Brown MD (1971). The pathophysiology of the disc disease. Orthop Clin N Am 2:359-70 
Buckwalter JA (1982). Fine structural studies of the human intervertebral disc. In: White AA, 
Gordon SL, eds. Idiopathic low back pain. St. Louis:CV Mosby,108-43 
Buckwalter JA, Pedrini A, Tudisco C, Pedrini V (1985). Proteoglycans of human infant 
intervertebral disc. Electron microsscopic and biochemical studies. J Bone Joint Surg 67A:284-94 
Buckwalter JA (1995). Spine Update. Aging and degeneration of the human intervertebral disc. 
Spine 20:1307-14 
Buntrock P, Jentzsch KD, Heder G (1982). Stimulation of wound healing, using brain extract with 
fibroblast growth factor (FGF) activity. II. Histological and morphometric examination of cells and 
capillaries. Exp Pathol 21:62-7 
77
Burmester JK, Qian SW, Roberts AB, et al (1993). Characterization of distinct functional domains 
of transforming growth factor beta. Proc Natl Acad Sci USA 90:8628-32 
Campbell IK, Wojta J, Novak U, Hamilton JA (1994). Cytokine modulation of plasminogen 
activator inhibitor-1 (PAI-1) production in human articular cartilage and chondrocytes. Down-
regulation by tumor necrosis factor alpha and  up-regulation of transforming growth factor beta and 
basic fibroblast growth factor. Biochim Biophys Acta 1226:277-85 
Canalis E (1985). Effect of growth factors on bone cell replication and differentiation. Clin Orthop 
193:246-63
Carlevaro MF, Cermelli S, Cancedda R, Descalzi-Cancedda F (2000). Vascular endothelial growth 
factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role 
during endochondral bone formation. J Cell Sci 113:59-69
Connolly DT (1991). Vascular permeability factor:a unique regulator of blood vessel function. J 
Cell Biochem 47:219-23 
Coppes MH, Masoni E, Thomeer RTWN, Groen GJ (1997). Innervation of ”painful” lumbar discs. 
Spine 22:2342-50 
Crean JK, Roberts S, Jaffray DC, Eisenstein SM, Duance VC (1997). Matrix metalloproteinases in 
the human intervertebral disc: role in disc degeneration and scoliosis. Spine 22:2877-84
Dailey L, Laplantine E, Priore R, Basilico C (2003). A network of transcriptional and signalling 
events is activated by FGF to induce chondrocyte growth arrest and differentiation. J Cell Biol 161: 
1053-66
Dailey L, Ambrosetti D, Mansukhani A, Basilico C (2005). Mechanismis underlying differential 
responses to FGF signalling. Cytokine and growth factor reviews 16:233-47 
78
Dangelo M, Sarment DP, Billings PC, Pacifici M (2001). Activation of transforming growth factor 
beta in chondrocytes undergoing endochondral ossification. J Bone Miner Res 16:2339-47
Delli Povi P,  Curatola AM, Kern FG, Greco A, Ittman M, Basilico C (1987). An oncogene isolated 
by transfection of Kaposis’s sarcoma DNA encodes a growth factor that is a member of the FGf 
family. Cell 50:729-37 
Derynck R, Jarrett JA, Chen EY, et al (1985). Human transforming growth factor beta 
complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-5 
Desai BJ, Gruber HE, Hanley EM Jr (1999). The influence of Matrigel or growth factor reduced 
Matrigel on human intervertebral disc cell growth and proliferation. Histol Histopathol 14:359-68 
Dickson C, Peters G (1987). Potential oncogene product related to growth factors. Nature 326:833 
Dickson IR, Happey F, Pearson CH, et al (1967). Variations of the protein components of human 
intervertebral disc with age. Nature 215:50-3 
Doita M, Kanatani T, Harada T, Mizuno K (1996). Immunohistologic study of the ruptured 
intervertebral disc lumbar spine. Spine 21:235-41 
Doita M, Kanatani T, Ozaki T, Matsui N, Kurosaka M, Yoshiya S (2001). Influence of macrophage 
infiltration on herniated disc tissue on the production of matrix metalloproteinases leading to disc 
resorption. Spine 26:1522-7 
Donohue WL (1939). Pathology of the intervertebral disc. Amer J Med Sci 198:419-37 
Dunstan CR, Boyce R, Boyce BF, et al. (1999). Systemic administration of acidic fibroblast growth 
factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats. J Bone 
Miner Res 14:953-9
Edwards DR, Murphy G, Reynolds JJ, et al (1987). Transforming growth factor beta modulates the 
expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-904 
79
Eguchi K, Migita k; Nakashima M, et al (1992). Fibroblast growth factor released by wounded 
endothelial cells stimulate proliferation of synovial cells.  J Rheumatol 19:1925-32 
Elfervig MK, Minchew JT, Francke E, Tsuzaki M, Banes AJ (2001). IL-1beta sensitizes 
intervertebral disc annulus cells to fluid-induced shear stress. J Cell Biochem 82:290-8 
Ellsworth JL, Berry J, Bukowski T, et al (2002). Fibroblast growth factor-18 is a trophic factor for 
mature chondrocytes and their progenitors. Osteoarthritis Cartilage 10:308-20
Elves MW, Bucknill T, Sullivan MF (1975). In vitro inhibition of leukocyte migration in patients 
with intervertebral disc lesions. Orthop Clin North Am 6:59-65 
Eyre D, Benya P, Buckwalter J, et al (1989). The intervertebral disc: Basic science perspectives. In: 
Frymoyer JW, Gordon Sl, eds. New perspectives on low back pain. Park Ridge, IL: American 
Academy of Orthopaedic Surgeons,147-207 
Ferrara N, Henzel WJ (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor 
specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-8 
Ferrara N, Leung DW, Cachianes G, Winer J, Henzel WJ (1991a). Purification and cloning of 
vascular endothelial growth factor secreted by pituitary folliculostellate cells. Methods Enzymol 
198:391-404
Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW (1991b). The vascular endothelial growth 
factor family of polypeptides. J Cell Biochem 47:211-8 
Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA (1989). Human KGF is FGF-related with 
properties of paracrine effector  of epithelial cell growth. Science 345:752-5 
Flaumenhaft R, Kojima S, Abe M, Rifkin DB (1993). Activation of latent TGFbeta. Adv Pharmacol 
24:51-76
Freemont AJ, Watkins A, Le Maitre C, et al. (2002). Nerve growth factor expression and 
innervation of the painful intervertebral disc. J Pathol 197:286-92 
80
Freemont AJ, Peacock TE, Goupille P, Hoyland JA, O’Brien JO, Jayson MIV (1997). Nerve 
ingrowth into diseased intervertebral disc in chronic back pain. Lancet 350:178-81 
Freemont AJ, Peacock TE, Goupille P, Hoyland JA, O'Brien J, Jayson MI (1998). 
Immunolocalization of major interstitial collagen types in human lumbar intervertebral discs of 
various ages. Virchows Arch 432:67-76
Frenz DA, Liu W, Williams JD, et al (1994). Induction of chondrogenesis: requirement for 
synergistic interaction of basic fibroblast growth factor and transforming growth factor beta. 
Development 120:415-24 
Fukumoto T, Sanyal A, Fitzsimmons JS, et al. (2000) Differential effects of IGF-I, bFGF and TGF
on proliferation and type II collagen mRNA expression  during periosteal chondrogenesis.  Trans 
Orthop Res Soc  25:1056. 
Fukuo K, Morimoto S, Kaj K, et al (1989). Association of increased intracellular free Ca2+ by 
platelet-derived growth factor with mitogenesis but not with proteoglycan synthesis in chondrocytes 
–effect of suramin. Cell Calcium 10:29-35 
Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N (1999). VEGF couples hypertrophic 
cartilage remodelling, ossification and angiogenesis during endochondral bone formation. Nat Med  
5:623-8
Gertzbein SD, Tile M, Gross A, Falk R (1975). Autoimmunity of the degenerative disc disease of 
the lumbar spine.  Orthop Clin North Am 6:67-73 
Gertzbein SD (1977). Degenerative disc disease of the lumbar spine: immunological implications. 
Clin Orthop 129:68-71 
Gosiewska A, Rezania A, Dhanaraj S, et al (2001). Development of a three-dimensional 
transmigration assay for testing cell—polymer interactions for tissue engineering applications. 
Tissue Eng  7:267-77
81
Gospodarowicz D (1975). Purification of a fibroblast growth factor from bovine pituitary. J Biol 
Chem  250:2515-20  
Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G (1977). Structural characterization and 
biological functions of fibroblast growth factor. Endocrin Rev 8:95-114 
Goupille P, Jayson MI, Valat JP, Freemont AJ (1998). The role of inflammation in disc herniation-
associated radiculopathy. Semin Arthritis Rheum 28:60-71 
Grotendorst GR, Chang T, Seppa HE, Kleinman HK, Martin GR (1982). Platelet-derived growth 
factor is a chemoattractant for vascular smooth muscle cells.  J Cell Physiol 113:261-6
Gruber HE, Fisher EC Jr, Desai B, Stasky AA, Hoelsher G, Hanley EN Jr (1997). Human 
intervertebral disc cells from the annulus: three-dimensional culture in agarose or alginate and 
responsiveness to TGF-beta1. Exp Cell Res 235:13-21 
Gruber HE, Norton Hj, Hanley EN Jr (2000a). Anti-apoptotic effects of IGF-1 and PDGF on human 
intervertebral disc cells in vitro. Spine 25: 2153-7 
Gruber HE, Hanley EN (2000b).  Human disc cells in monolayer vs 3D culture: cell shape, division 
and matrix formation. BMC Musculoskelet Disord 1:1-9 
Gruber HE, Norton HJ, Leslie K, Hanley EN Jr (2001). Clinical and demographic prognostic 
indicators for human disc cell proliferation in vitro: pilot study. Spine 26:2323-7 
Gruber HE, Ingram JA, Hanley EN Jr (2002). Tenascin in the human intervertebral disc: alterations 
with aging and disc degeneration. Biotech Histochem 77:37-41  
Gruber HE, Hanley EN Jr (2003). Recent advances in disc cell biology. Spine 28:186-93 
Grumbles RM, Shao L, Jeffrey JJ, Howell DS (1997). Regulation of the rat interstitial collagenase
promoter by IL-1 beta, c-Jun, and Ras-dependent signalling in growth plate chondrocytes. J Cell 
Biochem 67:92-102  
82
Grönblad M, Virri J, Tolonen J, et al. (1994). A controlled immunohistochemical study of 
inflammatory cells in disc herniation tissue. Spine 19:2744-51 
Guerne PA, Sublet A, Lotz M (1994). Growth factor responsiveness of human articular 
chondrocytes: distinct profile in primary chondrocytes, subcultured chondrocytes and fibroblasts. J 
Cell Physiol 15:476-84 
Guerne PA, Blanco F, Kaelin A, Desgeorges A, Lotz M (1995). Growth factor responsiveness of 
human articular chondrocytes in aging and development. Arthritis Rheum 38:960-8  
Guiot BH, Fessler RG (2000). Molecular biology of degenerative disc disease. Neurosurgery 
47:1034-40
Hamada T, Suda N, Kuroda T (1999). Immunohistochemical localization of fibroblast growth factor 
receptors in the rat mandibular condylar cartilage and tibial cartilage. J Bone Miner Metab 17:274-
82
Haro H, Kato T, Komori H, Osada M, Shinomiya K (2002). Vascular endothelial growth factor 
(VEGF)-induced angiogenesis in herniated disc resorption. J Orthop Res 20:409-15 
Hayes AJ, Benjamin M, Ralphs JR (2001). Extracellular matrix in development of the intervertebral 
disc. Matrix Biol 20:107-21
He C, Wilhelm SM, Pentland AM, et al (1989). Tissue cooperation in proteolytic activity cascade 
activating human interstitial collagenase. Proc Natl Acad Sci USA 86:2632-6 
Henson FM, Bowe EA, Davies ME(2005). Promotion of the intrinsic damage-repair response in 
articular cartilage by fibroblast growth factor-2. Osteoarthritis and Cartilage 13:537-44 
Hickery MS, Bayliss MT, Dudhia J, Lewthwaite JC, Edwards JCW, Pitsillides AA (2003). Age-
related changes in the response of human articular cartilage to IL-1  and transforming growth 
factor-  (TGF- ). J Biol Chem 278:53063-71 
83
Hicks GS, Duddleston DN, Russel LD, Holman HE, Shephard JM, Brown CA (2002). Low back 
pain. Am J Med Sci 324:201-11 
Hirabayashi S, Kumano K, Tsuiki T, Eguchi M, Ikeda S (1990). A dorsally displaced free fragment 
of lumbar disc herniation and its interesting histologic findings. Spine 15:1231-3 
Hirsch C, Schajowicz F (1953). Studies on structural changes in the lumbar annulus fibrosus. Acta 
Orthop Scand 22:184-9 
Hirsch C (1957). Studies on the pathology on low back pain. J Bone Joint Surg 41:237-43 
Horner A, Bishop NJ, Bord S, et al. (1999). Immunolocalization of vascular endothelial growth 
factor (VEGF) in human neonatal growth plate cartilage. J Anat 194:519-24
Hsu SM, Raine L, Fanger H (1981). Use of avidin-biotin peroxidase complex (ABC) in 
immunoperoxidase technique: A comparison between ABC and unlabeled antibody (PAP 
procedures. J Histochem Cytochem 29:577-80  
Huang SS, Huang JS (2005) TGF-  control of cell proliferation. J Cell Biochem 96:447-62 
Humzah MD, Soames RW (1988). Human intervertebral disc: structure and function. Anat Rec 
220:337-56
Ignotz RA, Massagues J (1986). Transforming growth factor beta stimulates the expression of 
fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 
261:4337-45
Jahner D, Hunter T (1991). The stimulation of quiescent rat fibroblasts by v-src and vfps oncogenic 
protein-tyrosine kinases leads to the induction of a subset of immediate early genes. Oncogene 
6:1259-68
Jave M, Howk R, Burgess W, et al (1986). Human endothelial cell growth factor: cloning, 
nucleotide sequence, and chromosome localization. Science 233:541-5 
84
Jim JJT, Noponen-Hietala N, Cheung KM, et al (2005). The Trp2 allele of COL9A2 is an age-
dependent risk factor for the development and severity of intervertebral disc degeneration. Spine 30: 
2735-42
Johnson W E B, Eisenstein S M, Roberts S (2001). Cell cluster formation in degenerate lumbar 
intervertebral discs is associated with increased disc cell proliferation. Connect Tissue Res  42:197-
207
Johnsson A, Heldin C-H, Wasteson Å, et al. (1984) The c-sos gene encodes a precursor of the B 
chain of platelet-derived growth factor. EMBO J 3:921-8 
Joyce ME, Roberts AB, Sporn MB, Bolander ME (1990). Transforming growth factor beta and the 
initiation of chondrogenesis and osteogenesis in rat femur. J Cell Biol 110:2195-207 
Kawaguchi Y, Osada R, Kanamori M, et al. (1999). Association between an aggrecan gene 
polymorphism and lumbar disc degeneration. Spine 24:2456-60  
Kerttula LI, Serlo WS, Tervonen OA, Paakko EL, Vanharanta HV (2000). Post-traumatic findings 
of the spine after earlier vertebral fracture in young patients: clinical and MRI study. Spine 
25:1104-8
Kieswetter K, Schwartz Z, Alderete M, Dean DD, Boyan BD (1997). Platelet derived growth factor 
stimulates chondrocyte proliferation but prevents endochondral maturation. Endocrine 6:257-64  
Kimmelman D, Kirschner M (1987). Synergistic induction of mesoderm by FGF and TGFbeta and 
the identification of an mRNA coding for FGF in the early Xenopus ymbryo. Cell 51:869-77 
Kimura T, Nakata K, Tsumaki N, et al. (1996). Progressive degeneration of articular cartilage and 
intervertebral discs. An experimental study in transgenic mice bearing a type IX collagen mutation. 
Int Orthop 20:177-81
Knochel W, Tiedemann H. (1989). Embryonic inducers, growth factors, transcription factors and 
oncogenes. Cell Differ Dev 26:163-71 
85
Kohyama K, Saura R, Doita M, Mizuno K (2000). Intervertebral disc cell apoptosis by nitric oxide: 
biological understanding of intervertebral disc degeneration. Kobe J Med Sci 46:283-95 
Koike Y, Uzuki M, Kokubun S, Sawai T (2003). Angiogenesis and inflammatory cells in lumbar 
disc herniation. Spine 28:1928-33 
Konttinen YT, Kemppinen P, Li TF, et al. (1999). Transforming and epidermal growth factors in 
degenerated intervertebral discs. J Bone Joint Surg Br 81:1058-63 
Kääpa E, Wang W, Takala TE, et al. (2000). Elevated protein content and prolyl 4-hydroxylase 
activity in severely degenerated human annulus fibrosus. Connect Tissue Res  41:93-9
Laiho M, Saksela O, Andreasen PA, Keski-Oja J (1986). Enhanced production and extracellular 
deposition of the endothelial-type plasminogen activator inhibitor in cultured human fibroblasts by 
transforming growth factor beta. J Cell Biol 103:2403-10 
Laiho M, Keski-Oja J (1989). Growth factors in the regulation of pericellular proteolysis: A review. 
Cancer Res 49:2533-53 
Lattermann C, Oxner WH, Xiao X, Li J, Gilbertson LG, Robbins PD, Kang JD (2005). The adeno 
associated viral vector as a strategy for intradiscal gene transfer in immuno competent and pre-
exposed rabbits. Spine 30:497-504 
Leao L (1960). Intradiscal injection of hydrocortisone and prednisolone in the treatment of low 
back pain. Rheumatism 16:72-7 
Lindblom K, Hultqvist G (1950). Absorption of protruded disc tissue. J Bone Joint Surg [Am] 
32:557-60
Lipets JS (2002). Pathophysiology of inflammatory, degenerative, and compressive radiculopathies. 
Phys Med Rehabil Clin N Am 13:439-49 
Lipson SJ, Muir H (1981). 1980 Volvo award in basic science. Proteoglycans in experimental 
intervertebral disc degeneration.  Spine 6:194-210
86
Lopez-Casillas F, Wrana JL, Massague J (1993). Betaglycan presents ligand to the TGF  signalling 
receptor. Cell 73:1435-1444 
Lotz M, Terkeltaub R, Villiger PM (1992). Cartilage and joint inflammation. Regulation of IL-8 
expression by human articular chondrocytes. J Immunol 148:466-73 
Lucore CL, Fujii S, Wun TC, Sobel BE, Billadello JJ (1988). Regulation of expression of type 1 
plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor. J Biol Chem 
263:15845-9
Lyons G, Eisenstein SM, Sweet MB (1981). Biochemical changes in intervertebral disc 
degeneration. Biochim Biophys Acta 673:443-53
Maeda S, Dean DD, Gomez R, Schwartz Z, Boyan BD (2002). The first stage of transforming 
growth factor beta1 activation is release of the large latent complex from the extracellular matrix of 
growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Calcif Tissue Int 70:54-65
Maes C, Carmeliet P, Moermans K, et al. (2002). Impaired angiogenesis and endochondral bone 
formation in mice lacking the vascular endothelial growth factor isoforms VEGF(164) and 
VEGF(188). Mech Dev 111:61-73
Maes C, Stockmans I, Moermans K, et al (2004). Soluble VEGF isoforms are essential for 
establishing epiphyseal vascularization and regulating chondrocyte development and survival. J 
Clin Invest 113:188-99 
Maigne J-Y, Rime B, Deligne B (1992). Computer tomography follow-up study of forty-eight cases
of nonoperatively treated lumbar intervertebral disc herniation. Spine 17:1071-4 
Marshall LL, Trethewie ER, Curtain CC (1977). Chemical radiculitis: A clinical, physiological and 
immunological study. Clin Orthop 129:61-7 
Marics I, Adelaide J,Raybaud F, et al (1989). Characterization of the HST-related FGF.6 gene, a 
new member of the fibroblast growth factor gene family. Oncogene 4:335-40 
87
Massague J (1990). The transforming growth factor beta family. Annu Rev Cell Biol 6:587-641 
Massague J, Seoane J, Wotton D (2005). Smad transcription factors. Genes and Dev 19:2783-10 
Matsunaga S, Nagano S, Onishi T, Morimoto N, Suzuki S, Komiya S (2003). Age-related changes 
in expression of transforming growth factor beta and receptors in cells of intervertebral discs. J 
Neurosurg 98:63-7
McAlinden A, Zhu Y, Sandell LJ (2001). Expression of type II procollagens during development of 
the human intervertebral disc. Biochem Soc Trans 30:831-8 
McCarron RF, Wimpee MW, Hudkins PG, Laros GS (1987). The inflammatory effect of nucleus 
pulposus: A possible element in the pathogenesis of low back pain. Spine 12:760-4 
Melrose J, Smith S, Little CB, Kitson J, Hwa SY, Ghosh P (2002). Spatial and temporal localization 
of transforming growth factor beta, fibroblast growth factor-1, and osteonectin, and identification of 
cells expressing alpha-smooth muscle actin in injured annulus fibrosus: implications for 
extracellular matrix repair. Spine 27:1756-64 
Mignatti P, Robbins E, Rifkin DB (1986). Tumor invasion of human amnionic 
membrane:Requirement for a proteinase cascade, Cell 47:487-98 
Mignatti P, Tsubai R, Robbins E, Rifkin DB (1989). In vitro angiogenesis of the human amniotic 
membrane: Requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol 
108:671-82
Minamide A, Hashizume H, Yoshida M, Kawakami M,Hayashi N, Tamaki T (1999). Effects of 
basic fibroblast growth factor on spontaneous resorption of herniated intervertebral discs. An 
experimental study in the rabbit. Spine 24:940-5 
Miyazono K, Maeda S, Imamura T (2005). BMP receptor signalling: Transcriptional  targets, 
regulation of signals, and signalling cross-talk. Cytokine and growth factor reviews 16:251-63 
88
Mohammadi M, Olsen SK, Ibrahimi OA (2005) Structural basis for fibroblast growth factor 
receptor activation. Cytokine and growth factor reviews 16:107-37 
Moscatelli  D, Presta M, Rifkin DB (1986). Purification of a factor from human placenta that 
stimulates capillary endothelial cell protease production, DNA synthesis and migration.  Proc Natl 
Acad Sci USA 83:2091-5 
Moses HL, Branum EL, Proper JA, Robinson RA (1981). Transforming growth factor production 
by chemically transformed cells. Cancer Res 41:2842-8 
Moon SH, Gilbertson LG, Nishida K, et al. (2000). Human intervertebral disc cells are genetically 
modifiable by adenovirus-mediated gene transfer: implications for the clinical management of 
intervertebral disc disorders. Spine 25:2573-9 
Moos V, Fickert S, Muller B, Weber U, Sieper J (1999). Immunohistological analysis of cytokine 
expression in human osteoarthritic and healthy cartilage. J Rheumatol 26:870-9  
Moses HL, Serra R (1996). Regulation of differentiation by TGF-beta. Curr Opin Genet Dev 6:581-
6
Murakami S, Kan M, McKeehan WL, de Crombrugghe B (2000). Up-regulation of the 
chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein 
kinase pathway. Proc Natl Acad Sci U S A  97:1113-8
Nagano T, Yonenobu K, Miyamoto S, Tohyama M, Ono K (1995). Distribution of the basic 
fibroblast growth factor and its receptor gene expression in normal and degenerated rat 
intervertebral discs. Spine 20:1972-8 
Nagano S, Matsunaga S, Takae R, Moromoto N, Suzuki S, Yoshida B (2000). Immunolocalization 
of transforming growth factor-betas and their receptors in the intervertebral disc of senescence-
accelerated mouse. Int J Oncol 17:461-6 
89
Nakajima F, Ogasawara A, Goto K, et al. (2001). Spatial and temporal gene expression in 
chondrogenesis during fracture healing and the effects of basic fibroblast growth factor. J Orthop 
Res  19:935-44
Nakase T, Ariga K, Miyamoto S, et al. (2001). Distribution of genes for bone morphogenetic 
protein –4, -6, growth differentiation factor-5, bone morphogenetic protein receptors in the process 
of experimental spondylosis in mice. J Neurosurg 94:68-75 
Naylor A, Happe F, Turner RL, et al (1975). Enzymic and the immunological activity in the 
intervertebral disc. Orthop Clin North Am 6:51-8 
Nerlich AG, Schleicher ED, Boos N (1997). 1997 Volvo Award winner in basic science studies. 
Immunohistologic markers for age-related changes of human intervertebral discs. Spine 22:2781-95 
Neufeld G, Gospodarowicz D (1986). Basic and acidic fibroblast growth factor interacts with the 
same cell surface receptor. J Biol Chem 261:5631-7 
Ng SCS, Weiss JB, Quennel R, Jayson MIV (1986). Abnormal connective tissue degrading enzyme 
patterns in prolapsed intervertebral discs. Spine 11:695-701 
Nishida K, Kang JD, Gilbertson LG, et al. (1999). Modulation of biologic activity of the rabbit 
intervertebral disc by gene therapy: an vivo study of adenovirus-mediated transfer of the human 
transforming growth factor beta 1 encoding gene. Spine 24:2119-25 
Nomura T, Mochida J, Okuma M, Nishimura K, Sakabe K (2001). Nucleus pulposus allograft 
retards intervertebral disc degeneration. Clin Orthop 389:94-101
Oegema TR Jr, Johnson SL, Aguiar DJ, Ogilvie JW (2000). Fibronectin and its fragments increase 
with degeneration in the human intervertebral disc. Spine 25:2742-7
Ohbayashi N, Shibayama M, Kurotaki Y, et al. (2002). FGF18 is required for normal cell 
proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 16:870-9  
90
Okuda S, Nyoui A, Ariga K, Nakase T, Yonenobu K, Yoshikawa H (2001). Mechanisms of age-
related decline in insulin-like growth factor-I dependent proteoglycan synthesis in rat intervertebral 
disc cells. Spine 26:2421-6  
Okuma M, Mochida J, Nishimura K, Sakabe K, Seiki K (2000). Reinsertion of stimulated nucleus 
pulposus cells retards intervertebral disc degeneration: an in vitro and in vivo experimental study. J 
Orthop Res 18:988-97 
Olney RC, Wanf J, Sylvester JE, et al (2004). Growth factor regulation of human growth plate 
chondrocyte proliferation in vitro. Biochem Biophys Res Commun 317:1171-82 
Osada R, Ohshima H, Ishihara H, et al. (1996). Autocrine/paracrine mechanism if insulin-like 
factor-1 secretion, and the effect of insulin-like growth factor-1 on proteglycan synthesis in bovine 
intervertebral discs. J Orthop Res 14:690-9 
Osaki M, Tsukazaki T, Yonekura A, et al. (1999). Regulation of c-fos gene induction and mitogenic 
effect of transforming growth factor beta-1 in rat articular chondrocytes. J Endocr  46:253-61 
Osti OL, Vernon-Roberts B, Fraser RD (1990). 1990 Volvo Award in experimental studies. Anulus 
tears and intervertebral disc degeneration. An experimental study using an animal model. Spine  
15:762-7
Ozaki S, Muro T, Ito S, Mizushima M (1999). Neovascularization of the outermost area of 
herniated lumbar intervertebral discs. J Orthop Sci  4:286-92 
Paajanen H, Haapasalo H, Kotilainen E, Aunapuu M, Kettunen J (1999). Proliferation potential of 
human lumbar disc after herniation. J Spinal Disord  12:57-60
Papavissiliou AG, Treier M, Chavrier C, Bohmann D (1992). Targeted degradation of c-Fos, but 
not v-Fos, by a phosphorylation-dependent signal on c-Jun. Science 258:1941-4 
Pattison ST, Melrose J, Ghosh P, Taylor TK (2001). Regulation of gelatinase-A (MMP-2) 
production by ovine inetrvertebral disc nucleus pulposus cells grown in alginate culture by 
transforming growth factor- (1) and insulin growth factor-I. Cell Biol Int 25:679-89 
91
Pearce RH (1993). Morphological and chemical aspects of intervertebral disc aging. In: Buckwalter 
JA, Goldberg VM, Woo SL-Y, eds. Musculoskeletal soft tissue aging: Impact on morbidity. 
Rosemont, IL: American Academy of Orthopaedic Surgeons,363-79 
Pedrozo HA, Schwartz Z, Gomez R, et al. (1998). Growth plate chondrocytes store latent 
transforming growth factor (TGF)-beta 1 in their matrix through latent TGF-beta 1 binding protein-
1. J Cell Physiol 177:343-54
Pedrozo HA, Schwartz Z, Robinson M, et al. (1999). Potential mechanisms for the plasmin-
mediated release and activation of latent transforming growth factor-beta 1 from the extracellular 
matrix of growth plate chondrocytes. Endocrinology 140:5806-16 
Pennington JB, McCarron RF, Laros GS (1988). Identification of IgG in canine intervertebral disc. 
Spine 13:909-12 
Peters KG, De Vries C Williams LT (1993). Vascular endothelial growth factors expression during 
embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel 
growth. Proc Natl Acad Sci USA 90:8915-9 
Pfander D, Kortje D, Zimmermann R, et al. (2001). Vascular endothelial growth factor in articular 
cartilage of healthy and osteoarthritic human knee joints. Ann Rheum Dis 60:1070-3 
Pfirrmann CW, Metsdorf A, Zanaetti M, Hodler J, Boos N (2001). Magnetic resonance 
classification of lumbar intervertebral disc degeneration. Spine 26: 1873-8 
Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH (1987). Stimulation of the chemotactic 
migration of human fibroblasts by transforming growth factor beta. J Exp Med 165:251-6 
Praul CA, Ford BC, Leach RM (2002). Effect of fibroblast growth factors 1, 2, 4, 5, 6, 7, 8, 9, and 
10 on avian chondrocyte proliferation. J Cell Biochem 84:359-66  
Pritzher KPH (1977). Aging and degeneration in the lumbar intervertebral disc. Orthop Clin N Am 
8:65-77
92
Pufe T, Petersen W, Tillmann B, Mentlein R (2001). The splice variants VEGF121 and VEGF189 
of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic 
cartilage. : Arthritis Rheum 44:1082-8  
Pujol JP, Galera P, Redini F, Mauviel A, Loyau G (1991). Role of cytokines in osteoarthritis: 
comparative effects of interleukin 1 and transforming growth factor beta on cultured rabbit articular 
chondrocytes. J Rheumatol Suppl 27:76-9 
Pujol JP, Galera P, Pronost S, et al (1994). Transforming growth factor-beta (TGF-beta) and 
articular chondrocytes. Ann Endocrinol (Paris) 55:109-20
Qi WN, Scully SP (1997). Extracellular collagen modulates the regulation of chondrocytes by 
transforming growth factor-beta 1. J Orthop Res 15:483-90  
Raghow R, Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH (1987). Transforming growth 
factor beta increases steady state levels of type I procollagen and fibronectin mRNAs 
posttransscriptionally in cultured human dermal fibroblasts. J Clin Invest 79:1285-8 
Rannou F, Corvol MT, Hudry C, et al. (2000). Sensitivity of annulus fibrosus cells to interleukin 1 
beta. Comparison with articular chondrocytes. Spine 25:17-23 
Rifkin DB (2005). Latent transforming growth factor-  (TGF- ) binding proteins: orchestrators of 
TGF-  availability.  J Biol Chem 280:7409-12 
Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB (1981). New class of transforming 
growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc 
Natl Acad Sci USA 78:5339-43 
Roberts AB, Sporn MB, Assoian RK, et al (1986). Transforming growth factor type beta: rapid 
induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc 
Natl Acad Sci USA 83:4167-71 
93
Roberts S, Caterson B, Menage J, Evans EH, Jaffray DC, Eisenstein SM (2000). Matrix 
metallaproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine 
25:3005-13
Rosenwald IB, Setkov NA, Kazakov VN, et al. (1995). Transient inhibition of protein synthesis 
induces expression of proto-oncogenes and stimulates resting cells to enter the cell cycle.  Cell 
Prolif 28:631-44 
Rosier RN, O'Keefe RJ, Crabb ID, Puzas JE (1989). Transforming growth factor beta: an autocrine 
regulator of chondrocytes. Connect Tissue Res 20:295-301  
Ross R, Glomset J, Kariya B, Harker L (1974). A platelet-dependent serum factor that stimulates 
the proliferation of arterial smooth muscles in vitro. Proc Natl Acad Sci USA 71:1207-10 
Rousche K T, Ford B C, Praul C A, Leach R M (2001). The use of growth factors in the 
proliferation of avian articular chondrocytes in a serum-free culture system. Connect Tissue Res  
42:165-74
Rozenblatt-Rosen O, Mosonego-Ornan E, Sadot E, et al. (2002). Induction of chondrocyte growth 
arrest by FGF: transcriptional and cytoskeletal alterations. J Cell Sci  115:553-62  
Saal JS, Franson RC, Dobrow R, et al (1990). High levels of inflammatory phospholipase A2 in 
lumbar disc herniations. Spine 15:674-8 
Saal JA, Saal JS, Herzog RJ (1990). The natural history of the lumbar intervertebral disc extrusion 
treated nonoperatively. Spine 15:683-6 
Sachs BL, Vanharanta H, Spivey MA, et al (1987). Dallas Discogram Description. A new 
classification of CT/discography in low-back disorders. Spine 12:287-93 
Saksela O, Moscatelli D, Rifkin DB (1988). Cell-associated plasminogen activation. Regulation and 
physiological functions. Annu Rev Cell Biol 4:93-126 
94
Sato Y, Rifkin DB (1989). Inhibition of endothelial cell movement by pericytes and smooth muscle 
cells: activation of latent TGFbeta like molecule by plasmin during co-culture. J Cell Biol 109:309-
15
Schollmeier G, Lahr-Eigen R, Lewandrowski KU (2000). Observations on fiber-forming collagens 
in the annulus fibrosus. Spine 25:2736-41 
Schweiki D, Itin A, Soffer D, Keshet E (1992). Vascular endothelial growth factor induced by 
hypoxia may mediate hypoxia-induced angiogenesis. Nature 359:843-5 
Shida JI, Jingushi S, Izumi T, Ikenoue T, Iwamoto Y (2001). Basic fibroblast growth factor 
regulates expression of growth factors in rat epiphyseal chondrocytes. J Orthop Res 19:259-64
Shimoaka T, Ogasawara T,  Yonamine A, et al. (2002). Regulation of osteoblast, chondrocyte, and 
osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF-10. J 
Biol Chem 277:7493-500  
Sive JI, Baird P, Jeziorsk M, Watkins A, Hoyland JA, Freemont AJ (2002). Expression of 
chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol 55:91-7 
Slack JMW, Darlington BG, Heath JK, Godsave SF (1987). Mesoderm induction in early Xenopus 
embryos by heparin binding growth factor. Nature London 326:197-200 
Sobajima S, Shimer AL, Chadderdon RC, et al (2005). Quantitative analysis of gene expression in a 
rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction. The Spine 
Journal 5:14-23 
Specchia N, Pagnotta A, Toesca A, Greco F (2002).  Cytokines and growth factors in the protruded 
intervertebral disc of the lumbar spine. Eur Spine J 11:145-52 
Spengler D, Oullette EA, Buttie M, Zeh J (1990). Elective discectomy for herniation of a lumbar 
disc. J Bone Joint Surg [Am] 72:230-7 
95
Steck E, Bertam H, Abel R, Chen B, Winter A, Richter W (2005). Induction of intervertebral disc-
like cells from adult mesenchymal stem cells. Stem Cells 23:403-11 
Stiles CD (1983). The molecular biology of the platelet-derived growth factor. Cell 33:653-5 
Taira M, Yoshida T, Miyagawa K, Sakamaoto H, Terada M, Sugimura T  (1987). cDNA sequence 
of human transforming gene hst and the coding sequence required for transforming activity.  Proc 
Nat Acad Sci USA 84:2980-4 
Takae R, Matsunaga S, Origuchi N, et al.  (1999). Immunolocalization of bone morphogenic protein 
and its receptors in degeneration of intervertebral disc. Spine 24:1397-401 
Takao T, Iwaki T, Kondo J, Hiraki Y (2000). Immunohistochemistry of chondromodulin-I in the 
human intervertebral discs with special reference to the degenerative changes. Histochem J 32:545-
50
Tammela T, Petrova TV, Alitalo K (2005). Molecular lymphangiogenesis: new players. Trends in 
Cell Biology 15:434-41 
Thomas DP, Sunters A, Gentry A, Grigoriadis AE (2000). Inhibition of chondrocyte differentiation 
in vitro by constitutive and inducible overexpression of the c-fos proto-oncogene. J Cell Sci 
113:439-50
Thompson JP, Oegema TR Jr, Bradford DS (1991). Stimulation of mature canine intervertebral disc 
by growth factors. Spine  16:253-60
Thorp BH, Anderson I, Jakowlew SB (1992). Transforming growth factor-beta 1, -beta 2 and -beta 
3 in cartilage and bone cells during endochondral ossification in the chick. Development 114:907-
11
Tischer E, Gospodarowicz D, Mitchell R, et al (1989). Vascular endothelial growth factor: a new 
member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 
165:1198-206
96
Trippel SB (1995). Growth factor actions on articular cartilage. J Rheumatol Suppl 43:129-32  
Trout JJ, Buckwalter JA, Moore KC (1982a). Ultrastructure of human intervertebral disc II. Cells of 
the nucleus pulposus. Anat Rec 204:307-14 
Trout JJ, Buckwalter JA, Moore KC, Landis SK (1982b). Ultrastructure of human intervertebral 
disc. I. Changes in notochordal cells with age. Tissue and Cell 14:359-69 
Tsuji H, Hirano N, Ohshima H, Ishihara H, Terahata N, Motoe T (1993). Structural variation of the 
anterior and posterior annulus fibrosus in the development of human lumbar intervertebral disc. A 
risk factor for intervertebral disc rupture. Spine 18:204-10
Tsuji M, Funahashi S, Takigawa M, Seiki M, Fujii K, Yoshida T (1996). Expression of c-fos gene 
inhibits proteoglycan synthesis in transfected chondrocyte. FEBS Lett  381:222-6  
Tsuji M, Hirakawa K, Kato A, Fujii K (2000). The possible role of c-fos expression in rheumatoid 
cartilage destruction. 7: J Rheumatol  27:1606-21  
Urban JP, McMullin JF (1988). Swelling pressure of the lumbar intervertebral discs: influence of 
age, spinal level, composition and degeneration. Spine 13:179-87 
van Beuningen HM,  van den Kraan PM, Arntz OJ, et al (1994). Transforming growth factor beta-1 
stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the 
murine knee joint. Lab Invest 71:279-90 
van den Berg WB, van der Kraan PM, Scharstuhl A, van Beuningen HM (2001). Growth factors 
and cartilage repair. Clin Orthop  391 Suppl: S244-50
van der Eerden BCJ, Karperien M, Wit JM (2003). Systemic and local regulation of the growth 
plate. Endocrine Rev 24:782-801 
Veilleux N, Spector M (2005). Effects of FGF-2 and IGF-I on adult canine articular chondrocytes in 
type II collagen-glycosaminoglycan scaffolds in vitro. Osteoarthritis and Cartilage13: 278-86 
97
Videman T, Leppavuori J, Kaprio J, et al. (1998). Intragenic polymorphisms of the vitamin D 
receptor gene associated with intervertebral disc degeneration. Spine  23:2477-85  
Villiger PM, Lotz M (1992). Differential expression of TGF beta isoforms by human articular 
chondrocytes in response to growth factors. J Cell Physiol 151:318-25
Wang L, Almqvist KF, Veys EM, Verbruggen G (2002). Control of extracellular matrix 
homeostasis of normal cartilage by a TGFbeta autocrine pathway. Validation of flow cytometry as a 
tool to study chondrocyte metabolism in vitro. Osteoarthritis Cartilage 10:188-98
Weidner N, Rice DT (1988). Intervertebral disc material: Criteria for determining probable 
prolapse. Hum Pathol 19:406-10 
Westall FC, Lennon VA, Gospodarowicz D (1978). Brain-derived fibroblast growth factor: identity 
with a fragment of the basic protein of myelin. Proc Natl Acad Sci U S A  75:4675-8  
Woertgen C, Rothoerl RD, Brawanski A (2000). Influence of macrophage infiltration of herniated 
lumbar disc tissue on outcome after lumbar disc surgery. Spine  25:871-5  
Wrana JL, Attisano L, Carcamo J, et al (1992). TGF  signals through heteromeric protein kinase 
receptor complex. Cell 71:1003-14 
Wright JK, Cawston TE, Hazleman BL (1991). Transforming growth factor beta stimulates the 
production of the tissue inhibitor metalloproteinases (TIMP) by human synovial and skin 
fibroblasts. Biochim Biophys Acta 1094:201-10 
Wroblewski J, Edwall C (1992). PDGF BB stimulates proliferation and differentiation in cultured 
chondrocytes from rat rib growth plate. Cell Biol Int Rep 16:133-44  
Wroblewski J, Edwall-Arvidsson C (1995). Inhibitory effects of basic fibroblast growth factor on 
chondrocyte differentiation. J Bone Miner Res 10:735-42
Yasuma T, Kouichi A, Yamaughi Y (1993). The histology of lumbar intervertebral disc herniation: 
the significance of small blood vessels in the extruded tissue. Spine 18:1761-5 
98
Yonekura A, Osaki M, Hirota Y, et al (1999). Transforming growth factor beta stimulates articular 
chondrocyte cell growth through p44/42 MAP kinase (ERK) activation. J Endocr 46:545-52 
Zafarullah M, Martel-Pelletier J, Cloutier JM, Gedamu L, Pelletier JP (1992). Expression of c-fos, 
c-jun, jun-B, metallothionein and metalloproteinase genes in human chondrocyte. FEBS Lett 
306:169-72
Zelzer E, Mamluk R, Ferrara N, et al (2004) VEGFA is necessary for chondrocyte survival during 
bone development. Development 131:2161-71 
Zhan X, Bates B, Hu X, Goldfarb M (1988). The human FGF-5 oncogene encodes a novel protein 
















Both fibrotic and angiogenic reactions take place in disc
herniations [7, 8, 29]. Herniated disc tissue has a tendency
to decrease in size with time [14, 22], and it has proteo-
lytic activity [17].
The TGF-β superfamily is composed of several growth
factors [4]. TGF-β has been found in almost all cells stud-
ied [1, 16, 20]. It regulates cellular growth and stimulates
extracellular matrix protein incorporation and collagen,
hyaluronic acid, and fibronectin production [9, 19]. Sub-
cutaneous injection of TGF-β in mice results in rapid in-
duction of fibrosis and angiogenesis [20]. In cartilage,
TGF-β stimulates production of tissue inhibitor of metal-
loproteinases (TIMP) [28], thus participating in the con-
trol process of connective tissue degradation. It also par-
ticipates in inflammatory responses during articular in-
flammation [13, 18]. Furthermore, TGF-β has an effect on
chondrogenesis and osteogenesis [6, 10].
TGF-βs are secreted from cells in the latent form,
which does not bind to TGF-β receptors. The latency-as-
sociated peptide is removed by enzymatic degradation by
proteases, resulting in activation of TGF-β [2, 5, 15, 23].
Abstract Transforming growth fac-
tor β (TGF-β) is a potent inducer of
angiogenesis and fibrogenesis. There
is presently little information about
the pathophysiological function of
TGF-β in herniated disc tissue. In or-
der to analyze the cellular role and
activation of TGF-β after disc herni-
ation we immunostained frozen ma-
terial from 38 disc herniation opera-
tions and from eight macroscopically
normal discs from organ donors.
Polyclonal TGF-β-I, TGF-β-II and
TGF-β receptor type II antibodies
were used with the avidin biotin
complex (ABC-) immunoperoxidase
method. All the herniated discs were
TGF-β immunopositive. Such im-
munoreactivity was mainly associ-
ated with disc cells. In a few sam-
ples, capillaries were also TGF-β im-
munopositive. Immunopositivity was
similarly observed in the control
discs. To analyze possible differ-
ences between the two groups, we
calculated the ratio of immunoposi-
tive disc cells. For all three antibod-
ies, a statistically significantly
(Mann-Whitney test, P=0.0001)
higher number of disc cells showed
immunopositivity in the herniated
discs. The increase in TGF-β recep-
tor immunopositivity suggested in-
duction of TGF-β receptors in herni-
ated discs. Our results support an ac-
tive regulatory role for TGF-β in
disc cell metabolism.
Keywords Herniated disc · TGF-β
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The actions of TGF-β are mediated via binding to cell sur-
face receptors [27].
Since TGF-β has been demonstrated to be a potent ac-
tivator of disc cells in cell cultures [24] and in vivo [12],
in the present study we wanted to analyze its role in her-
niated disc tissue: specifically, whether the number of
TGF-β immunopositive cells is raised by herniation and
whether the TGF-β receptor on disc cells is induced.
Materials and methods
Herniated disc material was obtained from 38 discectomy opera-
tions. As a normal control we used tissue from eight discs that had
been obtained from a disc tissue bank (–70°C) of five organ donors
(Table 1). None of the donors had a history of low back pain. Af-
ter removal, tissue material was immediately frozen to –70°C in
the operating theatre, and 8-µm-thick cryostat sections were fixed
in ice-cold acetone. For some specimens we performed Zamboni
prefixation to detect a possible difference in immunoreaction be-
tween prefixed and section-fixed samples. All immunoreactions
were detected using an avidin biotin complex- (ABC-) peroxidase
staining kit (Vectastain Elite, Vector Laboratories, Burlingame,
Calif.). All tissue sections were counterstained by hematoxylin and
eosin. Thus, all cells, including those showing no immunoreactiv-
ity, could be visualized and counted.
Antibodies
Polyclonal anti-human TGF-β-I, TGF-β-II and TGF-β receptor
type II antibodies raised in rabbits were used (Santa Cruz Biotech-
nology, Inc., Santa Cruz, Calif.), all at the dilution 1:50. There is
no cross-reactivity between these three different antibodies. We
chose antibodies to TGF-β-I and -II, in particular, since these are
the most common members of the TGF-β superfamily. An anti-
body to TGF-β receptor type II was chosen, since this receptor is
located in the cellular membrane, and it detects all members of the
TGF-β superfamily. As a positive control for the immunostaining
reaction, we used rheumatoid arthritic synovia tissue. Three sec-
tions were stained with each antibody from every specimen.
Immunohistochemical quantitation
All herniated and control disc samples studied consisted of nucleus
pulposus tissue only. The immunohistochemical analyses were
done in blind review by two observers. Positive staining for all
three TGF-β antibodies (TGF-β-I, TGF-β-II, and TGF-β receptor
type II) was quantified as the ratio of positive disc cells per cross-
sectional area to all disc cells. We took five random microscopic
fields at the magnification ×250 from all control discs and from ten
herniated discs. The mean of the cell counts obtained by the two
observers was used.
We counted 50 fields from herniated disc samples and 40 fields
from all control samples, and standard deviations were found to be
small (Table 2). Furthermore, when comparing groups, 95% confi-
dence intervals did not overlap at all. Thus, we considered our
counting material sufficient for statistical analysis.
For immunostaining control, sections were treated omitting the
primary antibody in the staining sequence. For all antibodies
(TGF-β-I, -II and receptor type II) preincubation with the corre-
sponding antigen (1:10) was done.
Statistical analysis
Statistical analysis was done using the SOLO statistical software
program (BMDP, Los Angeles, Calif.). Groups were compared us-
ing the nonparametric Mann-Whitney test. Level of statistical sig-
nificance was set at P<0.05.
Results
The disc samples studied are described in detail in Table 1.
Herniated disc samples were classified by the operating
surgeon as previously described [25]. In control discs, no
signs of autolysis were observed, i.e., all disc cells looked
intact, and they all showed a normal morphology macro-
scopically.
All discs studied, both disc herniations and controls,
showed TGF-β-I, -II and receptor type II immunopositiv-
ity. The immunoreaction for TGF-βs and TGF-β receptor
was mainly disc cell associated, located in the cytoplasm
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Table 1 Description of 38
disc samples from discectomy
operations and eight normal
controls (DHT disc herniation
tissue, DNT normal disc con-
trol tissue, S sequester, E ex-
trusion, P protrusion)
Tissue type Sex Prolapse type Duration of radicular Age Mean 
pain Mean (range) (range)
DHT (n=38) 22M/16F S=12; E=24; P=2 6.9 mths (3wks–36 mths) 41.6 (20–74)
DNT (n=8, 4M/1F – – 36.2 (13–53)
5 patients)
Table 2 Ratio of immunopositive (TGF-β-I, TGF-β-II and TGF-β
receptor type II) to total disc cells in herniated disc tissue and con-
trol disc samples: values for the total sum of immunopositive disc
cells to all disc cells in each group and the means, standard devia-
tions (SD) and 95% confidence intervals (CI) for each group are
given. Immunopositive disc cells were counted from eight normal
discs and ten herniated discs and their number was then compared
with the corresponding total cell number. For counting, five ran-
dom microscopic fields from each tissue sample were used
Type of studied Ratio of immunopositive to total disc cells
tissue
TGF-β-I TGF-β-II TGF-β receptor
type II
DHT (n=10)
Total sum 550/858 437/787 520/864
Mean 0.64 0.56 0.60
SD 0.09 0.15 0.08
95% CI 0.58–0.69 0.45–0.64 0.54–0.64
DNT (n=8)
Total sum 271/772 100/506 149/489
Mean 0.32 0.16 0.28
SD 0.10 0.11 0.12
95% CI 0.27–0.38 0.10–0.22 0.22–0.34
Group difference P<0.0001 P<0.0001 P<0.0001
of the cell (Fig.1, Fig.2 A). In some samples, we also
noted blood vessel associated immunoreactivity. For
TGF-β-I and TGF-β-II, immunoreactivity in disc cells
was noted in all 38 disc herniation samples, whereas only
one such sample lacked disc cell associated immunoreac-
tivity for TGF-β receptor type II.
We did not see any difference in immunoreaction be-
tween different types of herniated tissue samples, i.e., se-
questers, extrusions, and protrusions.
Blood vessel immunoreactivity was observed in 22/38
(58%)(TGF-β-I), 14/38 (37%)(TGF-β-II) and 14/38 (37%)
(TGF-β receptor type II) disc herniations, respectively.
Sections stained omitting the primary antibody against
corresponding antigen did not show any immunoreactiv-
ity. There was no immunoreaction after preincubation
with the corresponding antigen for any of the three anti-
bodies employed (Fig.2B). The rheumatoid arthritis syno-
via sections were immunopositive for all the antibodies.
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Fig.1 A Transforming growth factor (TGF-)β-I immunopositive
disc cells (open arrows) in nucleus pulposus of rapidly frozen her-
niated disc tissue from a 43-year-old male patient. Note the intense
cytoplasmic immunoreaction around counterstained nuclei. The
operation level of the sequestrated disc was L5-S1 [avidin biotin
complex (ABC-) peroxidase immunostaining (Vectastain); hema-
toxylin counterstaining; original magnification ×241]. B TGF-β
receptor type II immunopositivity in nucleus pulposus disc cell
groups (open arrows) in rapidly frozen herniated intervertebral
disc from a 40-year-old male patient. The operation level of the
disc protrusion was L4-L5 (immunostaining as in A; original mag-
nification ×241). C TGF-β-II immunopositivity (open arrow) in
cytoplasm/cell membrane of disc cell in nucleus pulposus. Rapidly
frozen herniated intervertebral disc from the same patient as in B




Fig.2 A TGF-β-II immunopositive nucleus pulposus disc cell (open
arrow) in a 43-year-old female organ donor (control disc). The
disc level was L2-L3 (immunostaining as in Fig.1A; original mag-
nification ×241). B Immunostaining control. Antigen preabsorp-
tion for TGF-β-II. Note the pale nuclei of nucleus pulposus disc





Comparison between prefixed and section-fixed samples
did not show differences in immunoreactivity.
Control discs showed fewer TGF-β and TGF-β recep-
tor immunopositive disc cells than the disc herniations
(Table 2). When comparing the two groups by the Mann-
Whitney test, significant differences (P<0.0001) were ob-
served for all the three antibodies. A significant correla-
tion (Spearman’s ρ=0.89, P<0.002) between TGF-β-I im-
munopositivity and TGF-β receptor type II immunoposi-
tivity in herniated disc samples was also noted. The corre-
lation between TGF-β-II and TGF-β receptor type II re-
mained at a non-significant level (ρ=0.45, P>0.05).
Discussion
TGF-β stimulates extracellular matrix component forma-
tion and regulates cellular growth and extracellular prote-
olysis [3, 9, 11, 19, 21]. It participates in angiogenesis and
in the early phase of inflammation [13, 18, 21]. Such pro-
teolytic activity has also been observed in herniated disc
tissue [17]. Thus TGF-β may be important in mechanisms
of disc tissue ageing and repair, which are presently in-
completely understood. New blood vessel formation (i.e.,
neovascularization), inflammation and the regulation of
cellular growth and extracellular matrix (e.g. proteogly-
can) formation and breakdown are all major processes in
tissue healing and/or degradation.
TGF-β may participate in the regulation of extracellu-
lar proteolysis [11, 17, 28] in disc herniation tissue. This
extracellular proteolysis and the suggested possible role in
the regulation of matrix production may be important for
the mechanisms of disappearance of prolapsed disc mate-
rial with time [14, 22].
Yasuma and co-workers have recently noted angiogen-
esis to be a sign of ageing in disc tissue [29]. Whereas
normally blood vessels are known to be sparse in disc tis-
sue, in disc herniation tissue, the expression of growth
factors, e.g., fibroblast growth factor (FGF) [25] and
TGF-β, in small capillaries is suggestive of an ongoing
active neovascularization process. Furthermore, such a
neovascularization process is supported by the expression
of platelet-derived growth factor (PDGF) and vascular en-
dothelial growth factor (VEGF) [26].
Conclusions
The marked statistical difference between immuno-
reactivity for TGF-β and its receptor type II in herniated
intervertebral disc tissue as compared with control discs
(Table 2) shows that this particular growth factor is acti-
vated. Furthermore, a statistical difference in TGF-β re-
ceptor type II immunoreactivity suggests receptor induc-
tion in disc herniation tissue, as compared with control
disc tissue. We surmise that the increased immunopositiv-
ity in herniated disc is due to local production and that the
increased immunopositivity for the TGF-β receptor will
provide an increased number of binding sites for TGF-β,
increasing the action of TGF-β on disc cells.
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Introduction
Proto-oncogenes encode proteins with three main sites of
action: the cell-surface membrane, the cytoplasm and the
nucleus [2]. The Jun oncogene is expressed as a 65-kd
protein [5]. It was first detected in cancer research [4],
which explains why it is called an “oncogene”. It is a
member of the early activating protein (AP-1) family of
transcription factors, which mediate the regulation of gene
expression in response to extracellular signaling [3]. For
example, stimulation of quiescent murine fibroblasts by
growth factors and by phorbol esters results in a rapid and
transient transcriptional activation of proto-oncogenes [7].
Abstract The oncoproteins c-Fos
and c-Jun create a transcriptional site
early response activating protein
(AP-1) mediating the regulation of
gene expression in response to extra-
cellular signalling by, for example,
cytokines. These proteins are impor-
tant in the signalling pathway from
the cell membrane to the nucleus.
Previously, oncoproteins have been
located in articular synovium and in
chondrocytes, participating in tran-
scription. There is, however, no such
study of intervertebral disc tissue. In
disc degeneration and after hernia-
tion, cell proliferation markers have
been demonstrated. In the present
study we visualize the AP-1 tran-
scriptional site factors c-Fos and c-Jun
in 38 human herniated intervertebral
disc tissue samples by immunohisto-
chemical staining with monoclonal
antibodies. No immunoreactivity
could be observed in control disc tis-
sue, indicating that after herniation,
disc cells are entering from the rest-
ing stage to the cell cycle. Further-
more, c-Jun immunoreactivity was
also observed in disc cell clusters,
thus demonstrating them to be active
transcriptional sites in disc tissue. 
c-Fos immunoreactivity was seen in
15/38 and c-Jun in 28/38 herniated
discs (39% and 74% respectively).
Immunopositive groups of disc cells
were noted in 7/28 (25%) of the on-
coprotein-immunopositive samples.
We did not see any difference in im-
munoreactivity between female and
male patients. Furthermore, we did
not notice any statistical difference
regarding the immunoreaction for
proto-oncogenes c-Fos and c-Jun in
extrusions, sequesters and protrusions.
Nor did immunostaining show any
significant relationship with preoper-
ative pain duration. We concluded
that, in herniated disc tissue, the on-
coproteins c-Fos and c-Jun are acti-
vated in disc cells and cell clusters.
In the future, learning more about
this transcriptional signal pathway
may result in new specific treatments
for intervertebral disc pathology.
Keywords Oncogene proteins · 
c-Fos protein · c-Jun protein · Disc
herniation
ORIGINAL ARTICLE








Oncoprotein c-Fos and c-Jun 
immunopositive cells and cell clusters 
in herniated intervertebral disc tissue
Received: 1 November 2000
Revised: 9 October 2001
Accepted: 21 December 2001
Published online: 19 March 2002
© Springer-Verlag 2002
J. Tolonen · M. Grönblad (✉) · J. Virri ·
E. Karaharju
Research Laboratory, Spine Research Unit,
Department of Orthopaedics and
Traumatology,






Department of Physical Medicine 
and Rehabilitation, 
Helsinki University Central Hospital, 
P. O. Box 340, 00029 HUS, Helsinki, 
Finland
S. Seitsalo
Orton Hospital, Helsinki, Finland
T. Rytömaa
Finnish Centre for Radiation 
and Nuclear Safety, 
Helsinki, Finland
Furthermore, transient inhibition of protein synthesis in-
duces expression of proto-oncogenes and stimulates rest-
ing cells to enter the cell cycle [18].
The proto-oncogene products c-Fos and c-Jun connect
or heterodimerize through their leucine zippers to form
the AP-1 transcription factor [15]. The transcriptional ac-
tivity of the heterodimer is regulated by signal-dependent
phosphorylation and dephosphorylation events.
In human chondrocytes, c-Fos and c-Jun genes are ex-
pressed both in normal and osteoarthritic articular carti-
lage [26]. Osaki et al. have demonstrated that in rat chon-
drocytes the cell growth inductive and the mitogenic ef-
fect of transforming growth factor β1 (TGF-β1) are medi-
ated by the c-Fos gene [13]. In an experimental osteoarthri-
tis (OA) model, oncoproteins were detected predominantly
in the synovial lining cells [16], whereas in normal syno-
vial lining cells such reactivity was low. Furthermore, in
OA cartilage chondrocytes at the superficial and middle
layers were found to participate in the synthesis of onco-
proteins [16].
Overexpression of the c-Fos proto-oncogene has re-
cently been shown to inhibit chondrocyte differentiation
[21]. Interestingly, however, the rates of proliferation and
apoptosis were unaffected. Nodule formation was inhib-
ited if induction of c-Fos was only at early stages of differ-
entiation [21].
The level of expression of c-Jun is lower in maturing
or hypertrophic chondrocytes than in proliferating chon-
drocytes [9]. This suggests that the c-Jun family negatively
regulates the maturation process of chondrocytes.
Activation of AP-1, a heterodimeric complex of Fos
and Jun proteins, is required for chondrocyte matrix me-
talloproteinase production and cell proliferation [10]. Cy-
tokines and growth factors induce reactive oxygen species
production, which is a signal pathway for activation of
AP-1. In herniated disc tissue, matrix metalloproteinase
activity is prevalent [17], and there is a change in the bal-
ance between degradative enzymes and endogenous in-
hibitors.
Clusters of disc cells have been observed in degener-
ated intervertebral disc tissue [8]. Earlier studies have re-
ported similar clusters of chondrocytes in osteoarthritic car-
tilage, where they have been linked to a possible produc-
tion of extracellular matrix components involved in ma-
trix repair [8]. In intervertebral disc tissue, such clusters
could perhaps participate in the repair of tissue damage,
but very little is so far known about such clusters of disc
cells.
We analyzed the transcription promoters c-Fos and 
c-Jun in herniated disc tissue in order to locate potential
cell transcription and cell activation, thereby identifying
possible differences in oncoprotein expression between
normal and herniated disc tissue. Previously there has been
no research concerning oncoprotein expression in inter-
vertebral disc tissue. These proteins are essential in the
signal pathway from the cell membrane to the nucleus.
Further knowledge regarding this signal pathway may
bring forth new specific treatments for disc pathology.
Materials and methods
We analyzed tissue material from 38 discectomy operations. As a
normal control we used nucleus pulposus material from a disc tis-
sue bank (–70°C) of four organ donors, none of whom had any his-
tory of low back pain. The control tissue was obtained by an ante-
rior approach. A detailed description of the clinical data of the disc
tissue material from the herniated discs and normal controls is given
in Table 1. The preoperative pain duration was reported by the pa-
tients in a routine low-back pain patient questionnaire, including
items on preoperative radicular pain duration, a pain drawing, the
Oswestry Disability Index and patient demographics.
After removal, tissue material was immediately frozen to –70°C
in the operating theater, and 8-µ-thick cryostat sections were fixed
in ice-cold acetone. Immunoreactions were detected using an avidin
biotin complex- (ABC-) peroxidase staining kit (Vectastain Elite,
Vector Laboratories, Burlingame, Calif., USA). Hematoxylin was
used for counterstaining.
We used monoclonal c-Fos and c-Jun antibodies (Santa Cruz
Biotechnology, Inc., Santa Cruz, Calif., USA), both at the dilution
1:50. As a positive control we used rheumatoid arthritic synovia
and human dermal skin samples. As a method control for mono-
clonal immunostaining, we also stained sections omitting the pri-
mary antibody. We also did immunostaining as above following
preabsorption of the two monoclonal antibodies with the corre-
sponding antigen at 1:10.
Three sections from each disc specimen were stained with both
antibodies. The presence or absence of immunostaining was com-
pared with clinical data (age, gender, preoperative pain duration
and prolapse type).
Statistical analyses were done using the SOLO statistical soft-
ware program (BMDP, Los Angeles, Calif., USA). Groups were
compared using either chi-square analyses or Fisher’s exact test, as
applicable. Level of statistical significance was set at P<0.05.
Table 1 Clinical data of 38 herniated disc samples from discectomy operation and five normal controls (DHT disc herniation tissue,
DNT normal disc control tissue, S sequestera, E extrusionb, P protrusionc)
Tissue type Sex(M/F) Prolapse type Radicular pain Age (years)
DHT (n=38) 22/16 S=12, E=24, P=2 3wks–36mths; mean=6.9mths 20–74; mean 41.6
DNT (n=4) 3/1 31–53; mean 43
a Protrusion is an abnormal bulging of the annulus fibrosus, which remains continuous
b Extrusion is where tissue is exposed to the epidural space, but remains continuous
c Sequester is free disc tissue material in epidural space [20]
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Fig.1 a Control disc from a 13-year-old female organ donor. Mono-
clonal c-Fos oncoprotein antibody at dilution 1:50 using the avidin-
biotin complex- (ABC-) immunostaining method, with hematoxylin
counterstaining (original magnification ×370). Note the lack of im-
munoreactivity (open arrows) b Oncoprotein c-Fos immunoposi-
tive disc cells (open arrows) in an extruded disc herniation sample
from a 39-year-old male patient (ABC-immunostaining, hematoxylin
counterstaining, original magnification ×370). c Higher magnifica-
tion of the oncoprotein c-Fos immunopositive cells (open arrows)
seen in b. Observe the perinuclear location of the immunoreaction
(ABC-immunostaining, hematoxylin counterstaining, original mag-
nification ×550)
Fig.2 a The same control disc as in Fig.1a, now stained with onco-
protein c-Jun monoclonal antibody at dilution 1:50 (ABC-immuno-
staining method, hematoxylin counterstaining, original magnification
×250). Note the total lack of immunoreactivity. Pale hematoxylin
counterstained nuclei can be seen (open arrows). b Oncoprotein
c-Jun immunopositive disc cell groups (conglomerates) (open ar-
rows) in an extruded disc herniation sample from a 45-year-old fe-
male patient (monoclonal antibody at dilution 1:50, ABC-immuno-
staining method, hematoxylin counterstaining, original magnifica-
tion ×370). c Higher magnification of the c-Jun immunopositive
cells (open arrows) seen in b. Observe the nuclear location of the
immunoreaction (ABC-immunostaining, hematoxylin counterstain-
ing, original magnification ×550)
Results
The clinical data of herniated discs are shown in Table 1.
Herniated disc tissue samples were classified by the oper-
ating surgeon as previously described [20, 22]. Control
discs showed a normal morphology macroscopically; no
signs of autolysis were observed, i.e. all disc cells looked
intact. All control discs were immunonegative for both 
c-Fos and c-Jun (Fig.1a, Fig.2b). Rheumatoid arthritic
synovia and dermal samples, studied as positive controls,
showed c-Fos and c-Jun immunopositive cells. Sections
stained omitting the primary antibody did not show any
immunoreaction for either of the oncoproteins. Neither
did sections preabsorbed with the corresponding antigen.
Oncoprotein c-Fos immunoreaction was noted in 15/38
herniated samples (39%) (Fig.1b,c) and for c-Jun in 28/38
(74%) (Fig.2b,c; Table 2). For each of these disc samples
studied, when immunopositivity was detected, it was ob-
served in all three sections cut through the respective
specimen. When a disc sample was immunonegative, none
of the three sections studied showed any immunoreactiv-
ity. Immunopositive clusters of disc cells (conglomerates,
i.e., ≥3 cells) were seen in 25% of the total immunopos-
itive samples (7/28) (Table 2). The immunoreaction in
these clusters of disc cells was mainly of the c-Jun type
(Fig.2b,c).
None of the studied herniated discs showed immunore-
activity only to c-Fos. Immunoreactivity only to c-Jun was
detected in 13 disc herniation samples and reactivity to
both oncoproteins in 15 disc herniation samples (Table 2).
Twenty-three of the herniated samples were from men
and 15 from women. The age of the patients varied from
20 to 74 years (mean 41.6 years). Twenty-four of the her-





antibodies at dilution 1:50) for
oncoproteins c-Fos and c-Jun.
Samples are arranged accord-
ing to prolapse type [Co Im-
munoreactivity in disc cell con-
glomerates (groups of cells)]
No. Sex Pain duration Prolapse Operation Staining result 
(age, years) (M/F) (months) type level c-Fos/c-Jun
1 (63) F 4 P L3/4 –/+
2 (40) M 36 P L4/5 –/+
3 (74) M 3 E L3/4 –/+
4 (39) M 2.5 E L3/4 +/+(Co)
5 (34) M 1.75 E L4/5 +/+
6 (55) F 3 E L2/3 –/–
7 (40) M 2.5 E L5/S1 +/+
8 (58) M 2.5 E L4/5 +/+
9 (61) M 3 E L5/S1 –/–
10 (20) M 3 E L5/S1 –/+
11 (44) M 12 E L4/5 –/+(Co)
12 (34) M 30 E L4/5 +/+
13 (36) F 6 E L5/S1 –/+(Co)
14 (45) F 6 E L5/S1 –/–
15 (49) F 5 E L4/5 –/+
16 (41) F 3.5 E L4/5 +/+
17 (43) M 4 E L4/5 +/+(Co)
18 (39) F 9 E L4/5 +/+
19 (34) M 5 E L4/5 +/+
20 (47) F 3.5 E L4/5 –/+(Co)
21 (33) F 12 E L5/S1 +/+
22 (29) M 7 E L3/4 –/+
23 (61) M 4 E L5/S1 –/–
24 (23) F 6 E L5/S1 –/–
25 (52) M 3 S L4/5 –/+(Co)
26 (33) F 2 S L5/S1 +/+
27 (33) F 0.75 S L4/5 –/–
28 (32) M 2.5 S L5/S1 +/+
29 (34) F 3 S L5/S1 –/+
30 (55) M 2 S L4/5 –/+
31 (34) F 13 S L4/5 –/–
32 (38) M 24 S L5/S1 +/+
33 (25) M 3.5 S L5/S1 –/–
34 (26) M 5 S L4/5 –/–
35 (43) M 6 S L4/5 –/–
36 (43) M 6 S L4/5 –/+(Co)
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niation samples were extruded, 12 sequestrated and 2 pro-
truded. Detailed immunoreaction in different subgroups is
shown in Table 3 and Table 4.
We did not note any gender-related differences in the
immunoreactivity. Nor were there any statistically signifi-
cant differences regarding proto-oncogene immunoreac-
tions in extrusions compared to sequestrations (Table 3).
The total number of protrusions (n=2) was too small to
make any statistical analysis.
Comparing the pain duration before operation, there
were no statistically significant differences between the
acute/subacute and chronic group regarding the immunore-
action for the proto-oncogenes c-Fos and c-Jun (Table 4).
Nor did the presence of immunoreaction in cell groups
(conglomerates) show any statistical difference between
these two groups (Table 4).
Discussion
Nuclear oncoproteins c-Fos and c-Jun (or its related pro-
teins JunB or JunD) represent the transcription factor AP-1
(activating protein-1), and they may act as an intracellular
messenger converting short-term signals generated by ex-
tracellular stimulators into long-term changes in cell phe-
notype. This is done by regulating the expression of down-
stream genes that possess an AP-1 binding site [1].
The importance of AP-1 transcription factors in chon-
drocyte differentiation has been highlighted in an in vitro
study by Thomas et al. [21]. In particular, their study found
that the induction of c-Fos resulted in a concomitant in-
crease in the expression of fra-1 and c-Jun. Furthermore,
the overexpression of c-Fos was found to directly inhibit
chondrocyte differentiation.
It has previously been shown that the growth-stimula-
tive effect of transforming growth factor β1 in chondro-
cytes is mediated by the activation of the oncoprotein 
c-fos gene [13]. This is mediated by protein kinase activa-
tion [25]. In the present study, we show the expression of
the oncoproteins c-Fos and c-Jun in herniated disc tissue.
We have previously reported expression of TGF-β and in-
duction of TGF-β receptor in these same tissues [23]. This
may suggest that the proliferative effect of TGF-β is at
least partly mediated by these oncoproteins in herniated
disc tissue as well.
In rheumatoid cartilage, the matrix metalloproteinase-1
(MMP-1) promoter is demonstrated to be activated by
Jun-related proteins as well as Fos/Jun-related protein het-
erocomplex [24]. Furthermore, c-Fos combined with any
of the Jun-related proteins failed to stimulate the tissue
inhibitor of metalloproteinases-1 (TIMP-1) promoter, al-
though it was activated by Jun-related protein heterocom-
plexes [24]. In the present study, we did not see c-Fos im-
munopositivity alone (Table 2), whereas c-Jun immunore-
activity was noted as well as the immunoreactivity to both
oncoproteins (Table 2). This may suggest that the proteo-
lytic activity is controlled by the expression of the c-Fos
and c-Jun oncoproteins in herniated disc tissue as well.
Interestingly, the oncoprotein expression in disc cell
clusters was mainly of the c-Jun type. This may indicate
that in disc cell clusters c-Jun may be more important than
c-Fos. Turnover of the matrix components is established
with an intricate balance between synthesis and degrada-
tion of the associated molecules, such as MMP and TIMP.
c-Fos has been demonstrated to be degradative [24],
whereas Jun-related proteins stimulate both MMP and
TIMP [24]. This may indicate that disc cell clusters par-
ticipate in the turnover of extracellular matrix components.
Marked degradative enzyme activity in disc tissue after
disc herniation has been noted previously [12]. Further-
more, disc tissue has a tendency to decrease in size after
herniation [11, 19]. Matrix metalloproteinase activation in
herniated disc tissue has previously been shown [17].
There was a change in the balance between degradative
enzymes (MMPs) and endogenous inhibitors (TIMPs) [17].
Regulation of this balance could be partly mediated by
AP-1 protein in disc tissue as well.
The duration of pain before operation had no signifi-
cant association with the expression of oncoproteins. The
results did not show any statistical difference between
acute/subacute and chronic herniations.
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Table 3 Immunohistochemical staining results for oncoproteins




Males (n=23) 10/23 18/23 5/18
Females (n=15) 5/15 10/15 2/10
Extrusions (n=24) 12/24 19/24 5/19
Sequesters (n=12) 3/12 7/12 2/7
Protrusions (n=2) 0/2 2/2 0/2
*Group differences nonsignificant (Fisher exact/Chi-square tests,
as applicable)
a Number of samples with c-Jun immunoreactive disc cell groups
of all samples with c-Jun immunoreactivity
Table 4 The relationship of immunoreactivity for oncoproteins 
c-Fos and c-Jun with pain duration before the disc herniation oper-
ation. In the acute/subacute group pain duration was ≤3 months, in
the chronic group pain duration was >3 months
Groups Immunoreactivity*
c-Fos c-Jun Conglomeratesa
Acute/subacute group (n=14) 6/14 11/14 2/11
Chronic group (n=24) 9/24 17/24 5/17
*Group differences were nonsignificant (Fisher exact/Chi-square
tests, as applicable)
a Number of samples with c-Jun immunoreactive disc cell groups
of all c-Jun immunoreactive samples
Previously it has been shown by Paajanen and co-
workers that the proliferation potential drops in recurrent
herniations [14]. That study did not show any correlation
between proliferative disc cells and the degree of disc de-
generation on magnetic resonance imaging.
The formation of clusters of disc cells is associated
with degenerative disc disease [8]. These clusters may
produce certain extracellular matrix components and they
may also function to repair damaged tissue. The pattern of
proliferation cell nuclear antigen (PCNA) and prolifera-
tion-associated antigen Ki-67 positivity in degenerated disc
tissue samples suggests that disc cell clusters arise through
increased cell proliferation [8]. Furthermore, colony for-
mation in vitro by annular intervertebral disc cells from
patients with degenerative disc disease and young controls
has previously been demonstrated [6].
Conclusions
Taken together, our findings of oncoprotein c-Fos and 
c-Jun expression in disc cells and cell clusters may indi-
cate that disc cells respond to disc herniation. This might
mean that disc cells participate in a reaction cascade,
where they are actively in contact with the surrounding
tissue. This also implies that more information about disc
cells will be required before we can better understand
mechanisms of disc degeneration and herniation, and the
tissue remodelling that follows upon a disc herniation.
Furthermore, in the future, we believe that disc cell re-
search regarding the signal pathway from the cell mem-
brane to the nucleus will provide more information on
how disc cells function in different stages of the cell cycle,
and in different pathological conditions. Pathological con-
ditions of interest include disc degeneration and disc her-
niation. This may provide us with new types of treatment,
e.g., gene therapy or perhaps blockage of the signal path-
way.
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Abstract Degenerated intervertebral
disc has lost its normal architecture,
and there are changes both in the
nuclear and annular parts of the disc.
Changes in cell shape, especially in
the annulus fibrosus, have been re-
ported. During degeneration the cells
become more rounded, chondrocyte-
like, whereas in the normal condition
annular cells are more spindle
shaped. These chondrocyte-like cells,
often forming clusters, affect extra-
cellular matrix turnover. In previous
studies transforming growth factor b
(TGFb) )1 and )2, basic fibroblast
growth factor (bFGF) and platelet-
derived growth factor (PDGF) have
been highlighted in herniated inter-
vertebral disc tissue. In the present
study the same growth factors are
analysed immunohistochemically in
degenerated intervertebral disc tissue.
Disc material was obtained from 16
discs operated for painful degenera-
tive disc disease. Discs were classified
according to the Dallas Discogram
Description. Different disc regions
were analysed in parallel. As normal
control disc tissuematerial from eight
organ donors was used. Polyclonal
antibodies against different growth
factors and TGFb receptor type II
were used, and the immunoreaction
was detected by the avidin biotin
complex method. All studied
degenerated discs showed immuno-
reactivity for TGFb receptor type II
and bFGF. Fifteen of 16 discs were
immunopositive for TGFb-1 and )2,
respectively, and none showed im-
munoreaction for PDGF. Immu-
nopositivity was located in blood
vessels and in disc cells. In the nucleus
pulposus the immunoreaction was
located almost exclusively in chon-
drocyte-like disc cells, whereas in the
annular region this reaction was ei-
ther in chondrocyte-like disc cells,
often forming clusters, or in fibro-
blast-like disc cells. Chondrocyte-like
disc cells were especially prevalent in
the posterior disrupted area. In the
anterior area of the annulus fibrosus
the distribution was more even
between these two cell types. bFGF
was expressed in the anterior annulus
fibrosus more often in chondrocyte-
like disc cells than in fibroblast-like
disc cells. Control discs showed cel-
lular immunopositivity for only
TGFb-1 and )2 and TGFb receptor
type II . We suggest that growth
factors create a cascade in interver-
tebral disc tissue, where they act and
participate in cellular remodelling
from the normal resting stage via disc
degeneration to disc herniation.
Keywords Intervertebral disc Æ
TGF-b Æ FGF Æ PDGF
Eur Spine J (2006) 15: 588–596
DOI 10.1007/s00586-005-0930-6 ORIGINAL ARTICLE
J. Tolonen Æ M. Grönblad
J. Virri Æ E. O. Karaharju
Spine Research Unit, Department of
Orthopaedics and Traumatology
and Department of Physical Medicine
and Rehabilitation, University of Helsinki,
Helsinki, Finland
R. D. Guyer
Texas Back Institute Research Foundation,
Plano, TX, USA
T. Rytömaa
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Intervertebral disc degeneration is a complex process
characterised by biochemical and structural changes in
both the nucleus pulposus and annulus fibrosus. The
distinction between normal ageing and degeneration is
important, but difficult to distinguish either morpho-
logically or biomechanically. Different types of annular
defects and tears, rim lesions, concentric tears and
radiating clefts, can be observed in conjunction with the
disc degeneration process [3].
To image degenerated discs, discography and mag-
netic resonance imaging (MRI) have been used. In some
comparative studies MRI seemed to be more accurate [4,
21]. On the other hand MRI signal intensity depends
strongly on the water content of the disc tissue sample
[30] and thus the early stages of degeneration which do
not affect the water content may not be detected by MRI
[30].
Discography offers a sensitive evaluation of disc
morphology and provides, compared to MRI, addi-
tional information about intradiscal pressure condition
and pain provocation [3].
The relationship between intradiscal pressure and
the morphological patterns in discography was first
observed by Nachemson [11]. During discography
typical pain reproduction has been noticed to associate
with annular tears extending to the outer annulus [16].
None of the discograms showing normal morphology
reproduced the patients’ typical pain [16].
Type-I collagen has been abundantly located as a
ring in the outer zone and in the outer lamellas of the
inner zone of the annulus fibrosus [22]. Type-II colla-
gen was present in the inner annulus, but not in the
outer zone. In degenerated annulus fibrosus collagen
biosynthesis has been noticed to be increased, but due
to the faster turnover the total content of collagen re-
mained unchanged [8]. The reinsertion of stimulated
nucleus pulposus cells in an experimental animal model
retarded disc degeneration [15]. It delayed the forma-
tion of cell clusters of chondrocyte-like cells, the
destruction of disc architecture, and production of
type-II collagen. Oegema et al have noted that in
degenerated discs fibronectin content was elevated
suggesting disc cell response to altered environment
[14]. Fibronectin was frequently present as fragments
capable of stimulating cells to produce metallopro-
teases and cytokines [14].
Growth factors are proteins regulating cell growth
and the turnover of extracellular matrix components.
We have previously demonstrated basic fibroblast
growth factor (bFGF), platelet-derived growth factor
(PDGF), vascular endothelial growth factor (VEGF)
and transforming growth factorb-1 and )2 and their
receptor type II in human herniated intervertebral disc
tissue [26–28]. In the present study we have focused on
these same growth factors targeting disc degeneration in
the absence of herniation.
Materials and methods
We obtained 16 discs from 12 patients operated for
painful degenerative disc disease at the Texas Back
Institute in Plano, TX, USA. The patients had under-
gone previous spine operations, mainly posterior fu-
sions. The disc samples were convenience samples and
the location of the sample within the disc prior to re-
moval was judged clinically by the operating surgeon.
Patients were operated by anterior fusion. Preoperative
evaluation of degeneration, pain and possible annular
tears were classified by the Dallas Discogram Descrip-
tion [20]. After removal, tissue representing different disc
regions was immediately frozen in liquid nitrogen in the
operating theatre. Anterior annulus fibrosus, nucleus
pulposus and posterior annulus fibrosus were stored at
)70C in a deep-freeze. Eight micrometer-thick cryostat
sections were fixed in ice-cold acetone. Eight normal
control discs were obtained from five organ donors.
Morphologically, all control discs lacked signs of
degeneration, such as fissures and annulus fibrosus and
nucleus pulposus could clearly be distinguished with well
demarcated annular lamellae, corresponding to
Thompson grades I and II [24]. The samples were col-
lected 1 h post-mortem in various hospitals in Finland.
In all cases the cause of death was unrelated to the spine.
The control disc material was treated identically to the
surgical samples. From frozen discs representative
samples of various disc regions (anterior/posterior
annulus fibrosus, nucleus pulposus) were cut with an
electric saw. The control disc samples were then stored
and processed further as described above.
All immunoreactions were detected using an avidin
biotin complex-(ABC-) peroxidase staining method
(Vectastain Elite, Vector Laboratories, Burlingame, CA,
USA). As chromogen substrate we used AEC (immu-
noreaction shown in red). Tissue sections were count-
erstained by haematoxylin.
Antibodies
Polyclonal anti-human TGF-b-1, TGF-b-2 and TGF-b
receptor type II antibodies (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA) were used at the dilutions
1:200,1:50 and 1:100 respectively. Polyclonal bovine
bFGF antibody (R & D Systems Inc., Minneapolis,
MN, USA) was used at the dilution 1:500 and poly-
clonal PDGF antibody (R & D Systems Inc) was used at
the dilution 1:100. For all antibodies (TGFb-1, )2,
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TGFb receptor type II, PDGF and bFGF) preincuba-
tion with the corresponding antigen (1:10) was done [26–
28]. Sections were also stained omitting the primary
antibody.
Samples were classified as being immunopositive if
more than 20 immunopositive cells were noted. If only a
few scattered immunopositive cells were found the total
disc sample was classified as being immunonegative, as
well as if there was a total lack of immunoreaction. All
samples were independently examined blinded to their
origin by two observers.
Statistical analysis
Statistical analysis was done using the Sigma Stat Ver-
sion 1.0 (Jandel Scientific GmbH, Erlerath, Germany)
software program. Groups were compared using the
Fisher exact test. The level of statistical significance was
set at P<0.05.
Results
Clinical data of the patients are described in Table 1.
The age of the patients varied from 29 years to
63 years (mean 44.8 years). According to the Dallas
Discogram Description the degree of degeneration was
3 in five discs and 2 in seven discs. In one disc the
degree of degeneration was 1. Discography data were
missing in three discs. The age of the control donors
varied from 28 years to 53 years (mean 43 years;
Table 2).
Immunopositivity of TGFb )1 and )2 was detected
in 15 of 16 degenerated discs, whereas TGFb receptor
type-II immunopositivity was noted in all degenerated
discs. All degenerated discs showed positive immunore-
action for bFGF, but somewhat surprisingly none of the
degenerated discs were PDGF immunopositive
(Fig. 1a).
Immunoreaction was present either in fibroblast-like
disc cells, mainly seen in the annular area of the discs, or
in chondrocyte-like disc cells (Fig. 1b, c), scattered more
evenly throughout the discs. Chondrocyte-like disc cells
were especially present in the nucleus pulposus. Fibro-
blast-like disc cells were spindle-shaped, often forming
lines, whereas chondrocyte-like disc cells were more
rounded, often forming cell clusters (Fig. 1c). Immuno-
positive (TGFb-1 and )2, and TGFb receptor type II
and bFGF) blood vessels were also detected.
Detailed results of the studied degenerative disc
samples are presented in Tables 3 and 4. Control discs
appeared normal according to conventional histological
staining. Furthermore, control discs did not show any
immunoreactivity for PDGF or bFGF. TGFb-I, -II and
TGFb receptor type II immunoreactivity was, however,
noted .
Sections that were stained omitting the primary
antibody did not show any immunopositivity. Antigen-
preabsorbed immunoreactions were also totally nega-
tive.
As can be deduced from Table 4, in the anterior
annulus the prevalence of bFGF immunopositivity in




[20] Deg Degree of disc degen-
eration (scale: 0–3), Leak degree
of disc rupture (scale: 0–4), Pain
provocation of pain (D dissim-
ilar pain, S similar pain, R pain
reproduction)
Patient Gender Age DDD grade Level Discography result
1. M 40 Deg 2Leak 4Pain R L4–5 Posterior rupture
2. F 29 Deg 3Leak 3Pain R L5-S1 Both anterior and
posterior rupture
3. M 63 - L2–3 Data missing
4. M 44 Deg 2Leak 2Pain D L4–5 Anterior rupture
5. F 31 Deg 2Leak 3Pain R L5-S1 Posterior rupture
Deg 2Leak 3Pain S L4–5 Posterior rupture
6. M 60 Deg 2Leak 4Pain S L5-S1 Posterior rupture
Deg 2Leak 3Pain D L4-L5 Posterior rupture
7. M 42 Deg 3Leak 3Pain L5-S1 Data missing
Deg 2Leak 3Pain L4-L5 Posterior rupture
8. F 47 Deg 3Leak 3Pain L5-S1 Posterior rupture
9. M 44 – L4-L5 Posterolateral
rupture
10. F 64 – L3-L4 Data missing
11. F 33 Deg 1Leak 4Pain S L4-L5 Posterior rupture
12 M 41 Deg 3Leak 3Pain S L3–4 Posterior rupture
Deg 3Leak 3Pain S L4-L5 Totally fissured
Table 2 Clinical data of control disc patients (organ donors)
Patient Gender Age Disc level
1. F 53 L3–4
2. M 45 L1–2
3. M 45 L3–4
4. F 41 L3–4
5. F 31 L2–3
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chondrocyte-like disc cells was particularly high (present
in 85,7% of samples). In the posterior annulus fibrosus
and nucleus pulposus all growth factors, with the
exception of PDGF which was totally absent from all
degenerated discs, were highly prevalent in chondrocyte-
like disc cells (present in 53.3–100% of samples). The
prevalence of growth factor immunopositivity in
fibroblast-like disc cells was lower (present in 0–50% of
samples), with the highest prevalence in anterior annulus
(present in 31.5–50% of samples).
Statistical differences in immunoreactivity with re-
spect to disc region and disc cell type are shown in Ta-
ble 5. In the nucleus pulposus immunopositivity was
almost exclusively located in chondrocyte-like disc cells.
In the posterior annulus fibrosus, which was often dis-
rupted, statistically significant immunopositivity in
chondrocyte-like disc cells was noted for bFGF, TGFb
)2 and TGFb receptor type II (P=0.0169, P=0.0025
and P=0.0183 respectively). Furthermore, bFGF and
TGFb-2 immunopositivity was more often located in
chondrocyte-like disc cells than in fibroblast-like disc
cells (P=0.0001 and P=0.0092 respectively). In the
anterior annulus fibrosus only for growth factor bFGF
(P=0.0063) immunopositivity in chondrocyte-like disc
cells predominated. Furthermore, only in the anterior
annulus fibrosus bFGF immunopositivy in chondrocyte-
like disc cells was detected more often than such
immunoreactivity for TGFb-1 and )2. In addition, only
in the anterior annulus fibrosus TGFb receptor type II
was located both in chondrocyte-like and fibroblast-like
disc cells (Table 5).
Discussion
Degenerated disc has lost its normal architecture. The
shape of the annulus cells changes markedly with
degeneration: a healthy disc contains spindle-shaped
cells, whereas in degenerated discs cells are more
rounded and are surrounded by unusual accumulations
of extracellular matrix components [6, 18]. In the
present study growth factor immunopositivity was no-
ted in spindle shaped (fibroblast-like) as well as roun-
ded (chondrocyte-like) disc cells. With respect to
different areas of the disc, immunopositivity in chon-
drocyte-like disc cells was highly prevalent for most
growth factors in the posterior annulus, and particu-
larly in the nucleus pulposus. Compared with the other
Fig. 1 In all figures the ABC-peroxidase immunostaining method
was used. The used AEC chromogen shows the specific immuno-
reaction in red. All the used antibodies were of polyclonal type and
as counterstain we used hematoxylin.a Platelet-derived growth
factor (PDGF) immunostaining in posterior annulus fibrosus from
a 40 year old male patient. Note the total lack of positive
immunoreaction. Arrows mark pale nuclei of disc cells. Original
magnification·370. b Transforming growth factor (TGFb-1)
immunopositive chondrocyte-like disc cells (open arrows) in
anterior annulus fibrosus. The surgical sample was obtained from
a 42-year-old male patient operated for painful degenerative disc
disease. The operation level was L5-S1. Original magnifica-
tion·370. c The TGFb-receptor type II immunopositivity (open
arrows) in cluster of chondrocyte-like posterior annulus fibrosus




growth factors, bFGF immunopositivity was highly
prevalent in chondrocyte-like disc cells particularly in
the anterior annulus. Interestingly, PDGF immunopo-
sitivity was, however, absent from all disc regions.
Thus in degenerated discs, there may be some regional
differences with respect to the expression of growth
factors. Growth factor expression is particularly pre-
valent in the rounded chondrocyte-like disc cells. In the
anterior annulus the prevalence of growth factor im-
munopositivity is somewhat more even between chon-
drocyte-like and fibrocyte-like disc cells. But also in this
region immunopositivity for bFGF was more prevalent
in the chondrocyte-like disc cells. The observed growth
factor immunoreactivity in disc cells suggests that these
cells may be actively regulating extracellular matrix
component turnover.
Discography showed disruption of the intervertebral
discs, especially in the posterior region. The immuno-
reactivity for growth factors was detected throughout
the discs, not only in the disrupted areas. Furthermore,
the fact that immunopositivity was observed more often
in chondrocyte-like, than fibroblast-like, disc cells may
suggest that the former disc cell type is more metaboli-
cally active participating in the cellular remodelling of
disc degeneration. We have in previous studies located
these same growth factors in herniated intervertebral
disc tissue [26–28]. In herniated disc tissue the predom-
inant immunopositive disc cell type was the chondro-
cyte-like disc cell [26–28]. Fibroblast-like disc cell
immunopositivity was rare in herniations. These findings
may suggest a step-by-step change in cell type from
normal disc tissue to pathological processes; i.e. disc
degeneration and disc herniation.
In this study and in our earlier studies on herniated
disc tissue [26–28] TGFb-1, )2 and TGFb receptor type
II were the only growth factors observed in control discs.
Some studies have suggested that this growth factor is
absent in control disc tissue [7, 23]. However, in a recent
biochemical tissue culture study on growth factors and
inflammatory mediators in patients undergoing surgery
for scoliosis, lumbar radiculopathy and discogenic pain,
production of TGFb-1 was demonstrated both in con-
trol (scoliosis) and degenerate human disc tissues [2]. In
the same study Burke et al. [2] demonstrated the pro-
duction of bFGF in control (scoliotic) as well as
degenerated human nucleus pulposus in vitro. However,
in the present immunohistochemical study and in earlier
study by us on herniated disc tissue [26] bFGF could not
be demonstrated in control discs. In a rat animal model
on disc degeneration Nagano et al. [12] could not ob-
serve bFGF in control discs. When comparing the in-
jured annulus fibrosus of merinos to intact ones, bFGF,
TGFb and osteonectin were strongly localized in blood
vessels and cells in the vicinity of annular lesion [9] The
immunohistochemical expression was maximal
12 month after the operation, and diminished by
26 months after the operation. In control discs, the
expression of bFGF and TGFb was localized to sparsely
distributed cells in the annulus fibrosus.
Table 3 Immunostaining results for transforming growth factor
(TGF) b-1 and )2, TGFb receptor type II, basic fibroblast growth
factor (bFGF) and platelet-derived growth factor (PDGF) in
degenerated intervertebral discs studied




1 Ant ann – – DC DC –
Nucleus DC DC DC DC –
Post ann DC DC DC DC –
2 Ant ann F DC DC .. ..
Nucleus F,DC F,DC F,DC .. ..
Post ann F F .. .. ..
3 Ant ann F F F – –
Nucleus DC DC DC DC –
Post ann DC DC F – –
4 Ant ann – – – DC –
Nucleus – – – DC –
Post ann – – F DC –
5 Ant ann – DC – DC –
Nucleus DC DC DC DC –
Post ann DC DC DC DC –
Ant ann – DC DC DC –
Nucleus F DC DC DC –
Post ann F DC DC DC –
6 Ant ann F F F F,DC –
Nucleus F F F F,DC –
Post ann – DC – – –
Ant ann F F F F,DC –
Nucleus DC DC DC DC –




6 Post ann DC F F DC –
7 Ant ann – DC DC – –
Nucleus DC DC DC DC –
Post ann DC DC DC .. –
Ant ann F F F,DC F,DC –
Nucleus DC DC DC DC –
Post ann F,DC F,DC F,DC DC –
8. Ant ann F F F,DC F,DC –
Nucleus DC DC DC DC –
Post ann – DC DC – –
9 Ant ann – F DC DC –
Nucleus DC DC DC DC –
10. Ant ann DC – F .. ..
Nucleus F,DC – DC .. ..
Post ann DC DC DC DC –
11 Ant ann DC DC F DC –
Nucleus DC DC DC DC –
Post ann .. DC – DC –
12. Ant ann DC DC DC DC –
Nucleus DC DC DC DC –
Post ann DC DC DC DC –
Ant ann F F F DC –
Nucleus DC DC DC DC –
Post ann – – DC DC –
DC chondrocyte-like disc cell immunopositivity, F fibroblast-like
disc cell immunopositivity, – no immunoreaction, .. data not
available, Ant ann anterior annulus fibrosus, Post ann posterior
annulus fibrosus, Nucleus nucleus pulposus
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In an experimental animal model the degeneration
process was delayed with the reinsertion of autogenous
activated nucleus pulposus [15]. This activation was
produced by coculturing nucleus pulposus cells with
annulus fibrosus cells. During the coculture both cell
types were proliferating. Furthermore, reinsertion of the
nucleus pulposus delayed especially the formation of
clusters of chondrocyte-like disc cells [15]. Such clusters
were noted in the present study both in the nucleus
pulposus and in annular areas of the degenerated discs.
Furthermore, injection of intact nucleus pulposus has
been demonstrated to be far more effective in delaying
degeneration rather than injection of only nucleus
pulposus cells [13], thus highlighting the importance of
the extracellular matrix. In chondrocyte-like disc cell
clusters marked matrix metalloproteinase activity has
been demonstrated [19]. Interestingly, such enzyme
activity was particularly intense in herniated discs [19].
The presence of growth factors, matrix metalloprotein-
ases and oncoproteins [29] suggests that these particular
disc cells have been activated in pathological conditions
and regulate the turnover of extracellular matrix com-
ponents. In rat degenerated intervertebral discs bFGF
and its receptor were localized in chondrocyte-like
Table 4 Summary of
immunostaining results for
TGF b-1 and )2, TGFb
receptor type II and bFGF in
degenerated intervertebral disc
tissue samples obtained from
various regions of the disc
DC chondrocyte-like disc cell, F
fibroblast-like disc cell
Disc area Growth Location of immunoreaction
DC F No immunoreactivity
Anterior annulus TGFb-1 3/16 7/16 6/16
Posterior annulus 8/15 3/15 4/15
Nucleus 13/16 4/16 1/16
Anterior annulus TGFb-2 6/16 7/16 3/16
Posterior annulus 11/15 2/15 2/15
Nucleus 13/16 2/16 2/16
Anterior annulus TGFb receptor type II 8/16 8/16 1/16
Posterior annulus 9/14 4/14 2/14
Nucleus 14/16 2/16 1/16
Anterior annulus bFGF 12/14 4/14 2/14
Posterior annulus 10/13 0/13 3/13
Nucleus 14/14 1/14 0/14
Table 5 Statistically significant
differences in TGF b-1, )2 and
TGF breceptor type II, and
bFGF immunopositivity in
different disc regions and disc
cell types. (Fisher Exact Test,
the level of statistical
significance p<0.05)
DC chondrocyte-like disc cell, F
fibroblast-like disc cell, bFGF
basic fibroblast growth factor,
TGFb-1 transforming growth
factor b-1, TGFb-2 transform-
ing growth factor b-2, TGFbrec






Anterior annulus fibrosus Cell type
DC bFGF versus TGFb )1 P=0.0007
DC bFGF versus TGFb )2 P=0.0106
DC bFGF versus no immunoreaction P=0.0004
DC TGFbrec versus no immunoreaction P=0.0155
F TGFbrec versus no immunoreaction P=0.0155
Antibody Localization of immunoreaction
bFGF DC versus F P=0.0063
Posterior annulus fibrosus Cell type
DC bFGF versus no immunoreaction P=0.0169
DC TGFb-2 versus no immunoreaction P=0.0025
DC TGFbrec versus no immunoreaction P=0.0183
Antibody Localization of immunoreaction
bFGF DC versus F P=0.0001
TGFb-2 DC versus F P=0.0092
Nucleus pulposus Cell type
DC bFGF versus no immunoreaction P<0.0001
DC TGFb-1 versus no immunoreaction P<0.0001
DC TGFb-2 versus no immunoreaction P=0.0002
DC TGFbrec versus no immunoreaction P<0.0001
Antibody Localization of immunoreaction
bFGF DC versus F P<0.0001
TGFb-1 DC versus F P=0.0038
TGFb-2 DC versus F P<0.0001
TGFbrec DC versus F P<0.0001
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rounded cells, and the proliferation capacity of these
cells exceeded that of normal annular spindle-shaped
cells [12].
Experimental animal models suggest important
functions for the above growth factors in intervertebral
disc physiology and pathophysiology. Minamide et al.
[10] have shown that epidural application of bFGF in
the rabbit facilitates the resorption of the sequestrated
intervertebral disc fragment, and stimulates neovascu-
larization and proliferation of inflammatory cells. This
effect was dose-dependent. In cell cultures, TGFb and
FGF have been demonstrated to be potent cellular
proliferation stimulators [25]. Cells from the nucleus
pulposus and the transition zone reacted more than
annulus fibrosus cells. Furthermore, TGFb was far more
potent than FGF as a stimulator of cellular prolifera-
tion. In addition, TGFb-1 decreased the level of active
matrix metalloproteinase-2 (MMP-2) in nucleus pulpo-
sus cells [17]. Furthermore, the cell surface levels of
metalloproteinase inhibitors also decreased. In another
cell culture study, the presence of TGFb first enhanced
cellular proliferation, later on the mitogenic response
decreased [5]. In addition, TGFb-1 is a potent stimulator
for proteoglycan production by disc cells [1].
Since there was a time gap between discography and
the operation, possible local irritation by the discogra-
phy procedure was not present at the time of operation
when the tissue samples were taken for analysis. Of note,
the growth factor immunoreactivity was detected
throughout the discs, not only in the disrupted posterior
areas.
Earlier we noted marked PDGF immunoreactivity
in herniated disc tissue [27]. This immunoreactivity was
located in blood vessels and cells, both chondrocyte-
like disc cells and fibroblast-like disc cells. In the
present study such disc cell-associated immunoreactiv-
ity was not observed. Furthermore, normal control
discs were totally PDGF immunonegative. This may
suggest that PDGF is latent until the disc becomes
herniated. Characterising the nature of the PDGF
activator, whether another growth factor or some other
substance in the nerve root area, will require further
research. We expect that more information on disc cell
remodelling, production of different proteins that affect
the extracellular matrix and cell proliferation, may be
obtained by focusing future research on signal transfer
mechanisms in disc cells and the gene activation pro-
cess in these cells.
Fig. 2 Expression of growth
factors (bFGF, TGFb-1, )2
and TGFb receptor type II) in
different disc regions. (DC
chondrocyte-like disc cell, F
fibroblast-like disc cell, bFGF





Our results show that growth factors are expressed in
degenerated discs, in a different pattern than in control
discs. Different types of expression were observed in the
various disc areas (Fig. 2). In degenerated interverte-
bral disc tissue chondrocyte-like disc cells in the nu-
cleus pulposus were immunopositive to all other
growth factors except PDGF. In the anterior annulus
fibrosus the most prevalent growth factor present in
chondrocyte-like disc cells was bFGF. TGFb receptor
type II was expressed in both chondrocyte-like and
fibroblast-like disc cells, whereas in the posterior
annulus fibrosus the most prevalent growth factors
expressed in chondrocyte-like disc cells were bFGF and
TGFb-2.
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